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Abstract
This project was undertaken as part of a commercial evaluation of two probiotic 
strains for subsequent use in the European market. Probiotic bacteria are thought to act 
as competitive exclusion agents against food borne pathogens by several mechanisms. 
The aim of the study was to characterise the probiotic strains Lactobacillus salivarius 
59 and Enterococcus faecium PXN-33, determine the safety of the probiotic strains and 
to evaluate the strains ability to competitively exclude Salmonella Enteritidis.
Analysis of the two novel probiotic strains in vitro confirmed their identity by 
biochemical and genetic analyses and demonstrated that neither probiotic strains 
possessed virulence or antibiotic resistance genes. When inoculated into specific 
pathogen free (SPF) White Leghorn Chicks to test for host tolerance, histological 
analysis of the gastro intestinal mucosa indicated that L. salivarius 59 and E. faecium 
PXN-33 were not detrimental towards the host.
Inhibition of Salmonella Enteritidis by the probiotic strains was evaluated in 
vitro using cell free culture supernatant (CFCS) assays and plate diffusion assays. 
Inhibition was observed in both assays. Priming of macrophages with Enterococcus 
faecium and subsequent challenge with Salmonella Enteritidis increased TNF-a and IL- 
6 pro-inflammatory cytokines suggesting Salmonella inhibition was facilitated by 
inununo-modulation.
Following in vitro analysis two in vivo trials were conducted. The first trial 
involved dosing of SPF chicks by oral gavage with the competitive exclusion (CE) 
product as individual or dual preparations followed by subsequent inoculation of the 
birds with Salmonella Enteritidis. A statistically significant reduction of Salmonella 
Enteritidis as determined by direct microbiological enumeration of samples from GI 
tissues and cloacal swabs was observed at day 43 in the dual treatment group compared 
to the control group. In a second study, SPF chicks were dosed with the probiotic 
preparation using four distinct dosing regimes and challenged by in contact sentinel 
birds dosed with S. Enteritidis. Significant reductions in Salmonella colonisation were 
observed in the chicken’s GI tract as compared to control groups.
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Chapter 1 -  Introduction
1.1 Salmonella in poultry: an introduction to the problem
1.1.1 Salmonella and poultry farming: an economic and public health problem
Poultry related products are an important source of cheap protein, which has 
become a billion pound industry in Britain. The total value of United Kingdom (UK) 
meat and meat related products for 2004 was estimated to be worth approximately £8.3 
billion (Table 1.1). The value of poultry meat for the same year was estimated as £1.2 
billion whilst egg production was worth an additional £435 million (Table 1.1). A 
conservative estimate of disease control costs, in the absence of major disease 
outbreaks, is between 10-15% of total production cost. Disease control costs include 
bio-security, disease treatment, loss of produce and disease monitoring. The 
Department for Environment, Food and Rural Affairs (DEFRA) and Scottish Executive 
Environment and Rural Affairs Department (SEERAD) estimate the UK Government’s 
expenditure for the control of Salmonella in commercial avian flocks is approximately 
£1.7 million annually. Additional industry costs of Salmonella control are estimated to 
be a further £6 million annually according to recent figures released by Reading 
University (www.apd.rdg.ac.uk/AgEcon/livestockdisease/index.htm).
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Table 1.1 UK production value for meat products 2004. Net value of commodities from meat and meat 
related products in the UK for 2004 (DEFRA, 2005).
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Members of the Salmonella spp. are Gram negative, non-lactose fermenting, 
bacilli which are typically 2-4pm by 0.5 pm in size. As of 2005 the Salmonella genus 
consists of two species, S. bongori (previously designated as the subspecies obsolete) 
and S. enterica. S. enterica was further sub-divided into six subspecies including 
enterica (which contain the pathogenic species of warm blooded animals), salamae, 
arizonae, diarizona, houtenae and indica (Tindall et al, 2005). Within these subspecies 
over 2500 serovars are known of which less than 100 are of epidemiological 
significance. Salmonella colonisation is endemic within commercial poultry layer and 
meat flocks with Salmonella Enteritidis predominating as the most prevalent serovar. 
Recent studies during a thirteen month period between 2005 and 2006 reported that on 
average 23.7% of broilers raised within the European Union (EU) were positive for 
Salmonella colonisation (EPSA, 2007). Approximately 37% of the birds reported as 
positive were infected with S. Enteritidis (EFSA, 2007). Surveillance studies of 
commercial layer flocks also indicated that 54% of birds were infected with Salmonella 
and that the predominant S. Enteritidis isolates were phage types (PT) 4, 6, 7 and 35 
(Snow et al, 2007).
Infected poultry may present symptoms including pyrexia, scours, abortion, 
blood poisoning, general malaise, impotence and increased mortality. Presentation of 
illness from S. Enteritidis in poultry is dependent upon the age of infection and also the 
S. Enteritidis strain type. Poppe et al (1993) showed that a UK S. Enteritidis PT4 strain
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presented greater pathology in day old chicks as compared to Canadian S. Enteritidis 
PT4, PT8 and PT16 strains (Poppe et al, 1993). Unlike other Salmonella species S. 
Enteritidis has the ability to disseminate from the gastrointestinal tract into other tissues 
such as the chicken reproductive organs (Figure. 1.1) (Cox, 1995). Chicks infected 
within a couple of days post hatch are highly susceptible and are unable to provide an 
effective immune response resulting in persistent infections (Cast & Holt, 1998; Holt et 
al, 1999). Chicks can become infected vertically (from adult via the egg to chick) or 
horizontally (from the environment or from feed) (van de Giessen et al, 1994).
Infection in the reproductive tissues leads to the incorporation of S. Enteritidis 
into intact eggs as well as infection from improperly prepared meat. Particular virulence 
factors enable S. Enteritidis to persist as a potential human pathogen in poultry. The 
production of lipopolysaccharide (LPS) has also been closely linked to the organism’s 
virulence, particularly its ability to infect a large number of tissue types, such as the 
spleen. Although S. Enteritidis infection of poultry may lead to pathology it is common 
for the disease to remain silent. Silent infection coupled with the wide tissue 
distribution of S. Enteritidis in the chick presents particular problems in preventing 
zoonotic transmission to humans.
S. Enteritidis often does not affect poultry weight gain or performance; silent 
infection thus can increase the likelihood of zoonotic transmission to humans. In both 
developed and developing countries Salmonella is a leading cause of bacterial food- 
bome disease (White et ah, 1997; Cardinale et al, 2004). S. Enteritidis is a leading 
cause of poultry related salmonellosis in man (Cardinale et al, 2004). During 2006 
there were 160,649 reported cases of human Salmonella food poisoning in the EU 
(EFSA, 2007). The young, old and immuno-compromised are particularly vulnerable 
and infection may, on rare occasions, contribute to mortality. Symptoms of human S. 
Enteritidis infection include diarrhoea, nausea and vomiting, stomach pains and cramps, 
fever, headache and malaise. Although loss of poultry performance due to S. Enteritidis 
occurs, the major concern is with public health and control of this zoonotic pathogen. 
Thus the reduction of poultry related infection has implications for both the economy 
and public health.
In the past, control strategies for Salmonella species and other food-borne 
bacterial pathogens included the incorporation of antibiotics into poultry feed (de 
Oliveira et al, 2004). The increasing problem of bacterial resistance in poultry has led 
to the withdrawal of antibiotics in animal feed in 2006 (EU Commission, 1998). A
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study by Dias de Oliveira et al. (2004) have demonstrated high levels of antibiotic 
multi-resistance, particularly to sulphonamides and nitrofurantoin (both used to treat 
human infection) and a lack of resistance linked phage types indicating the transfer 
resistance genes (de Oliveira et al, 2004).
Several strategies are employed to ensure that commercial flocks are Salmonella 
free. The most important aspect of Salmonella control in commercial flocks is good 
animal husbandry and high standards of hygiene in the bird houses. Other strategies 
have been employed to control Salmonella in poultry including breeding of genetically 
resistant birds, the use of competitive exclusion organisms and vaccination (Babu et al,
2004). The most established of the three methods above, excluding animal husbandary 
practises is the use of vaccination. Currently two types of Salmonella vaccine exsit 
attenuated live vaccine and inactivated vaccines. These vaccines are often administered 
to breeder and layer flocks but the effectiveness is dependent upon the targeted serovar, 
host species and also if reduction rather than eradication is the aim of the strategy (for a 
comprehensive review read Doyle & Erickson, 2006). With the need to replace 
antibiotic supplements with effective alternatives, scientists have turned their attention 
to, the development of probiotics which reduce Salmonella carriage.
1.2 The physiology of the host
1.2.1 The poultry digestive system
The gastro-intestinal (GI) track of poultry is a dynamic organ that provides 
essential digestive functions. The GI track of poultry comprises many components seen 
in the human digestive systems with almost identical functions. It should be noted, 
however, that there are also significant differences between the digestive tracks of 
mammalian and poultry species. Food is firstly taken up by the beak of the bird. Poultry 
lack teeth for mastication and cannot swallow in the same fashion as humans. Instead 
the birds use a rigid tongue to force the food into the stomach which is aided by the 
presence of the hyoid bone hinge attached to the lower jaw. When the stomach is at 
capacity the bird can also store food in a storage organ called the crop (Figure 1.1). 
Food is moistened in the mouth and crop due to the presence of digestive glands but 
very little of the digestive process occurs at this point. Chickens have a two part 
stomach that is typical of poultry species. The first part of the stomach termed the pro- 
ventriculas, provides chemical digestion due to acidity which can be as low as
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approximately pH 2 (Famer et al, 1942). The second part of the poultry stomach is 
called the ventriculas or gizzard. The gizzard provides mechanical digestion due to its 
strong muscular composition (Figure 1.1). Mechanical digestion in the gizzard of hard 
material such as grain is aided by the presence of grit ingested by the bird. Following 
initial digestion in the pro-ventriculas and gizzard, the food travels into the small 
intestine for further digestion and nutrient absorption.
The small intestine begins at the gizzard exit with the duodenal loop comprising 
of the duodenum, jejunum and ileum (Figure 1.1). Digestive enzymes from the pancreas 
and the bile produced in the liver are mixed with the food bolus in the duodenal loop. 
The food bolus can be pushed through the digestive tract by peristalsis for absorption of 
nutrients along the digestive tract. Poultry also exhibit a digestive feature not seen in 
humans where by food can be transported from the small intestine further up the GI 
tract via reverse peristalsis. Movement of food via reverse peristalsis aids neutralisation 
of gastric secretions and further prolongs digestion thus ensuring the maximal 
extraction of nutrients from the food source. Digestive enzymes from the pancreas such 
as a-amylase, dipeptidase I & II, tripeptidase and lipase aid the digestion of 
carbohydrates, proteins and lipid (Krogdahl, 1985). Enzymes such as maltase a-limit 
dextrins, carboxylase and sucrase are produced and secreted from the epithelia (Moran, 
1985). Bile produced in the liver and stored in the gall bladder aids the émulsification 
and digestion of fatty material (Lindasy et al, 1969; Krogdahl, 1985; Moran, 1985). 
The duodenum, in part, but predominantly the remainder of the small intestine perform 
the function of nutrient absorption. The point at which the duodenum ends and the 
jejunum begins is located at where the liver and pancreatic ducts intersect the intestinal 
tract. The jejunum and ileum are separated by a small protrusion called the vitelline 
diverticulum which is a remnant of the attachment of the yolk sac during the chick’s 
early development. The small intestine intersects the large intestine at the ileo-caecal 
junction where the two caeca spur from the intestinal tract (Figure 1.1).
Passage of food through the small intestine to the large intestine takes 
approximately four hours but can take as little as two hours (Shires et al, 1987; Meier 
et al, 1995). The large intestine is comprised of the colon and cloaca (Figure 1.1). Food 
that is partially digested can be further broken down in the two caeca where 
fermentation of foodstuffs occurs. The colon absorbs the water but also may provide 
some nutrient absorption from digested food. The cloaca is comprised of three sections 
the cuprodenum, urodeum and proctodeum where the colon, urogentical tract and
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proctodeal openings meet. Passage of food through the entire digestive tract takes 
approximately six hours and is excreted through the cloaca often in tandem with urea 
from the urogentical tract (Shires et al, 1987). The rapidity, acidity, enzymic 
composition and structure of the chick gut play a part in determining the niche in which 
both probiotic bacteria and pathogens can colonise. Composition and structure of the 
intestine should be considered an integral part of probiotic selection and pathogen 
treatment.
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Figure 1.1 The gastrointestinal system o f poultry. The figure depicts the GI tract of poultry. Salmonella 
enter the digestive tract predominately by the ileum and can then persist in the two colic ceaca and spleen 
(not shown).
esophagus
crop (liigluvius)
jejunum
pancreas
proventriculus
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Image adapted from the website of the University of Arizona, Institutional Animal Care and Use 
Committee (lACUC) www.iacus.arizona.edu
1.2.2 The poultry immune system
The immune system of chickens is comprised of the innate and adaptive
immune system. Both arms of the immune system work in synergy to protect the host 
from pathogenic organisms including pathogenic prokaryotic, eukaryotic and 
eukaryotic multi-cellular organisms. Adaptive immune response to pathogenic bacteria 
is comprised of the humoral and cell mediated responses. The humoral and cell 
mediated immune responses often work in synergy to clear bacterial infections. The 
progression of acquired immune responses and whether the response is predominantly 
humoral or cell mediated is dependent upon a network of professional regulatory
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immune cells and non-specialised cells which have come into contact with pathogens or 
are located in close proximity to a pathogenic challenge.
The GI track also provides a barrier against pathogenic bacteria and comprises 
many defensive immunological components. The immune system of poultry is 
composed of primary lymphoid tissue including the embryonic yolk sac, thymus, bursa 
of Fabricius and bone marrow (Seto, 1981). The secondary lymphoid tissue is 
composed of central organs such as the spleen, ceacal tonsils and gland of Harder and 
the peripheral tissues such as the cervical lymph nodes, palatine tonsils, pharyngeal 
nodular aggregates and intestinal lymphoid tissue (Seto, 1981).
During early development, prior to hatching, the embryonic yolk sac provides 
the majority of haemopoietic stem cells. Chicken bone marrow provides a pool of stem 
cells that produce erythrocytes and granulocytes. As the bird matures the bone marrow 
also produces T and B cells. The bursa of Fabricius is the predominant source of B cells 
in the early bird and studies have shown that the early removal of this organ results in 
impaired humoral immunity (Fitzsimmons et al, 1973). Both the spleen and thymus do 
not initially produce lymphocytes; before they are able to produce lymphocytes stem 
cell migration to these organs is required. The thymus, once populated with stem cells, 
produces T-cells but also performs the task of major histo-compatibility (MHC) 
restriction thus monitoring the reactivity of T-cell population (Zinkemagel & Doherty, 
1974). The spleen provides erythropoiesis and granulocytopoiesis early in chick 
development but by 10 days of age it matures and becomes a lymphoid organ where 
numerous lymphocytes are present. For a comprehensive review of immune tissue 
development read Seto (1981).
1.3 Salmonella and the host.
1.3.1 Subversion of the host hy Salmonella Enteritidis.
Salmonella is a host adapted pathogen which employs a variety of mechanisms 
for host functional modulation for attachment, invasion and survival within the target 
organism. Salmonella spp. manipulate cell functions for colonisation and survival 
purposes with a variety of virulence factors and modulator proteins. Salmonella 
infection is characterised by the attachment of the bacteria to the intestinal epithelia, 
tissue invasion and, in the case of S. Enteritidis in poultry, dissemination to peripheral 
tissues such as the spleen, liver and ceacal tonsils. Deep tissue invasion is also seen in
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S. Typhimurium murine models and S. Typhi in humans. Much of what is known about 
systemic infection by Salmonella has been modelled in mice and thus much of what is 
known about Salmonella pathogenesis originates from scientific understanding of S. 
Typhimurium.
Attachment of Salmonella to the epithelium is mediated by the presence of 
fimbriae located on the bacterial cell wall. S. Enteritidis has several types of fimbriae, 
including S. Enteritidis fimbriae (SEE) 17 and SEF21, and flagella (Dibb-Fuller et ah, 
1999). Recent analysis of different S. Enteritidis strains from around the world has 
indicated that its enhanced ability to disseminate into peripheral tissues maybe due to 
the production of fimbriae, in particular Salmonella Enteritidis fimbriae (SEE) 17 (Cox, 
1995). Salmonella have been shown to preferentially attach to and invade M-cells 
(Jepson & Clark, 2001). These cells are located primarily in Peyer’s patches which are 
most abundant in the intestinal ileum. M-cells perform the function of antigen sampling 
of the luminal contents by pinocytosis. Once attached to target cells invasion of the 
epithelial cells is aided by the complex process of host manipulation resulting in 
Salmonella endocytosis uptake (Figure 1.2). Salmonella can subsequently translocate 
across the epithelium into the basolateral tissue. Here Salmonella can be cycled back 
into the lumen of the gut through epithelia cell replacement via Paneth cell 
differentiation in the intestinal crypts. Salmonella may also infect CD 18 expressing 
phagocytes, including macrophages, by macropinocytosis and disseminate to the 
reticuloendotheilial system engulfed by the infected phagocyte (Vazquez-Torres et al. 
1999) (Figure 1.2). Salmonella may also infect macrophages directly at the gut 
epithelial surface and recent research indicates manipulation of macrophages through 
the host protein TRIP6 for rapid dissemination to peripheral tissues (Worley et al, 
2006). The pathology of the intestinal tract is thought to occur due to the recruitment of 
polymorphonuclear lymphocytes to the site of infection and the subsequent release of 
cytotoxic substances such as oxygen free radicals and lysozyme. Disruption of tight 
junctions by Salmonella invasion is also thought to contribute to intestinal pathology 
although Salmonella has been shown to repair this damage to reduce inflammatory 
responses (Liao et al, 2008).
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Cellular invasion and dissemination by Salmonella is controlled by a complex 
system of molecular signals which manipulate host cell functions for pathogenic 
colonisation. The major components are predominantly found in the two pathogenicity 
islands Salmonella pathogenicity island 1 (SPIl) and Salmonella pathogenicity island 2 
(SPI2). SPIl encodes over twenty proteins that constract a molecular injection tube called 
the “needle complex” that injects an assortment of proteins that hijack host cell functions 
(for a comprehensive review read Kimbrough & Miller, 2002). The transport of these 
proteins is aided by chaperone proteins that target the s to the host target.
Historically SPIl encoded proteins induce changes in the host cytoskeleton for 
uptake of Salmonella by endopinocytosis. The principle proteins in this molecular 
hijacking are SopE, SopE2, SigD, SipA, SipC, SspC and SptP (Haraga et al, 2008). 
Expression of these proteins and also the needle complex is controlled by HilA a regulator 
protein that binds to the promoter sequence of invF. HilA expression is induced by specific 
environmental changes that act as a signal for Salmonella invasion of the host including the 
presence of volatile fatty acids (van Immerseel et al, 2004). The expression of InvF, a 
transcription regulator, and Sic A result in the expression of the SPIl proteins (Darwin & 
Miller, 2000). The effector molecules SopE, SopE2 and SigD activate the host Rho GTPase 
Cdc42, Racl and RhoG (Hapfelmeier et al, 2004). The activation of these Rho GTPases 
results in activation of N-WASP and WAVE-2 which subsequently recmits Arp2/3 to the 
site of membrane ruffles (Haraga et al, 2008). This in turn results in actin rearrangement 
and subsequent cytoskeletal reorganisation. The resultant cellular changes induce the 
classical membrane mffles reminiscent of Salmonella invasion (Figure 1.3). SipA causes 
actin polymerisation while SipC and SspC nucleates and bundles actin at specific foci 
beneath the site of Salmonella invasion (Haraga et al, 2008). After the induction of 
Salmonella membrane ruffles and initiation of subsequent invasion. Salmonella releases 
SptP which counters the action of SopE, SopE2 and SigD by the stabilisation of the host 
cytoskeleton (Fu & Galan, 1999). It should be noted that several other transcription 
regulators and effector proteins are employed by Salmonella to initiate invasion of host 
cells but the subject matter is too vast to be covered in this thesis.
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Figure 1.3 S. Enteritidis HEp-2 association visualised using scanning electron microscopy results.
Scanning electron microscopy of S. Enteritidis association after 3hrs incubation at 37°C to HEp-2 cells. 
Arrows indicate membrane ruffling (Image taken by the author at the Veterinary Laboratories Agency).
The proteins encoded by SPI2 predominantly regulate Salmonella survival in the 
vacuole in enterocytes and lysosome of phagocytes respectively. SPI2 proteins also 
regulate movement of Salmonella in the Salmonella-conimmng vacuole (SCV). 
Manipulation of the host cell microtubule network allows Salmonella to traverse the 
epithelial membrane via movement through the enterocytes intracellularly. Expression of 
SPI2 genes is regulated by sensory regulator systems including the two component 
PhoP/PhoQ sensor. Low magnesium concentration and low pH detected by PhoP and PhoQ 
respectively result in a cascade that stabilises promoter binding proteins such as RpoS (Tu 
et al, 2006). Promoter binding proteins, such as RpoS, subsequently result in the 
expression of SPI2 proteins. Thus the sensory mechanisms such as PhoP/PhoQ two 
component system senses when Salmonella have invaded intracellularly and subsequently 
initiate expression of those genes required for intracellular survival (Tu et al, 2006). SPI2 
encodes a type three secretion system (TTSS) and needle complex which, like the needle 
complex encoded by SPIl, is used to inject effector proteins into the host. Microtuble 
hijacking occurs by the secretion of SifA into the cytoplasm of the infected enterocytes and
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macrophages. SifA binds to the host cell protein SKIP (SifA and kinesin interacting 
protein) resulting in the formation of Salmonella-màwcQà filaments (Sif) (Boucrot et al,
2005). Sif originate from the SCV and allow movement of the SCV interacellularly and 
may also accommodate the expansion of the SCV as Salmonella replicates. Movement of 
the SCV along Sif is aided via the recmitment of negative end directed microtubule motor 
dynein by the effector protein SseF (Boucrot et al, 2005; Haraga et al, 2008). This 
controls the movement of Salmonella during enterocyte trancytosis and also maintains the 
position of the SCV in the macrophage. Several reports have also indicated that Salmonella 
SPI2 encoded proteins prevent the fusion of the SCV with the lysosome in macrophages 
although this mechanism of intracellular survival has become a contentious issue since the 
demonstration of Salmonella survival of phagolysosome fusion (Haraga et al, 2008). 
Manipulation of the host cell systems by Salmonella is one of the most elegant and 
complex biological systems currently understood and is also cmcial to the pathogensis of 
this organism.
1.3.2 Host responses to Salmonella infection
Host immune responses are dependent on many factors including the age of the
chicken when colonised by Salmonella, the severity of initial infection, host stress factors, 
the strain of Salmonella infecting the chicken and the strain line of the host. Many of these 
factors have been studied and have elucidated a basic understanding of immune responses 
required for effective clearance of Salmonella. Regulation of chick immune responses is 
dependent upon several specialised immune cells including macrophages, dendritic cells 
and regulatory T-cells which regulate the immune response. Immune regulatory cells 
primarily orchestrate the immune system, including other regulatory cells and effector 
cells, via a complex set of signalling pathways which include chemokines and cytokines. It 
should be noted that the production of these signalling molecules is not restricted to 
regulatory cells as effector inunune cells and cells that are not specialised immune cells can 
produce a variety of cytokine signalling molecules. It should be noted that infected 
chickens, excluding birds exposed to infection at a very early age, show limited pathology 
which is often presented as a silent infection. The first line of defence is the innate immune 
response and effective mobilisation of this response is a necessity for adequate activation of 
the acquired response.
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1.3.3 The innate immune response
The innate immune system is comprised of a several components including those
that serve functions other than immunity, such as skin and gastric acid producing cells, and 
more specialised components such as specific leukocytes. During the early stage of 
Salmonella colonisation of poultry the innate immune response mobilises in order to 
control infection. This response, termed the acute phase response, is characterised by 
increased expression of pro-inflammatory cytokines from epithelial cells, such as 
interleukin (IL)-8, resulting in an influx of heterophils and macrophages to the site of 
infection. Macrophages and heterophils are both capable of phagocytosing extra-cellular 
Salmonella but heterophils may also release cytotoxic substances, including lactoferrin, 
myeloperoxidase and oxygen free radicals that lyse infected cells and kill extracellular 
Salmonella. Phagocytosis of Salmonella by macrophages results in the release of an array 
of cytokines that drive the acquired immune response due to their effect on T-helper (Th) 
cells which also further perpetuate the acute phase response. Macrophages also present 
phagocytosed Salmonella protein fragments to Th cells that, in concert with macrophages, 
induce a Th-1 or Th-2 biased immune response.
Several acute phase response cytokines have been implicated in Salmonella 
clearance including IL-8, TNF-a, IL-6, macrophage inflammatory protein (MIP) and IL-ip. 
The paradox of Salmonella infection is that the organism requires the recruitment of 
macrophages for dissemination within the host but that the recruitment of inflammatory 
cells also results in the clearance of infection. As was discussed above these cytokines play 
a major role in the recruitment of immune cells required for control of Salmonella 
infection. Several reports have shown that these cytokines are expressed upon Salmonella 
contact. Withanage et al. (2005) has shown that Salmonella clearance in SPF Rhode Island 
red chicks is dependent upon the expression of inflammatory mediators IL-6 and MIP. 
Kogut et al. (2005) showed that the priming of heterophils by recombinant interferon 
(INF)-y resulted in increased expression of several pro-inflammatory cytokines including 
IL-ip and IL-6 in response to Salmonella challenge. It has also been shown that depletion 
of tumour necrosis factor (TNF)-a (an acute phase response cytokine) with antibodies 
reduces the effectiveness of vaccination in mice (Mastroeni et ah, 1992). Thus this
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indicates that the expression of inflammatory cytokines is required to eliminate Salmonella 
from the host. Interestingly Salmonella actively suppress the inflammatory response 
suggesting that the attenuation of these responses is important for pathogen survival. 
Stimulation of Cdc42 by Salmonella effector molecules, such as SopE, triggers the 
activation of mitogen-activated protein kinases (MAPK) which result in activation of 
transcription factors such as nuclear factor (NF)-kB. The induction of this transcription 
factor results in expression of pro-inflammatory cytokines such as IL-8 (Haraga et al, 
2008). Previous reports by Haraga et al (2003) have shown the inhibition of NF-kB by the 
SPIl TTSS effector protein SspHl which, in turn, appears to counter those responses 
induced by effector proteins such as SopE. The inhibition of NF-kB by this effector protein 
indicates Salmonella actively suppress the expression of pro-inflammatory cytokines 
(Haraga & Miller, 2003).
It can be concluded that the acute phase response is required for clearance of 
Salmonella colonisation in poultry and that this response is so detrimental to Salmonella 
survival that the organism actively counters these responses. The innate immune response 
is vital for clearance of Salmonella in poultry but for effective short and long term 
clearance and control, adequate induction of acquired responses is also required.
1.3.4 The acquired immune response
As was mentioned above there are two types of acquired responses to bacterial
infection namely the humoral and cell mediated responses. Cell mediated immune 
responses are Th cell dependent whereas humoral responses can be Th cell dependent and 
independent. Humoral and cell mediated immune responses have primary and secondary 
immune stages. The first stage is characterised by the recognition of specific immunogens 
followed by the activity of effector cells to clear the principal infection. The second stage 
of adaptive immune responses is the development of immune memory whereby memory T- 
cells and B-cells return to a resting state which can be reactivated for effector cell functions 
after subsequent re-exposure to the immunogens. The humoral response is important in 
Salmonella control in poultry and forms the basis of vaccination strategies. Whilst this arm 
of poultry immune response is important, this thesis predominately focuses on 
manipulation of the acute phase response and cell mediated response and as such the
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humoral response will not be discussed further (for a comprehensive review read van 
Immerseel et al, 2005).
The cell mediated response principally controls viral and intercellular pathogens. 
Induction of the cell mediated response results in the activation and activity of natural killer 
(NK) cells and cytotoxic T-cells (CTC). Cell mediated immunity is accompanied by the 
induction of an inflammatory response due to the activity of effector cells. Professional 
antigen presenting cells (AFC) present immunogens through MHC class II molecules on 
the AFC to Th cells. Cytokine production results in expansion of Th cell populations and 
stimulates the activity of CTC which recognise infected cells via the presentation of 
immunogens by MHC class I molecules. The recognition of infected cells by CTC and NK 
cells results in a “lethal hit” leading to the apoptosis of the infected cell.
The cell mediated response is regulated by several cytokines produced by 
macrophages and Th cells. Upon presentation of Salmonella antigen in association with 
macrophage MHC complexes to Th cells, macrophages produce IL-12 and IL-18. After 
antigen presentation and also IL-18 and IL-12 stimulation by the macrophages, Th cells 
further differentiate to mature Th cells and produce INF-y, IL-2 and TNF-p. The production 
of IL-2 induces Th and CTC population expansion. INF-y further activates macrophages 
which subsequently also produce INF-y. The production of INF-y also activates cytotoxic 
T-cells and stimulates B-cells to produce a specific type of antibody termed 
immunoglobulin (Ig)-G2a. The importance of the expression of these cytokines for 
clearance of Salmonella infection has been extensively studied. Frevious reports by 
Lehmann et al (2001) have indicated a critical role in the expression of IL-12 for the 
clearance and effective induction of cell mediated immune responses required for pathogen 
control. In this study mice that were deficient in EL-12p40 had lower survival rates than 
wildtype mice after Salmonella infection and that the immune response induced to 
infection was Th-2 biased (Lehmann et al, 2001). It has also been shown that priming of 
chicken derived heterophils with recombinant IL-2 increased expression of EL-18 and IL-8 
in response to S. Enteritidis infection indicating possible strategies for increasing cell 
mediated responses (Kogut et al, 2003). The same study also reported increased 
expression of INF-y suggesting that improved INF-y expression can lead to better Th-1 
driven cytokine responses from heterophils (Kogut et al, 2005). This observation agrees
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with previous reports that the carrier state of S. Enteritidis in the ceacal tonsils of young 
and mature six week old birds was dependent upon the ability to express INF-y. The bird 
line 6i had a higher bacterial load of S. Enteritidis in the caeca and also lower expression of 
INF-y in the same tissue as compared to bird line 151 (Sadeyen et ai, 2004). They also 
noted that IL-18 expression did not significantly differ as compared to healthy controls. 
The author suggests that the lack of correlation between INF-y and IL-18 expression may 
indicate that INF-y expression in response to Salmonella infection is regulated by IL-12. It 
has also been shown in mice that pups compared to adult mice show a significantly higher 
burden of S. Typhimurium in peripheral tissues (Rhee et al, 2005). Further analysis by this 
group explained this disparity of bacterial load in peripheral tissues by huge variation in 
IFN-y expression; pups showed significantly lower expression of IFN-y as compared to 
adult mice. The importance of INF-y expression was also shown by Withanage et al. 
(2005) where clearance of Salmonella in Rhode Island chickens was dependent upon the 
expression of cell mediated immune response cytokines INF-y and IgG, IgM and IgA 
(Withanage et al, 2005). It should be noted however that a study by Beal et al. (2005) 
indicated that IL-ip and INF-y expression in caecal tonsils did not correlate to chicken 
strain line and age dependent clearance of Salmonella (Beal et al, 2005). Additionally 
previous reports by Kaiser et al (2005) have shown that primary chicken kidney cells 
(CKC) infected with S. Enteritidis suppressed IL-lp and IL-2 mRNA expression whereas 
INF-y expression was unaffected and IL-6 expression increased (Kaiser et al, 2000). These 
reports would indicate that INF-y expression is not a principal cytokine for Salmonella 
clearance in poultry although it should be noted that these studies are the exception rather 
than the rule. From the reports above it is clear that induction of the cell mediated response 
for Salmonella clearance is dependent upon INF-y, IL-12 and possibly EL-18 expression.
It should also be noted that Salmonella actively inhibit the cell mediated response of 
the host to infection, including inhibition of cytokine production which drives these 
responses. Previous reports by Alaniz et al (2006) have shown that S. Typhimurium 
actively mask the fimbriae protein FliC during macrophage internalisation. FliC is a potent 
antigen that induces the expression of several pro-inflammatory cytokines. Activation of 
the PhoP regulator results in internal compartmentalised expression of FliC due to SPI2 
expression. Reduced presentation of FliC by murine dendritic cells to CD4+ Th cells was
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also shown in this model. The reduced interaction between Th cells and dentritic cells via 
the TCR/CD28 and MHC-II/CD86/antigen complexes resulted in reduced expression of 
TNF-a and IL-12. The resultant attenuation of these cytokines reduced expression of IFN-y 
and subsequently reduced Th cell production of INF-y. This study showed Salmonella 
adaptations of avoidance of the host cell mediated immune response (Alaniz et al, 2006). 
Furthermore van der Valden et al. (2005) showed direct contact between T lymphocytes 
involved in cell mediated immunity and Salmonella reduced T cell proliferation, 
independent of SPIl or SPI2 gene expression (van der Velden et ah, 2005). From the 
studies above it is clear that cell mediated responses by the host to Salmonella infection are 
required for clearance of this pathogen and that the pathogen also dedicates resources to the 
subversion of these responses.
1.4 Probiotics
1.4.1 Defining Probiotics, Prebiotics and Synbiotics
In 1965 the term probiotic was first used by Lilly & Stillwell (1965) to describe an 
excreted product from one protozoan that resulted in the promotion of growth of another 
protozoan (Lilly & Stillwell, 1965). Subsequently the term probiotic was used to describe 
numerous beneficial biological interactions including the promotion of microbial growth by 
tissue extracts (Shortt, 1999). In 1974 Parker was the first to describe probiotics as 
beneficial food supplements that promoted the production of a healthy gut flora. Parker’s 
description of probiotics was too general due to the inclusion of antibiotics in his definition 
(Parker, 1974). Fuller suggested the generally excepted definition of probiotics given below 
in 1989 (Fuller, 1989). As the science of probiotics matured the concept of prebiotics was 
introduced in 1995 by Gibson & Roberfroid (1995). Prebiotics are substances that are non- 
digestible food ingredients that promote the growth/activity of natural intestinal bacterial 
species within the gastrointestinal tract (Gibson & Roberfroid, 1995). The concept of using 
prebiotics and probiotics in conjunction as a mixed preparation was termed synbiotics 
(Gibson & Roberfroid, 1995).
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1.4.2 Historical and conceptual developments in probiotics
A probiotic is defined as ‘a live microbial feed supplement which beneficially 
affects the host animal by improving its intestinal microbial balance’ (Fuller, 1989). Since 
the beginning of the 21®^ century probiotic use in the veterinary, medical and food industry 
has rapidly expanded. With the realisation of the limitations and dangers of using 
antibiotics without restraint, adequate alternatives are being sought thus particular attention 
has been given to the development of probiotic and prebiotic products (Chow, 2002).
Foods containing live microorganisms have been consumed by people for 
thousands of years and descriptions of cultured dairy products can be found in the Bible 
(Hosono, 1992). Even before the description of bacteria, many of these products were used 
therapeutically (Shortt, 1999). The concept of probiotics, as it is understood today, 
probably began with the Russian Nobel Prize winning scientist Eli Metchnikoff and his 
description of the beneficial effects of fermented yoghurt. In Metchnikoff s 1907 
publication The Prolongation of Life it was suggested inter alia that the extended life span 
of Bulgarian peasants could be attributed to the consumption of Lactobacillus species 
within fermented yoghurts (Metchnikoff, 1907). In 1906 Cohendry performed studies on 
Lactobacillus bulgaricus resulting in the discovery that the bacteria persisted in stools for 
up to 12 days and also that the natural gut flora of man was predominately composed of 
Gram-positive bacteria (Shortt, 1999). In the same year Tissier discovered Bifidobacterium 
in breast-fed infants and suggested the need for specific bacteria in maintaining health 
(Shortt, 1999). Over the following 50 years, the use of live micro-organisms in food 
products became more fashionable. In 1919, encouraged by the reports of Metchnikoff 
from both his 1907 publication and his work at the Pasteur Institute, Isaac Carasso 
established the Spanish company Danone (Shortt, 1999). Carasso promoted the beneficial 
effects of yoghurts to the medical profession and often had workshops to discuss their use 
(Shortt, 1999). In the 1930’s Shirota established a company in Japan that produced yoghurt 
products which later became Yakult. Shirota concentrated his research on bacterial species 
that could survive passage through the human digestive tract resulting in the production of 
his first fermented yoghurt containing Lactobacillus casei Shirota (Shortt, 1999). During 
the 1950’s the medical profession took particular interest in using live cultures for the re­
establishment of the natural intestinal flora after treatment with antibiotics thus preventing
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conditions such as antibiotic associated diarrhoea (Cheplin & Rettger, 1922; Salminen et 
al, 1998). By the 1950’s the use of live microbial food products in the food and medical 
sector had become well established.
1.4.3 Design and selection of probiotics
There are over 20 criteria for the selection of a safe and functional probiotic 
product. These can be grouped into four categories: Appropriateness, Technological 
suitability. Competitiveness and Performance & functionality (Klaenhammer & Kullen, 
1999). Appropriateness refers mainly to probiotic safety in humans i.e. that the bacteria are 
generally regarded as safe (GRAS) and are of host origin. Technological suitability criteria 
determine the practical aspects of production and storage in food products. 
Competitiveness describes the ability of a probiotic to persist within the host organism and 
withstand environmental stresses. Performance and functionality criteria relate to the ability 
of the probiotic to exert beneficial effects on the host. The selection criteria have been 
collated over the past 20 years taking into account safety (Appropriateness), production 
(Technological production), bacterial survival (Competitiveness) and probiotic activity 
(Performance and functionality) (Klaenhammer & Kullen, 1999).
Performance and functionality is of particular interest due to the lack of 
understanding of the mechanisms involved. Some claimed beneficial probiotic affects 
include the interference and exclusion of pathogens, reduction of carcinogenic and 
mutagenic activity, improvement of host serum cholesterol and blood pressure, reduction in 
incidence and length of diarrhoea, prevention of vaginitis and maintenance of mucosal 
integrity (Klaenhammer & Kullen, 1999). Due to the lack of data describing probiotic 
mechanisms some of the claims of positive benefits must be interpreted with caution 
although other beneficial effects have been described and are generally accepted. For 
example a study involving 64 healthy women demonstrated that the oral administration of 
Lactobacillus rhamnosus GR-1 and Lactobacillus fermentum RC-14 over 2 months 
improved the vaginal flora by increasing the presence of lactobacilli and decreasing 
coliforms & yeast in the vaginal area. The likely mechanism of action is by ascending 
colonisation of the probiotic cultures from the rectal area, although immunomodulation
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could also be possible (Avonts et ah, 2004). Bifidobacterium lactis LKM512 has also been 
shown to convey positive affects when ingested by reducing gut mutagenicity in healthy 
adults. The results indicate that LKM512 yogurt increases gut spermidine levels and that 
this increase results in desmutagenicity (inactivation of mutagens) (Matsumoto & Benno, 
2004). The integrity of the mucosal barrier has also been shown to be influenced by the 
species of associated bacteria. In vitro experiments involving rat excluded colonic loop 
tissue demonstrated reduced paracellular permeability when colonised with Lactobacillus 
brevis. In contrast, colonisation with wild-type Escherichia coli isolated from rats resulted 
in increased paracellular permeability (Garcia-Lafuente et al, 2001). Additionally the 
administration of Lactobacillus rhamnosus and other lactobacilli to infants has also been 
shown to reduce the duration of infantile gastroenteritis caused by rotavirus (Shomikova et 
al, 1997). The prevention of antibiotic-associated diarrhoea, particularly through resultant 
overgrowth of Clostridium difficile, has also been prevented through the administration of 
Saccharomyces cerevisiae (boulardii) (Surawicz et al, 1989). As the scientific 
communities understanding of performance, functionality and competitiveness increases 
the selection criteria will become more appropriate and definitive.
The EU has recently introduced new directives in order to regulate the use of 
probiotics as animal feed additives in correlation to guidelines proposed by the Scientific 
Committee on Animal Nutrition (SCAN) (Wright, 2005). Regulation 1831/2003 EU 
regulates the use of animal feed additives, while Council Directive 87/153/EEC stipulates 
the assessment guidelines for feed additives. Council Directive 87/153 EEC requires that 
probiotic feed supplements fulfil five important criteria:
1) Safety has to be assessed in accordance with the test set out in the directive 
guidelines
2) Strains that produce toxins are not permitted
3) Strains that have known virulence factors are not permitted
4) Strains that produce antibiotic substances of clinical or veterinary significance are 
not permitted
5) Strains that carry transmissible resistance determinants against antibiotics are not 
permitted
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1.4.4 Administration of probiotic products to poultry
Commercial poultry probiotic products available today can be separated into two 
categories, competitive exclusion products that are defined and those that are undefined. In 
defined competitive exclusion products, such as Protexin Lifestart for All Animals® and 
Protexin Pro-Soluble for All Animals®, the micro-organisms that compose the product have 
been identified (www.animal-health-protexin.com). In contrast undefined competitive 
exclusion products, such as Aviguard® and BROILACT®, are products where the bacterial 
cultures are either partially or completely undefined (Carita, 1992; Nakamura et al, 2002). 
Particular problems arise when trying to evaluate the effectiveness of undefined 
competitive exclusion products. Due to the reduced ability to evaluate the probiotic 
mechanisms in these products, the scope for product improvement is limited compared to 
defined products. Due to the rapid increase in data concerning probiotic products it is 
conceivable that these products will comer the commercial market. Once individual and 
particular combinations of probiotic strains are identified as producing the primary 
probiotic effect, emphasis can then shift into enriching these organisms with other feed 
additives such as prebiotics.
The dose and administration of commercial probiotics is an important factor in their 
effective use (Votava et al, 1987; Carita, 1992). The recommended dose of each micro­
organism varies between products due to the strength of probiotic action and industrial 
production limitations. Recommended doses usually fall within the range of 1x10  ^cfu of 
bacteria per kg of feed and 1x10^  ^ cfu of bacteria per kg of feed. Examples include 
Toyocerin® which has approximately 1x10  ^cfu of Bacillus cereus var. toyoi per kg of feed 
for use in poultry whereas AlCare’’'''', a probiotic product for swine, is administered at 1x10  ^
to 1x10^ ® cfu of Bacillus cereus var. toyoi per kg of feed (Cartmen & La Ragione, 2004). 
Nurmi and Rantala developed the first competitive exclusion product to be administered to 
chickens (Nurmi & Rantala, 1973). This was administered by oral gavage directly into the 
stomach of the chicks. This method was particularly crude and extremely impractical for 
broiler farmers who would have to administer the product to thousands of birds. Over the 
years other methods have been developed to administer probiotic supplements into animal 
feed including pellets, capsules, paste, powder and granules (Fuller, 1989). The form in 
which the probiotic is administered depends on the use of the product e.g. as a prophylactic
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and also on the species of animals being dosed (Fuller, 1989). For example in pigs and 
cattle Protexin Pro-Soluble® is administered as a powder whereas in chickens it is 
administered in the water supply (www.animal-health-protexin.com). The preferred method 
of dosing chickens with probiotic products has been via drinking water, although problems 
have arisen due to the refusal of chicks to drink the water with the probiotic product 
(Carita, 1992). More recently the use of droplet application systems have been developed 
that can improve the administration of probiotics to chicks (Carita, 1992). These systems 
range from the use of simple hand-held garden sprayers to modified bronchitis vaccination 
apparatus (Carita, 1992).
1.4.5 The use of L. salivarius and E. faecium as probiotics in poultry
L. salivarius spp. and E. faecium spp. have been extensively studied and are 
accepted as distinct species within the phylum of firmicutes. Typically L. salivarius are 
Gram-positive micro-aerophilic, non-sporing, non-motile rods approximately 0.6-0.9|im by 
1.5-5pm in size. L. salivarius spp. shows no growth at 15°C and variable growth at 45°C 
with optimal growth between 35 and 40°C and has a low G+C content of approximately 
34.7 moles % (Bergey et al, 2002). L. salivarius was first described as a new species by 
Rogosa et al, (1953) and has been isolated from humans, primarily from dental samples 
but also from the gastrointestinal tract (Dunne et al, 2001; Smith et al, 2001). Members of 
E. faecium spp. are Gram positive, micro-aerophilic, non-sporing, non-motile coccus 
approximatley 1pm in size. E. faecium grows in 6.5% NaCl, between 10 and 45°C, at pH 
9.6, can survive at 60°C for 30mins and typically has a low G+C content of between 35 to 
40 moles % (Schleifer & Kilpper-Balz, 1984; Bergey et al, 2002). E. faecium was accepted 
as a new species in 1956 which was formally known as Streptococcus faecium (Barone et 
al, 2000). E. faecium is found ubiquitously in both man and animals and is readily isolated 
from poultry (Quednau et al, 1998).
It is generally accepted that Lactobacillus species’ are a heterogeneous group with 
unstable taxonomy (Schleifer & Ludwig, 1995). Until recently L  salivarius were thought 
to be hetero-fermentors of sugars but recent discoveries, made possible by the sequencing 
of L. salivarius UCC118, have shown that it is likely that L  salivarius species are homo-
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fermenting lactic acid bacteria (Claesson et al, 2006). In poultry L. salivarius is a 
commensal intestinal organism of the adult bird residing in high numbers, particularly 
within the crop (Brooker & Fuller, 1975). L. salivarius has been shown to be effective as a 
probiotic for many diseases including infectious mastitis, inflammatory bowel disease and 
enteric infections (Feighery et al, 2007; Jimenez et al, 2008).
The administration of L. salivarius as a probiotic supplement for Gram negative 
bacteria in poultry has been demonstrated previously. In vivo studies by Fuller (1977) with 
L. salivarius 59 demonstrated a substantial reduction in the pH of the crop of poultry (pH 
5.70 reduced to pH 4.00). The reduction in pH correlated with a significant drop in the total 
numbers of E. coli in the crop. Previous experiments have shown that inhibition of E. coli 
in vivo by L. salivarius 59 is directly dependent upon inhibitory substances such as lactic 
acid (Fuller, 1977). Additionally studies have indicated that the inhibition of S. Enteritidis 
by L. salivarius spp. is entirely pH dependent and that the effect could not be neutralized 
by the addition of catalase (Garriga et al, 1998). L. salivarius CTC2197 has also been 
shown to clear caecal colonisation of S. Enteritidis C-114 in poultry by day 21 post­
infection (Pascula et al, 1999). It should be noted that Pascula and colleagues used a non- 
invasive strain of S. Enteritidis. Although L. salivarius species do produce bacteriocins the 
production of these substances appear only to be effective against Gram positive bacteria 
(Corr et al, 2007). L. salivarius species including the isolate used in our studies have been 
shown to be effective in the treatment of several diseases. It has also been demonstrated 
that this species can inhibit Salmonella in poultry and potential probiotic mechanisms of 
action have been suggested.
E. faecium species, like L. salivarius species, have been shown to produce 
bacteriocins active against Gram positive bacteria. Some of these bacteriocins are 
expressed at specific stages of bacterial growth such as the exponential phase and 
stationary phase of growth (Leroy et al, 2002; Marekova et al, 2003). Previous reports by 
Carina et al, (1999) demonstrated the production of bacteriocins by E. faecium J96 that 
antagonize the growth of S. Gallinamm and S. Pullomm. Furthermore Laukova et al, 
(2003) has suggested significant reduction in the colonisation of Japanese quails by S. 
Düsseldorf was due to the production of Enterocin A by E. faecium EK13. It is also 
possible the inhibition of Salmonella by E. faecium PXN-33 could be by the production of
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inhibitory metabolites that are not bacteriocins. Carina et al, (2000) showed that pre­
treatment of broilers with E. faecium J96 reduced mortality caused by S. Pullorum from 
50% to 25%. A significant 1 log fold reduction in S. Düsseldorf isolated from the ceaca of 
Japanese quails was also observed 168hrs post inoculation with E. faecium J96 (Laukova et 
al, 2003). E. faecium spp. has been shown to inhibit Salmonella spp. in poultry and the 
production of bacteriocins has been suggested as a potential mechanism of action. Thus it 
has been shown that both L. salivarius and E. faecium can inhibit Salmonella in poultry and 
both have shown different mechanisms of activity.
1.4.6 Other food supplements as intervention agents to control Salmonella in poultry
In recent years the use of prebiotics in the prevention of poultry infection has 
become a popular area of research. Monosaccharides, disaccharides, oligosaccharides and 
polysaccharides have been used in poultry as prebiotics. These may bind to the target 
pathogen directly but more commonly are utilised by the intestinal fiora resulting in the 
production of metabolites such as bacteriocins. Importantly the numbers of desired 
beneficial bacteria are increased. Mannose is a monosaccharide often used as a prebiotic 
due to Type 1 (FI) fimbriae of Salmonella binding to mannose residues on the epithelial 
glycoproteins. Free mannose and preparations of yeast mannan-oligosaccharide are thought 
to interfere with Salmonella binding to host cells. Fructo-oligosaccharides have been 
shown to promote the growth of Enterococcus faecium, Lactobacillus lactis and 
Pediococcus species in vitro. Modification of metabolic activity of the intestinal flora has 
also been proposed due to the fermentation of indigestible saccharides into volatile fatty 
acids, lactate, carbon dioxide, methane and hydrogen (van Immerseel et al, 2002). Recent 
reports by Tzortzis et al, (2005) elegantly showed the activity of these two mechanisms by 
galactooligosaccharides in vitro and in vivo. The oligosaccharide mixture inhibited 
Salmonella binding to HT29 cells, presumably by the saturation of Salmonella cell binding 
receptors, and also promoted the growth of Bifidobacterium spp. in vitro and also in a 
continuous culture model (Tzortzis et al, 2005). Furthermore recent reports have shown 
the use of isomaltooligosaccharides in poultry to promote Bifidobacterium growth ex vivo 
and have demonstrated the ability of this oligosaccharide to inhibit Salmonella growth in
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vitro (Chung & Day, 2004). Recent research into the use of prebiotics to enhance clearance 
of Salmonella in poultry opens new possibilities for the effective clearance of these 
zoonotic pathogens. The use of prebiotics and probiotics offers another tool for the control 
of S. Enteritidis in poultry and may one day become an integrated part of pathogen control 
in commercial poultry production.
1.4.7 Mechanisms of probiotic competitive exclusion
The competitive exclusion of pathogenic bacteria by a probiotic product is thought 
to occur through the action of one or more of the five known key mechanisms 
(Klaenhammer & Kullen, 1999). Probably the most obvious is competition for substrates 
and nutrients. Unlike other probiotic mechanisms the fluidity and complexity of nutrient 
and substrate utilisation in the gastrointestinal tract makes defining the specifics of this 
mechanism extremely difficult. The second mechanism is immunomodulation of the gut 
mucosa. Unlike the human gut mucosa, avian species lack the presence of peripheral 
encapsulated lymph nodes; instead the gut-associated lymphoid tissue (GALT) is a major 
secondary lymphoid tissue. The GALT plays an important role in the prevention of viral, 
bacterial and toxic material entering the body via the gut mucosa. In recent research the 
effect of probiotics on the GALT tissue in mice was described. Mice which were given a 
probiotic fresh cheese containing Streptococcus thermophilus, Lactobacillus lactis. 
Bifidobacterium bifidum, Lactobacillus acidophilus and Lactobacillus paracasei were able 
to up-regulate the phagocytic activity of peritoneal macrophages and increase the number 
of IgA"*" producing cells in the small intestine (Medici et al, 2004). Another mechanism for 
the action of probiotic micro-organisms is the production of bacteriocins. In an in vitro 
study five Lactobacillus strains were shown to produce bacteriocins; the starter culture 
strain Lactobacillus acidophilus was shown to produce the largest amounts whilst human 
gut-flora isolates, such as Lactobacillus casei, produced significantly less (Avonts et al,
2004). Although in vitro experiments do indicate that probiotic strains produce active 
bacteriocins the scope of activity and the resultant antimicrobial effect on gut pathogens is 
debatable (Ouwehand et al, 1999). Inhibition of pathogenic bacteria by the production of 
volatile fatty acids or reduction of intestinal pH by the production of lactic acid has also 
been proposed as a probiotic mechanism (Klaenhammer & Kullen, 1999). This remains
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poorly defined due to the fluidity of the intestinal environment; whilst the action of such 
products may affect the localised micro-environment the overall effect on the intestine still 
remains to be described. The final probiotic mechanism is competition with both 
commensal and pathogenic bacteria for receptor sites. Adherence to the mucosal epithelium 
is considered to be an important characteristic of a probiotic (Klaenhammer & Kullen, 
1999). Bacteria often bind to the intestinal mucosa through the action of proteins or 
glycoproteins termed lectins. A recent study into receptor binding competition between 
probiotic strains and Salmonella Typhimurium in cell lines from man and poultry indicated 
Enterococcus faecalis actively excluded Salmonella Typhimurium by competing for 
binding sites in CRL-21 17 chicken cell lines. Furthermore Lactobacillus lactis and 
Bacillus distasonis also protected undifferentiated Caco-2 cells and CRL-21 17 chicken 
cells lines from Salmonella Typhimurium invasion (Wagner et al, 2002).
Whilst the probiotic activity of bacteria has been observed in many studies, the 
mechanisms through which competitive exclusion occurs remains poorly defined. 
Resources thus should be dedicated towards research in this area with a view to manipulate 
and improve probiotics in the future.
1.4.8 Competitive exclusion of Salmonella using probiotics in poultry
A small number of antibiotics were used to improve weight gain in poultry and act 
as bacterial prophylactics but this has led to rising antibiotic resistance of bacteria in 
poultry. With the withdrawal of antibiotics from animal feed in 2006, scientists are looking 
at probiotics as a serious alternative. Particular success has been achieved with undefined 
avian caecal cultures in the competitive exclusion of Salmonella species from poultry, 
which has resulted in the production of several commercial products. Only a handful of 
monoculture probiotics have been shown to exclude S. Enteritidis from poultry. The lack of 
modelling on individual species coupled with the complexity of probiotic interactions with 
both pathogenic bacteria and the host organism has hindered the description of probiotic 
mechanisms.
The use of intestinal content preparations from adult chickens to stop chick infection 
with Salmonella was first described by Nurmi and Rantala in 1973 resulting in a marked
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decrease in chick infection. This method of probiotic treatment was termed competitive 
exclusion (Nurmi & Rantala, 1973). Caecal bacterial culture application to newly hatched 
chicks was subsequently shown to prevent infection by S. Enteritidis in numerous models 
including White Leghorn Chicks. This probiotic product could be administered in several 
ways such as in water, by direct spray or inclusion in feed slurry (Corrier et al., 1994). 
With the success of undefined competitive exclusion preparations in the 70s and 80s the 
first commercial avian caecal products were marketed in the 1990s. BROILACT®, a 
commercial undefined caecal competitive exclusion preparation, has been shown to protect 
broiler chickens from oral challenge by S. Enteritidis PT4, with significant reductions in S. 
Enteritidis numbers in caecal contents (Nuotio et al., 1992; Schneitz, 1992). Aviguard, 
another commercial undefined competitive exclusion product, was designed to be used as a 
spray treatment or administered in drinking water. Aviguard, like BROILACT®, was 
designed to exclude S. Enteritidis and S. Typhimurium from chickens. Aviguard was also 
successful at reducing the persistence of Salmonella species with the effect of reducing 
tissue colonisation and death in the chicks (Nakamura et al, 2002). The treatment of chicks 
with enrofloxacin for S. Enteritidis infection was also greatly improved when a competitive 
exclusion culture was administered after completion of the antibiotic course (Seo et al, 
2000).
Generally the applications of multispecies probiotic cultures are significantly more 
effective at reducing Salmonella infection (Timmerman et ah, 2004). Exceptions to this 
common dogma were reports by Edens and colleagues that pure cultures of Lactobacillus 
reuteri decreases Salmonella and Escherichia coli colonisation in chicks and turkey poults 
(Edens et al, 1997). Studies conducted by La Ragione and Woodward described the 
reduction of colonisation and persistence of S. Enteritidis in a 1-day-chick model after pre­
dosing with Bacillus subtilis PY79 (La Ragione & Woodward, 2003). In the pre-dosed 
animals, 90% showed no shedding of S. Enteritidis with the remaining 10% shedding low 
numbers of Salmonella compared to 80% of birds showing high or medium shedding in the 
contol group at 36 days post infection. Additionally Bacillus subtilis also appeared to 
reduce Clostridium perfringens (the aetiological agent of necrotic enteritis in poultry) over 
a longer period of time suggesting immunomodulation or possibly spore germination 
resulting in delayed competitive exclusion (La Ragione & Woodward, 2003). La Ragione
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and colleagues were able to demonstrate that, after a single oral dose of Lactobacillus 
johnsonii F19785, the colonisation and persistence of Clostridium perfringens in 1 day old 
chicks was suppressed (La Ragione et al, 2004).
Several recent reports have shown the use of Lactobacillus to inhibit S. Enteritidis in 
poultry. Vicente et al (2008) and Higgins et al (2007) both reported the use of commercial 
Lactobacillus spp. probiotic preparation FM-Bl 1 to inhibit S. Enteritidis in vivo (Higgins et 
al, 2007; Vicente et al, 2008). Both studies used day old commercial broilers infected 
with Salmonella on day 1 and treated with FM-Bl 1 on day 2. Salmonella recovery from the 
chicks was reduced but not eliminated. Van Coillie et al (2008) also reported similar 
observations with L. reuteri R-17485 and R-17753 in a specific pathogen free (SPF) six 
day old chick model, although in this study the birds were treated with the probiotics prior 
to Salmonella infection (van Coillie et al, 2007). Caution should be taken in the 
interpretation of the results from these studies. Firstly they were conducted in young birds 
over short periods of time. The developmental maturity of the host in terms of immune 
competence play a role in susceptibility and the transmission of Salmonella among flocks is 
far from uniform. Additionally the cyclic nature of infection from environmental sources 
may, and often does, ensure persistent colonisation of birds at various stages. Secondly in 
the studies referenced above the probiotic preparation was used therapeutically to clear 
Salmonella colonisation. The value of this type of treatment should be questioned; if a 
flock is confirmed as positive for Salmonella why use probiotic treatment as a therapy 
when there is justification to treat the animals with antibiotics? These studies should be 
seen as proof of principle and not a justification for use in the commercial market. 
Commercial flocks take 6 weeks to rear for meat production and the dynamic nature of 
Salmonella infection during these 6 weeks due to host development and environmental 
cycling warrant studies that simulate these conditions at least in part. Studies have been 
conducted over longer periods of time which, while not ideal, have more closely modelled 
probiotic inhibition of S. Enteritidis in poultry. A model used by Pascula et al, (1999) 
showed L. salivarius CTC2197 clearance of caecal colonisation of S. Enteritidis C-114 by 
day 21 post-infection. Again it should be noted that Pascula and colleagues used a non- 
invasive strain of S. Enteritidis but the experimental design included a period of chick 
development that included a partially mature host immune response. Administration of
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Bacillus cereus and Saccharomyces species to commercial broilers during a 47 day period 
which were subsequently challenged at age 12 days with S. Enteritidis showed improved 
weight and feed conversion as compared to the control group (Gil de los Santos et al,
2005). Although this model was specifically designed to evaluate weight gain rather than 
reduction in Salmonella carriage it would, in this author’s opinion, provide substantially 
better data of the efficacy of probiotic bacteria for the inhibition of Salmonella as compared 
to those found in the literature over the last five years.
The inadequate modelling of probiotic inhibition of Salmonella infection of poultry in 
recent years is, in this author’s opinion, due to the increased regulation covering these 
agents on the commercial market and the rise of cost for animal experimentation. 
Furthermore the stringency and cost of commercial testing of these agents is pushing 
research into countries lacking experience and resources for quality experimentation. The 
1970’s to the early 1990’s were the golden age of modelling probiotic inhibition of 
Salmonella in poultry whereas recent research, compared to earlier studies, lacks the design 
to give confidence of products working in the commercial market. Undoubtedly more is 
now known about probiotic mechanisms of action than ever before but it appears the more 
that is known the more fearful bureaucratic organisations are to implement this knowledge 
in a structured and logical manner.
1.4.9 Probiotic immune-modulation
The majority of research into probiotic immunomodulation has focused on the anti­
inflammatory effect of these organisms for attenuation of diseases such as inflammatory- 
bowl disease (IBD) (Pathmakanthan et al, 2004; Rioux & Fedorak, 2006). The use of 
probiotics to calm inflammation in the gut has received much attention due to the high 
profile and ubiquitous distribution of these important human diseases. Infection with 
Salmonella induces a different type of response and, as was discussed earlier in this 
Chapter, clearance of Salmonella from the host requires induction of pro-inflammatory 
immune response. The aim for probiotic immunomodulation of the host for clearance of 
Salmonella would thus be improved by the induction of pro-inflammatory cytokines. It 
should also be noted that induction of Th-2 responses result in increased antibody
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dependent immunity and that the induction of this response may improve long term
protection from Salmonella colonisation (Haghighi et al, 2005).
The induction of host acute pro-inflammatory and T-cell responses to Salmonella 
infection by probiotic bacteria has been shown to prevent S. Typhimurium colonisation of 
mice. It has been shown that the administration of milk fermented with L. helveticus R389 
to mice prevented colonisation by S. Typhimurium (Vinderola et al, 2007). Subsequent 
studies by the same group demonstrated that the administration of milk fermentation 
product to mice increased IL-2 and TNF-a expression in the small intestine, as observed by 
histological examination (Vinderola et al, 2007). IL-2, as discussed earlier in this Chapter, 
causes the expansion of T-cell populations and TNF-a drives the acute phase response. The 
two studies mentioned above suggest that the induction of pro-inflammatory cytokines and 
cytokines important in T-cell population expansion are important in S. Typhimurium 
clearance. In contrast to this study Haghighi et al (2008) demonstrated that the 
administration of a probiotic preparation, including Lactobacillus spp.. Bifidobacterium 
spp. and Enterococcus spp., resulted in the attenuation of INF-y and IL-12 cytokine 
expression in the caecal tonsils in response to S. Typhimurium. This observation, in 
conjunction with the reduction of Salmonella colonisation in mice, suggests a role for
attenuation of the immune response for S. Typhimurium clearance (Haghighi et al, 2008).
It should be noted that the changes in cytokine expression may not be linked to the 
clearance of Salmonella and that the production of inhibitory metabolites was the inhibiting 
factor. This picture is made even more complex by the fact that different cell types respond 
differently to probiotic bacterial stimulation. It was observed by O’Hara et al (2006) that 
pre-treatment of HT-29 cells with L. salivarius and B. inf antis attenuated pro-inflammatory 
IL-8 and NF-kB expression to S. Typhimurium. Although this anti-inflammatory was seen 
in epithelial cells they also demonstrated that dendritic cell expression of TNF-a was 
increased. This would suggest that probiotic immunomodulation is cell type specific. 
Whilst the anti-inflammatory response to probiotics by the epithelium may be required for 
commensal gut colonisation the pro-inflammatory response observed in dendritic cells 
would suggest that APC probiotic contact can induce inflammatory responses (O'Hara et 
al, 2006).
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The induction of the acute phase response and cell mediated immunity is required 
for clearance of Salmonella from poultry. Probiotic bacteria that enhance these responses 
would presumably improve the ability of the host to prevent Salmonella colonisation. To 
date only a small number of studies have been conducted that look at the ability of 
probiotic bacteria to enhance these host responses to Salmonella. Furthermore the results 
from these studies often appear contradictory. This contradiction in results might be due to 
other probiotic competitive exclusion mechanisms such as the production of inhibitory 
metabolites or the induction of humoral responses. It should be noted however that S. 
Enteritidis colonisation of poultry is considered to be commensal. As such the host does not 
necessarily mount an acute inflammatory response for clearance of this organism. In order 
to aid clearance of S. Enteritidis in poultry probiotic immunomodulation should induce an 
inflammatory response similar to a response by the host to an invading pathogen. Thus the 
induction of the acute phase response and activation of cell mediated immunity by 
probiotic bacteria in chickens may offer another mechanism for the control S. Enteritidis in 
commercial poultry production.
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1.5 Aims and objectives
The aforegoing introduction gives evidence that Salmonella Enteritidis is still a 
serious food borne zoonosis and that probiotics can be considered as possible components 
in intervention. The overall aim of this study was to investigate the suitability of two 
probiotic strains supplied by the sponsor to suppress S. Enteritidis in poultry. As part of this 
study, the opportunity was taken to test several hypotheses as to how this suppression may 
be mediated. Thus the specific aims and objectives are:-
1) Confirm that the two probiotic strains have characteristics akin to other strains belonging 
to the same species and also to confirm the organisms’ identity and growth characteristics.
2) Confirm that the two strains are safe for use as probiotics in poultry including a lack of 
transferable antibiotic resistance gene and that the strains are not cytotoxic.
3) Assess that the two probiotic bacteria can inhibit S. Enteritidis growth in or attachment 
to the host using in vitro and in vivo models.
4) Establish if the probiotic mechanism of competitive exclusion of S. Enteritidis in the 
host is due to immunomodulation, competition of receptor sites or the production of 
inhibitory metabolites.
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Chapter 2 - Materials and methods
2.1 Bacteriological methods
2.1.1 Bacterial strains
E. faecium PXN-33 and L. salivarius 59 were kindly supplied by the projects 
corporate sponsors. E. faecalis NCTC 29212 and E. faecium NCTC 12202 were obtained 
from the National Collection of Type Cultures (NCTC). Staphylococcus aureus American 
Type Culture Collection (ATCC) 5923 and L. salivarius National Collection of Industrial, 
Food and Marine Bacterial (NCIMB) 11975 were obtained from the ATCC and the 
NCIMB. Escherichia coli OlllrNM B171, E. coli 0127:H6 EC2348/69 and E. coli 
O78:K80 EC34195 were obtained from the Veterinary Laboratories Agency (VLA) culture 
collection. E. faecalis MMH 594, E. faecium C68, E. faecalis 219 and E. faecium C38 were 
kindly donated by Vanessa Vankerckhoven of the University of Antwerp.
2.1.2 Bacterial culture and enumeration
All bacterial cultures were stored at -80°C in heart infusion broth (HIB) 
supplemented with glycerol (30%) prior to use. Composition and preparation of media is 
given in appendix 1. Lactobacilli were grown for 48hrs micro-aerophilically using BBL® 
GasPaks® (Becton and Dickinson™ Oxford, U.K.) on de Man, Rogosa, Sharpe (MRS). 
Enterococci were grown micro-aerophilically on Slanetz and Berkey (SB) agar at 37°C for 
16hrs. E. coli were grown for 16hrs aerobically on Luria-Bertani without glucose (LB-G) 
agar. Where indicated E. coli, enterococci and lactobacilli were subsequently inoculated 
into LB-G, HIB and MRS broth. Broth cultures for enterococci and lactobacilli were 
incubated statically for 16hrs at 37°C whereas E. coli were incubated shaking at 200rpm for 
16hrs at 37°C. Bacteria for tissue culture adhesion and invasion assays were cultured 
aerobically in Luria Bertani (LB) agar for E. coli strains, HIB for enterococci and in MRS 
for lactobacilli at 37°C for 24 hrs statically. Bacteria were then centrifuged at 2600g for 10 
minutes at ambient temperature and were re-suspended in PBS to an optical density of 1.2 
for E. coli strains 1.8 for enterococcal strains and 2.1 for lactobacilli strains ABS at 540nm.
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Bacteria for tissue explant adhesion assays were cultured as above. Bacteria for in vivo 
studies were cultured in LB {S. Enteritidis), HIB (enterococci) and MRS (lactobacilli) broth 
at 37°C with gentle agitation, aerobically for 16 hrs and diluted in PBS to the desired CPU 
m l'\ Where different culture conditions are used these are described within the relevant 
materials and methods.
Bacterial suspensions were serially diluted in O.IM phosphate-buffered saline 
(PBS) (pH 7.4). Three 20|il spots of appropriate dilutions were plated onto dried agar 
plates and allowed to soak into the plates (Miles & Misra, 1938). Plates were subsequently 
incubated at 37°C for 24hrs and then enumerated.
2.1.3 Gram stain
L. salivarius 59 and Staphylococcus aureus ATCC 5923 were cultured for 16hrs 
micro-aerophilically using BBL® GasPaks® (Becton and Dickinson™ Oxford, U.K.) on de 
Man, Rogosa, Sharpe (MRS) agar and Luria-Bertani without glucose (LB-G) agar 
respectively. E. faecium NCTC 12202 and E. faecium PXN-33 were grown micro- 
aerophilically on Slanetz and Berkey (SB) agar at 37°C 16hrs.
A sweep of the 16hrs cultures was smeared onto a glass slide and heat fixed. Crystal 
violet was added to the smear for 60 seconds and subsequently washed for 5 seconds with 
water. The slide was then flooded with iodine solution and allowed to stand for 60 seconds. 
The excess iodine was rinsed off with water for 5 seconds and ethanol decolouriser was 
added. The decolouriser was rinsed over the sample until all excess crystal violet was 
removed. The sample was then rinsed with the water for 5 seconds and the slide was 
flooded with safranin. Excess safranin was washed off with water after 60 seconds as 
previously described. The slides were allowed to air dry and were examined under oil 
immersion light microscopy (Zeiss). Sample morphology was recorded as rod or cocci and 
Gram positive or Gram negative.
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2.1.4 Motility test
L. salivarius 59 and E. faecium PXN-33 were cultured 16hrs micro-aerophilically 
on MRS agar and SB agar, respectively. Escherichia coli OllliNM  B171 (non-motile, 
negative control) and E. coli 0127:H6 EC2348/69 (motile, positive control) were grown 
on LB-G aerobically at 37°C 16hrs. Single colonies were picked with an inoculation needle 
and stabbed into the centre of a universal containing 0.35% semi-solid ‘sloppy’ LB-G agar 
{E. coli control strains and E. faecium PXN-33) and MRS agar (L. salivarius 59). Motility 
stabs were incubated at 25°C, 37°C and 42°C for 24 hrs. Motility was observed as diffuse 
growth out from the point of inoculation.
2.1.5 Catalase test
L. salivarius 59 and S. aureus ATCC 5923 (positive control) were grown for 16hrs 
micro-aerophilically at 37°C on MRS and LB-G and respectively. E. faecium PXN-33 and 
E. faecium NCTC 12202 (negative control) were grown at 37°C, for 16hrs, micro- 
aerophilically on SB agar. A small amount of hydrogen peroxide was sucked up into a 
glass capillary tube. One colony of the respective strains was ‘picked’ by using the open 
end of the capillary tube. Production of gas within the capillary tube was recorded as 
catalase positive.
2.1.6 Haemolysin assay
Single bacterial colonies of L. salivarius 59, E. faecium PXN-33 and S. aureus 
ATCC 5923 (p-haemolytic positive control) were inoculated as a streak across the centre of 
Sheep Blood Agar plates using an inoculating loop and then incubated micro-aerophilically 
at 37°C for 16hrs. The plates were then examined for the presence of p or a haemolysis.
2.1.7 API 50CH and API 20Strep for spéciation of both probiotic cultures
BioMerieux API 50CH and API 20Strep were used to determine bacterial species 
according to the manufacturer’s instructions. For API 50 CH, in brief, L. salivarius 59 and 
L. salivarius NCIMB 11975 were grown 16hrs on 5% sheep’s blood agar. Approximately
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10ml of distilled water was distributed into the honeycomb tray which was to house the 
API strip. The 16hr cultures were removed from the plate and inoculated into API 50 CHL 
medium. Tubes of the API strip were inoculated with prepared suspension and incubated at 
37°C for 48hrs. Visual readings were taken at 24hrs and 48hrs and subsequently crossed 
reference with APIWEB® software.
For API 20Strep E. faecium PXN-33 and E. faecium NCTC 12202 were grown for 
16hrs on 5% sheep blood agar. Approximately 10ml of distilled water was distributed into 
the honeycomb tray which was to house the API strip. The 16hrs cultures were removed 
from the plate and inoculated into API Suspension Medium at a turbidity greater than 4 
McFarland. From VP test to the LAP test the tube and cupules were filled with the 
prepared suspension whilst only the tube and not the cupule for the subsequent ADH test 
was filled with the suspension. Zero point five milliletres of the suspension was added to 
API GP medium. After vortexing the API GP medium the remaining tubes (RIB to GLYG) 
were filled. After 4hrs aerobic incubation at 37°C one drop of VP 1 and VP 2 was added to 
the VP cupules. Two drops of NIN was subsequently added to the HIP test. One drop of 
ZYM A and ZYM B was added to PYRA, aGAL, PGUR, PGAL, PAL and LAP test 
cupules and was left to react for lOmins. After lOmins visual readings were taken and the 
API strip was re-incubated for a further 20hrs. Visual readings were taken after the 
subsequent reading and the API profiles were crossed reference with the APIWEB® 
software.
2.1.8 Growth curve
Growth curves of E. faecium PXN-33 and L. salivarius 59 were carried out as 
follows. E. faecium FXN-33 and L. salivarius 59 were cultured in Heart Infusion Broth 
(HIB) broth and MRS broth, respectively for 16hrs shaking at 200rpm. E. faecium PXN-33 
and L. salivarius 59 were diluted into HIB broth and MRS broth respectively, to 1x10  ^
cfu/ml. A lOOfXl aliquot of diluted culture was added to 100ml of HIB broth {E. faecium 
PXN-33 diluted culture) and 100ml of MRS broth (L. salivarius 59 diluted culture). 
Cultures were incubated at 37°C with shaking at 200rpm and inoculated onto plates in ten­
fold serial dilutions onto SB plates for E. faecium PXN-33 and MRS plates for L. salivarius
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59 determined the cfu/ml. Bacterial counts were determined at 0, 1, 2, 3,4, 5, 6, 7, 8, and 9 
hrs.
2.1.9 Acid tolerance assay
Essentially the method was as described by Tsai et al, (2004). L. salivarius 59 and 
E. faecium PXN-33 were grown for 16hrs statically at 37°C in MRS broth and SB broth 
respectively. E. coli O78:K80 (acid resistant positive control) and E. coli O78:K80 Rpos 
mutant (acid sensitive negative control) was grown for 16hrs in LB-G at 37°C shaking at 
200rpm. Prior to the addition of cultures the pH of O.IM PBS (pH 7.2) was adjusted to 2.0,
2.5 and 3.2 using 0.1 N HCl (Conway et ah, 1987). One hundred microlitres of 16hrs 
cultures at 1x10  ^ cfu/ml of test and control strains were transferred to 2ml of the 
appropriate (PBS) and incubated at 37°C for 3hrs. Controls, which showed very little or no 
change in test and control organism viability, were performed at pH 7.2 under the same 
condition. After incubation, viable bacterial counts were determined by plating serial 
dilution onto the appropriate agar. Control plates were incubated aerobically at 37°C for 
24hrs. L. salivarius 59 and E. faecium PXN-33 were incubated at 37°C for 24hrs micro- 
aerobically and the viable cell counts were determined.
2.1.10 Bile tolerance
Bile tolerance was determined as described by Gilliland et al, (1984) with 
modifications. L. salivarius 59 and E. faecium PXN-33 were grown for 16hrs in MRS broth 
and HIB broth, respectively. One percent of the 16hrs cultures were inoculated into MRS 
(L. salivarius 59) and HIB {E. faecium PXN-33) broth containing no bile, 0.3%, 0.6%, 
0.9% of Oxgall bile (BBL). Two hundred microlitres of inoculated cultures were added to 
SLS IWAKI micro-titre plates. Medium containing various preparations of bile but without 
culture inoculations were used as blank controls. Plates were incubated (37°C) and read at 
600nm optical density (O.D.) by the FLUOstar Optima® (BMG) every hour for 24hrs. 
Control O.D. values were subtracted from the O.D. values obtained for the test organisms. 
The acquired O.D. values were converted to the log 10 and plotted against time.
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2.1.11 Conditioned medium assay
L. salivarius and E. faecium were grown statically whereas S. Enteritidis was grown 
shaking at 200rpm for 16hrs at 37®C in BHIB. L. salivarius and E. faecium medium was 
centrifuged at 3000g for 10 minutes. The probiotic supernatant was removed and filtered 
sterilized using 0.2pm filters. The subsequent cell free supernatants were either adjusted to 
pH 7.2 or were used unadjusted after reading the pH of the conditioned medium. 
Subsequently the conditioned medium was inoculated with -1x10^ cfu/ml of S. Enteritidis. 
A duplicate range of conditioned medium preparations remained un-inoculated and used as 
blank controls. Two hundred microlitres of the S. Enteritidis and blank conditioned 
medium were inoculated into a 96 well micro-titer plate. Plates were incubated at 37°C and 
shaken briefly prior to being read at an optical density of 600nm using a Flurostar Optima®. 
Optical density readings were taken at time point zero then at 5hrs and subsequently every 
hour for 24 hrs.
2.1.12 Probiotic inhibitory diffusion assay
E. faecium and L. salivarius were grown statically for 16hrs at 37°C in MRS broth. 
Semi confluent lawns of S. Enteritidis were prepared as described previously (Andrews,
2006). Briefly S. Enteritidis was grown for 16hrs on LB-G at 37°C. A selection of S. 
Enteritidis colonies were inoculated into saline solution to give a final preparation at a 
turbidity of 0.5 McFarland. Ten micro-litres of the suspension were inoculated into 1ml of 
saline solution. The inocula were spread onto Iso-Sensitest agar to give a semi-confluent 
lawn of growth. Six millimetre diameter BD blank paper discs were inoculated with 20ul 
MRS broth. The remaining discs were inoculated with lOpl, 15pl and 20pl of 16hr cultures 
of the probiotic strains. A bank disc was also included as a non-inoculated control and a 
positive control disc containing 30pg of amoxycillin/clavulanic acid was also used. Plates 
were incubated at 37°C for 24 hrs and the zones of inhibition were measured.
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2.1.13 Minimum inhibitory concentration (MIC) of antibiotics
E. faecium PXN-33 and E. faecalis NCTC 29212 were grown for 16hrs statically at 
37°C in HIB. L. salivarius 59 and S. aureus ATCC 25923 were grown for 16hrs in MRS 
broth statically and LG-G broth shaking at 200rpm, respectively, at 37°C. Sixteen hour 
cultures were serially diluted to give approximately 1x10  ^cfu/ml of culture.
MIC’s were performed according to the British Society of Antimicrobial 
Chemotherapy (BSAC) (Andrews, 2001). The antibiotic doubling series used were as 
follows (MIC concentration given is ng/pl):- No antibiotic, 0.03, 0.06, 0.12, 0.25, 0.5, 1, 2, 
4, 8, 16, 32, 64, 128. When calculating the amount of antibiotic to add to the medium, 
adjustments were made for potency, if the antibiotic was not 100% potent. Where potency 
was not stated, it was assumed that the antibiotic was 100% potent. Stock solutions of 
antibiotics (50ml) were prepared at twice the final top level concentration (256|ig/ml). Up 
to 5ml of ethanol, 0.1 M NaOH or 0.1 M HCl were used to dissolve the antibiotics as 
required. The prepared antibiotic solutions were filter sterilised using a 0.22|im filter. Iso- 
Sensitest double strength agar (10ml volumes in uni versais) was melted and then cooled to 
50°C in a water bath.
For 5% blood Iso-Sensitest agar plates, 2ml of horse blood was added to 8mls of 
double distilled water for 128 ng/pl serial dilution preparation. For no antibiotic and the 
dilution series 0.003 ng/pl to 64 ng/pl antibiotic, 1ml of horse blood was added to 9mls of 
double distilled water. The sterile antibiotic solutions were double diluted into the prepared 
10ml volumes of sterile distilled water plus blood (for 5% horse blood Iso-Sensitest plates) 
or into lOmls of double distilled water (for Iso-Sensitest plates without 5% horse blood). 
The antibiotics were diluted over the MIC range. The Antibiotic solutions (10ml) were 
poured into the tempered 10ml volume of molten double strength agar, gently mixed, than 
immediately poured into a labelled Petri dish. The Agar was allowed to set before drying 
the plates for 30 minutes. Dried plates were inoculated with bacterial suspension prepared 
as above using multi-point inoculators. After 24hrs of aerobic incubation at 37°C MICs 
were recorded as the lowest (minimum) concentration of antibiotic to inhibit growth of the 
test organism by ~ 90% of its normal growth (compared to the control plates) or more.
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2.2 Molecular biology methods 
2.2.1 Preparation of genomic DNA
A Qiagen DNeasy® Tissue Kit was used to prepare genomic DNA from bacterial 
whole cells. The manufacturer’s instructions were followed with some modification. L. 
salivarius 59 and E. faecium PXN-33 were grown for 16hrs in MRS broth and SB broth 
respectively. Three millilitres of 16hrs culture was harvested at 6000g for 10 minutes. L. 
salivarius 59 was re-suspended in ISOpl of 20mg/ml lysozyme in TE buffer and incubated 
for 16hrs at 37°C. In contrast E. faecium PXN-33 was re-suspended in 180pl of 5mg/ml 
lysozyme in TE buffer for 30minutes at 37°C. One 20pl loop of Proteinase K was added to 
500pl of TE buffer to make the Proteinase K solution. One hundred and ten microlitres of 
Proteinase K and llOpl 10% (w/v) SDS was added to the lysis/bacterial suspensions and 
incubated at 65°C for 30 minutes. Two hundred micro-litres of 97% ethanol was added to 
the lysed bacterial solution and was mixed by 6 inversions to precipitate the genomic DNA. 
The precipitated DNA/bacterial solution was added to the DNeasy Mini Spin Column and 
centrifuged at 6000g for 1 minute. The flow-through was discarded and 500jil of Buffer 
AWl was added. The spin column was then centrifuged again at 6000g for 1 minute and the 
flow-through was subsequently discarded. Five hundred micro-litres of Buffer AW2 was 
added and the spin tube was centrifuged at ll,600g for 3mins to dry the column. To elute 
the DNA 50pl of distilled water was added to the spin column membrane and incubated at 
room temperature. After 3mins the column was centrifuged at 6000g for Imin and the 
DNA concentration of the supernatant was determined using a Nano-Drop® (Nano-Drop 
Technologies).
2.2.2 Preparation of eukaryotic RNA
Total RNA was isolated from HDl 1 cells using the RNeasy mini prep kit® (Qiagen) 
according to the manufactures instructions. HD 11 cells were disrupted using 350pl of RTL 
lysis buffer containing p-mercaptoethanol. The lysate suspension was added to the 
QIAshredder mini spin columns® (Qiagen) centrifuged at 14,100g for two minutes on a 
table top microfuge. Subsequently 350pl of 70% ethanol was mixed to the lysate and added 
to a RNeasy mini column. The mini columns were then centrifuge for 15 seconds at
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8,400g. Columns were washed with 700pl RWl buffer and then subsequently with 500pl 
of RPE by centrifuging the columns for 15 seconds at 8,400g. Columns were washed again 
with 500[xl RPE for 2 minutes at 8,400g rpm. Columns were dried by centrifuging at 
13,000 rpm for 1 minute. RNA was eluted into 50pl of Ambion® RT-PCR grade (not 
DEPEC treated) H2O by centrifugation twice at 8,400g. To remove DNA, samples were 
treated with Ambion® Turbo DNase I™ as described in the manufactures instructions.
2.2.3 Polymerase chain reaction (PCR) including BOX PCR strain typing
Amplification of target DNA was carried out by PCR (Saiki et al, 1988). Reactions 
for amplification by PCR consisted of Thermophilic DNA polymerase lOX magnesium 
free buffer (5pi), 1.5mM MgCl2 , 2.5 units of Taq polymerase (Promega), 200pM dNTP’s 
(Amersham Biosciences), lOpmols of each primer (Table 2.1), Ip of 20ng/pl to 50ng/pl 
DNA concentration of complete genomic DNA, and were made to a final volume of 50pl 
using sterile distilled H2O. PCR amplifications were performed for 1 cycle at 95°C for 5 
minutes (initial denaturing); 30 cycles of 95°C for 2 minutes (denaturing), at the required 
annealing temperature for 1 minute (Table 2.1) and 72°C for 2 minutes (extension); 1 cycle 
at 72°C for 10 minutes (final extension). PCR reactions were stored at -20°C until required.
BOX PCR was adapted in our laboratory from previously described methods 
(Versalovic et al, 1994; Kim et al, 2002). The reaction was conducted as described above 
except the BOX-AIR primer was used as the forward and reverse primer. The template 
DNA was added at a concentration of lOOng and the annealing temperature of 35°C was 
used instead of the standard melting temperature based annealing temperatures in order to 
increase the number of BOX-repetitive type sequence amplifications.
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Table 2.1 Primers for spéciation o fh .  salivarius and E. faecium. Primer source and annealing temperature 
of diagnostic PCR used for spéciation of L. salivarius 59 and E. faecium PXN-33.
Gene Primer name Oligonucleotide sequence Annealing Assession Source
(S'to 30 temp. no.
I L. salivarius Universal 616V AG A GTT TGA TCC TGG CTC AG 58°C AB175737 Ehrmann et
i 16 rRNA Spez92R G AA TGC AAG CAT TGG GTG TA al, 2002
E. faecium Fi GCAAGGCTTCTTAGAGA 54°C API38282 Dutka-Malen
ddÏE .faecium F2 CATCGTGTAAGCTAACTTC et a i, 1995
i BOX-repeat BOX-AIR ACGTGGTTTGAAGAGATTTTCG 35°C - Kim et al..
1 motif 2002
Adapted from Ehrmann & Kurzak et al, (2003) and Dutka-Malen et al, (1995).
2.2.4 PCR using HotStarTaq
HotStarTaq DNA polymerase (Qiagen) was used for amplification of virulence 
factors by PCR reactions according to the manufacturer’s recommendations. In brief 25pi 
of HotStarTaq DNA polymerase was added to 10 pmols of each primer (Table 2.2), Ipl of 
between 20ng/pl and 50ng/pl of complete genomic DNA made up to a final volume of 50 
pi per PCR reaction with distilled water. PCR amplifications were performed for 1 cycle at 
95°C for 15 minutes (initial denaturing); 30 cycles of 94°C for 2 minutes (denaturing), at 
the required annealing temperature, 56°C for 1 minute and 72°C for 2 minutes (extension); 
1 cycle at 72°C for 10 minutes (final extension). PCR reactions were stored at -20°C until 
required.
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Table 2.2 Primers o f enterococcal virulence factors. Primer names, product size, sequence and gene 
designation for enterococcal virulence factors.
Gene Virulence
factor
Primer
name
Oligonucleotide sequence (5’ to 3’) Product 
size (bp)
Assession
no.
t Asal Aggregation ASA 11 GCACGCTATTACGAACTATGA 375 X17214
substance ASA 12 TAAG A A AGA AC ATC ACC ACGA
GelE Gelatinase GEL H TÀTGACÀATGCTTTTTGGGAT -  - " ^ )^ 1 8 5  '
GEL 12 AGATGCACCCGAAATAATATA
CylA Cytolysin CYTI ” ÀCTCGGGGÀTTGATÀGGC........... 688 AF454824 '
CYTIib GCTGCTAAAGCTGÇGCTT
Esp Enterococcal ESP 14F AGÂ TTTCÀ TClW GÀ frCTTœ AY322150^
surface protein ESP 12R AATTGATTCTTTAGCATCTGG
Hyaluronidase HYLnl ' ACAGAAGAGCTGCAGGAAATG 276 AF544400 ]
{ HYLn2 GACTGACGTCCAAGTTTCCAA
Table adapted from Vankerckhoven et al, (2004).
2.2.5 Separation of DNA fragments by agarose gel electrophoresis
For analysis of small DNA fragments (less than 1 kb) a 1.5 % (w/v) agarose gel, in 
1 X TAB buffer was prepared. A DNA molecular marker of established DNA band size was 
also ran alongside the DNA samples. A 1 Kbp DNA ladder (Invitrogen) was used as the 
DNA molecular marker and 250 ng of each marker was loaded on the gel. A 6 x DNA 
loading buffer (2 pi) and water (5 pi) was added to the sample (5 pi) before loading. The 
agarose gel was placed in a Sub-Cell tank (Bio-rad) and submerged in 1 x TAB buffer and 
electophoresed at 100 V for 1 hour. The gel was stained in an ethidium bromide solution (1 
pg/ml) for 30 minutes and the DNA was visualised under ultra-violet light.
2.2.6 Pulse Field Gel Electrophoresis methods
PFGE was performed as previously described with modifications (Jacobsen et al, 
1999; Turabelidze et al, 2000; Garcia-Migura et al, 2005). One point five millilitres of a 
16hr culture was centrifuged at SOOOrpm on a tabletop microfuge for lOmins. Bacterial 
pellets were washed once in 1ml of SE buffer (75mM NaCl and 25mM EDTA pH 7.4). 
Samples were subsequently re-suspended in 0.5ml SE buffer. Zero point five millilitres of 
tempered (50°C) 2% Seakem Gold (Cambrex, East Rutherford, N.J.) was added to the 
bacterial suspension and pipetted into disposable plug moulds. Plugs were subsequently
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lysed in 0.5ml lysis buffer (50mM EDTA pH 8.2, 0.05% N-lauroysarcosine, 2mg/ml 
lysosyme and 3U/ml of mutanolysin) at 37°C for 16hrs. The plugs were then incubated 
overnight at 53°C in 0.5 ml of a solution containing lOmM Tris, 0.5 M EDTA (pH 8.5), 
1% sodium dodecyl sulfate, and 2 mg of proteinase K per ml. The agarose plugs were 
washed six times for 30 min in 1.5 ml of SE buffer to remove proteinase K (Jacobsen et al, 
1999). Restriction digestion of chromosomal DNA was carried out by using 25 units of 
Smal (Promega, Southampton, United Kingdom) for 2hrs at 25°C. Pulsed-field gel 
electrophoresis (PFGE) was performed on a CHEF DREI system (Bio-Rad, Hercules, 
Calif.) in 0.5% TBE extended-range buffer (Bio-Rad) with re-circulation at 14°C. DNA 
restriction fragments were resolved in 0.8% SeaKem Gold agarose in 0.5% TBE buffer. 
DNA from Salmonella Braenderup H9812 restricted with Xbal was used as a size marker 
(Garcia-Migura et al, 2005). Restriction fragments were resolved under the running 
conditions: Block 1, 200 V, initial time, 3.5 s, final time, 25 s, 12h; block 2, 200 V, initial 
time, 1 s, final time, 5 s; 8 h; total time, 20 h. The Gels were subsequently stained in 
lOOpg/ml of Ethidium bromide (Sigma, Alderich) for 25mins and de-stained for 70min 
changing the sterile water every 30mins (Turabelidze et al, 2000).
2.2.7 QRT-PCR of avian cytokines.
Cytokine production by HD 11 cells was quantified by TaqMan® qRT-PCR as 
described previously (Kaiser et al, 2000; Moody et al, 2000; Rothwell et al, 2004). 
Primers and probes described in Table 2.3 were used to determine cytokine mRNA levels 
of the HD 11 cells. Probes were previously designed to lie across the splice junctions of the 
appropriate genes and were labelled at the 5’ end with the fluorescent reporter dye 5- 
carboxyfluoroscein (FAM) and at the 3’ end of the probe with the quencher N,N,N,N’~ 
tetramethyl-6-carboxyrhodamine (TAMRA).
Template mRNA isolated from the HDll macrophages was amplified by one-step 
qRT-PCR using The Reverse Transcriptase qPCR Master Mix kit® (Eurogentec) as 
instructed by the manufacturer. Each reaction was made up to a final volume of 25pl 
consisting of 7.5pmol of each forward and reverse primer (i.e. a final concentration of 
300nM), 2.5pmol of probe (i.e. final concentration of lOOnM) and 5.0|il volume of
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template. Amplification of target mRNA (i.e. 28S rRNA, IL-lp, IL-6 and IL-10 mRNA) 
and detection of fluorescent FAM report signal was performed in the Stratagene® MxSOOOP 
Real-Time PCR system, with cycle conditions; 50°C for 2mins and 96°C for 5mins 
(dénaturation), 60°C for 30mins (reverse transcription), 95°C for 5mins (reverse 
transcription inactivation and Hot GoldStar DNA polymerase activation); followed by 40 
cycles of 94°C for 20 seconds (dénaturation) and 59°C for 1 min (primer annealing and 
extension).
Quantification of detected mRNA was based on the increasing strength of the 
fluorescent FAM reporter signal during PCR. This occurred due to Hot GoldStar DNA 
polymerase digestion of the probe during the amplification reaction which resulted in the 
release of the bound 5’ reporter dye FAM from the 3’ bound quencher TAMRA. The 
passive reference dye 6-carboxy-%-rhodamine (ROX) was also included in each reaction. 
ROX was not involved in the mRNA amplification, but was used to normalize the FAM 
reporter signal and correct for fluorescent fluctuations which arose from the changing 
conditions during the reaction.
Calibration curves were performed on the LPS positive control for the cytokines 
and 28S rRNA gene to ensure a linear relationship between the reduction in sample and the 
reduction in fluorescence. Results were obtained as mean cycle threshold values (Ct) i.e. 
the PCR cycle at which the increasing reporter dye signal passed the significance threshold 
of the baseline/background fluorescence. Results were reported as Ct values subtracted 
from 40 [i.e. (40-Ct)], because 40 PCR cycles were used in each amplification reaction; 
therefore, (40-Ct) was the negative end point. This was done because there is an inverse 
relationship between the amount of template mRNA in a sample and Ct.
The amount of expressed 28S rRNA in each cell is constant and as such can be used 
to baseline the cytokine mRNA in the sample i.e. to correct for the variation in the number 
of cells sampled in each experimental reaction. The mean Ct value of 28S rRNA for all the 
experimental samples, positive control sample and negative control sample was calculated. 
The individual 28S rRNA Ct values used to calculate the mean were divided by the mean 
28S rRNA value to give the difference factor. The 40-Ct value for the investigated cytokine 
was multiplied by the slope of the cytokine calibration curve. This was subsequently 
divided by value obtained when the difference factor was multiplied by the slope of the
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28S mRNA calibration curve to give the adjusted cytokine 40-Ct value for each sample. 
The adjusted cytokine 40-Ct value for the positive control and samples was taken away 
from the adjusted cytokine 40-Ct value for the negative control to give the 40-Ct difference 
between the treatments or positive control and the negative control. As duplication of RNA 
occurs roughly every two cycles in the PCR, 2 was multipled by the power of the 
difference factor to calculate the fold change in cytokine production between the sample or 
positive control and the negative control (un-stimulated) i.e. using the method
of analysis. Each reaction was performed in duplicate on three experimental samples on 
two occasions.
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Table 2.3 Primers and probes for qRT-PCR amplification of chicken cytokine mRNA and 28S rRNA.
Target gene, sequence, exon boundary location, accession number and reference of original primer and probe 
design.
RNA Probe/ Probe/primer sequence Exon Assession Source
target Primer boundary no.
1 28S Probe
Forward
FAM-AGGACCGCTACGGACCTCCACCA-7AM/M
GGCGAAGCCAGAGGAAACT
X59733 (Kaiser et 
al, 2000)
1 Reverse GACGACCGATTTGCACGTC
IL-1 Probe
Forward
Reverse
FAM-CCACACTGCAGCTGGAGGAAGCC-7AMRA
GCTCTACATGTCGTGTGTGATGAG
TGTCGATGTCCCGCATGA
5/6 AJ245728 (Kaiser et 
al, 2000)
r i L . 6 Probe FAM-AGG AGA AATGCCTG ACGA AGCTCTCCA-7AA/FA 3/4 AJ250838 (Kaiser et
1 Forward GCTCGCCGGCTTCGA al, 2000)
1 Reverse GGTAGGTCTGAAAGGCGAACAG
IL-10 Probe
Forward
Reverse
FAM-CGACGATGCGGCGCTGTCA-FAMFA
CATGCTGCTGGGCCTGAA
CGTCTCCTTGATCTGCTTGATG
3/4 AJ621614 (Rothwell 
et al, 
2004)
Table adapted from Kaiser et al, (2000) and Rothwell et al, (2004).
2.2.8 Transmission electron microscopy of cell surface appendages
For the elaboration of any surface appendages of interest, E. faecium PXN-33, L. 
salivarius 59 and E. coli 0127:H6 EC2348/69 was cultured in SB, MRS and LB-G 
medium respectively for 18hrs. One percent of culture was re-inoculated into 3ml of the 
appropriate medium and incubated statically for a further 18hrs. For L. salivarius 59 3ml of 
the 16hrs culture was centrifuged at 3000 g for 2 minutes and washed in 1.5ml O.IM PBS 
pH 7.2 (McGroaty, 1994). Cells were washed twice more and then re-suspended in lOOpl 
of PBS and incubated at 37°C for 50 minutes. For E. faecium PXN-33 and E. coli 0127:H6 
EC2348/69 3mls of the 16hrs culture was washed as described above. Cells were then re­
suspended in 3ml of appropriate culture medium and incubated at 37°C for 50 minutes. 
Cells were centrifuged as described above and re-suspended in lOOpl PBS. 50pl of the 
prepared suspensions were placed on sterile dental wax. Formvar’’''^  carbon coated grids 
were placed on top (silver side down) of each spot for 15 minutes. Excess liquid was 
removed on blotting paper and the grid (silver side down) was placed onto a 50pl spot of 
potassium phosphate, tungsten (KPT) negative stain for no longer than 15 seconds. Grids 
were carefully blotted dry and viewed using a Philips CM 10 transmission electron 
microscope.
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2.3 In vitro and ex vivo methods
2.3.1 Association and competition assays
Tissue culture assays were performed essentially as described previously with 
minor modifications (Kang, Mathan et al, 1995; Dibb-Fuller et al, 1999; Dibb-Fuller et 
al, 2001). Bead stock cultures of tissue culture cells were stored in Cryo-tubes in liquid 
nitrogen (-196°C). When required cells were removed from liquid nitrogen and thawed at 
37°C in a water bath. Thawed cells were reconstituted in Eagle’s Modified Medium 
(EMM) (Sigma) or Dulbecco’s Modified Eagles Medium D5671 (DMEM) (Sigma) 
supplemented with foetal calf serum (10% v/v, Autogenbioclear), non-essential amino- 
acids (1% v/v. Sigma) and gentamicin (50jig/ml, Sigma). Reconstituted cells were placed 
in 30ml of the above medium and placed into 250ml tissue culture flasks and incubated at 
37°C in the presence of 5% CO2 in air until a confluent mono-layer was present. Confluent 
mono-layers were trypsinised and mono-layers sown at 2 x 10^  cells per well in 24 well 
micro-titre plates and were grown to confiuency after 48hrs before use.
RAW macrophages were maintained as described by (Fritsche et al, 2003). In brief 
cells were grown in DMEM D5671 (Sigma) supplemented with 10% FBS, 2mM l-  
glutamine, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. Caco-2 cells were maintained 
as described by Haque et al, (2004). Brush border expressing (C2BBe) cells were 
maintained in Dulbecco’s modified Eagle’s medium with 4 mM L-glutamine, adjusted to 
contain 1.5 g/1 sodium bicarbonate, 4.5 g/1 glucose (90%) and foetal calf serum (10%) 
supplemented with 0.01 mg/ml human transferrin. Cells were grown to confiuency and 
differentiated for 15 days before use in invasion assays. The human HEp-2 cell line 
(European Collection of Animal Cell Cultures, EC ACC 86030501), was sown at 2 x 10^  
cells per well in 24 well micro-titre plates and mono-layers were incubated for 48 hrs in 
Eagle’s Minimal Essential Media (EMEM). The mucus secreting cell line HT2916E were 
sown at 2 X 10^  cells per well in 24 well micro-titre plates and mono-layers were 
subsequently incubated for five days, with feeding on alternate days. By five days a 
confluent mucus layer was present on the surface of the HT2916E cells. All assays were 
repeated at least four times on a minimum of three separate occasions.
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HEp-2, Caco-2 and HT2916E mono-layers were washed twice with Hank’s 
Balanced Salt Solution (HBSS) to remove cell debris and residual gentamicin. Inocula for 
tissue culture assays were prepared by streaking from the stock culture onto LB-G {S. 
Enteritidis (S1400), MRS (L. salivarius 59) and SB {E. faecium PXN-33) media. Discrete, 
well-isolated colonies were inoculated into the appropriate broth and grown for 16hrs, 
shaking at 37°C. Sixteen hour cultures were re-suspended in O.IM PBS (pH 7.2) to give an 
optical density reading of 1.2 {S. Enteritidis), 2.1 (L. salivarius 59) and 1.6 {E. faecium 
PXN-33) ABS (540nm) then diluted (1/20) in DMEM, non-essential amino acids (1% v/v. 
Sigma), and L-glutamine (Sigma) to give approximately 5 x 10^  cfu/ml. The number of 
bacteria given in each inoculum to each mono-layer was determined by plating ten-fold 
serial dilutions on appropriate agar.
Association assays were performed as described previously with modifications (La 
Ragione et al, 2000; Best et al, 2005). For association assays, the bacterial inocula were 
added to give 5x10  ^cfu/well. Mono-layers were then incubated at 37°C supplemented with 
5% CO2 in air for 3hrs. The supernatant was removed and the mono-layers were washed 
(x3) with HBSS to remove non-adherent bacteria. Mono-layers were disrupted for 10 
minutes with a solution of 1% Triton X-100 (Sigma) and gentle vortexing using a 12mm 
magnetic stirrer. After disruption, 10-fold serial dilutions were plated onto appropriate agar 
and incubated 16hrs at 37°C to determine the numbers of cell-associated and adherent 
bacteria.
For competition assays L. salivarius 59 and E. faecium PXN-33 were allowed to 
associate as described above for 3 hrs at which point the mono-layers were washed (x3) 
with HBSS, after which the cells were re-inoculated with 5x10  ^cfu/well of S. Enteritidis. 
Plates were incubated at 37°C (5% CO2 in air) for a further 2 hrs and washed (x3) with 
HBSS. The mono-layers were then disrupted with a 1% solution of Triton X-100 (Sigma) 
and the numbers of S. Enteritidis association were determined.
2.3.3 Scanning electron microscopy of HEp-2 cells
Mono-layers were prepared for bacterial adherence as described above for 
association assays. All media was aspirated and replaced with 3% (v/v) glutaraldehyde
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(Sigma) in O.IM PBS (pH 7.2). Mono-layers were fixed for 16 hrs in 3% (v/v) 
glutaraldehyde in O.IM PBS (pH 7.2) at 5°C.
Samples were subsequently processed by Bill Cooley at the VLA as described 
herein. Specimens were washed in O.IM PBS (pH 7.2) and post fixed in 1% (w/v) osmium 
tetroxide in the same buffer, then rinsed in six changes of phosphate buffer, dehydrated in 
ethanol and placed in hexamethyldisizane for 5 minutes. Specimens were subjected to 
critical point drying with liquid carbon dioxide. Air dried specimens were fixed to 
aluminium stubs with silver conductive paint, sputter coated with gold and examined using 
a Stereo-scan S250 MarklH SEM at 10-20KV.
2.3.4 Giemsa staining of HEp-2 and HT29 cells
Mono-layers were prepared for bacterial adherence as described above for 
association assays. Each well was inoculated with the bacterial inocula and incubated for 3 
hrs at 37°C, 5% CO2. Mono-layers were washed (xl) with HBSS and then fixed with 3% 
buffered formalin for 30 minutes and washed (x3) with sterile distilled H2O. Mono-layers 
were stained with 10% Giemsa stain (Sigma) for 1 hour then washed (x3) with distilled 
water. Mono-layers were differentiated with 1% (v/v) acetic acid for 2 minutes and washed 
once with sterile distilled H2O. Cover slips were then removed from the 24 well plates and 
mounted on glass slides using DPX (Sigma). Cover slips were examined using high-power 
oil immersion light microscopy (Zeiss).
2.3.5 Tissue culture growth of HDll macrophages and stimulation assays
Tissue culture assays were performed essentially as described previously with 
minor modifications. Bead stock cultures of tissue culture cells were stored in Cryo-tubes 
in liquid nitrogen (-196°C). When required cells were removed from liquid nitrogen and 
thawed at 37°C in a water bath. Thawed cells were reconstituted in RPMI supplemented 
with foetal calf serum (2.5% v/v, Autogenbioclear), TPB (2.5%), Chick serum (2.5%), 
NaHC03 (7.5%), 200mM L-Glutamine, 0.5mg/ml Folic acid, non-essential amino-acids 
(1% v/v. Sigma) and gentamicin (50|Xg/ml, Sigma). Reconstituted cells were placed in
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30ml of the above medium and placed into 250ml tissue culture flasks and incubated at 
41°C in the presence of 5% CO2 aerobically until a confluent mono-layer was present. 
Confluent mono-layers were trypsinised and mono-layers sown at 2 x 10^  cells per well in 
24 well micro-titre plates and were grown to confiuency for 48hrs before use.
Stimulation assays were performed as described previously with modifications (La 
Ragione et al, 2000; Best et al, 2005). For stimulation assays, the bacterial inocula was 
added to give 5x10  ^cfu/well prepared in RPMI medium supplemented with L-Glutamine 
(1%) and non-essential amino-acids (1%). A medium control well and a positive control 
well containing 5ug/well of LPS were included. Mono-layers were then incubated 
aerobically at 41°C supplemented with 5% CO2 for 3hrs. The supernatant was removed and 
HDl 1 RNA was isolated as described in section 2.2.2.
2.3.6 RAW macrophage cytokine response assays
E. faecium PXN-33, L. salivarius 59, a 50:50 preparation of both probiotic strains 
and S. Enteritidis (S1400) were inoculated onto plates pre-seeded with 1x10  ^ cfii/well 
RAW macrophages grown to approximately 75% confiuency at 37°C. For 5hr cytokine 
response assays 1ml of bacterial inocula was added to give 5x10  ^ cfii/well and 1ml of 
medium only was added for medium control. Mono-layers were then incubated at 37°C 
supplemented with 5% CO2 aerobically for 5hrs. Supernatants were removed and analysed 
by enzyme-linked immunosorbent assay (ELISA).
For RAW macrophage cytokine response to co-infection with E. faecium PXN-33, 
L. salivarius 59 or a combination of the two organisms with subsequent S. Enteritidis 
stimulation was determined as follows. Probiotic preparations at the same cfu/ml as above 
were incubated for 3hrs. The supernatant was removed and S. Enteritidis (SI400) was 
inoculated for a further 2hrs and subsequently the supernatant was removed for analysis.
For the probiotic control values the probiotic preparations were inoculated onto 
RAW macrophages for 3hrs and the medium was removed. The probiotic inoculation was 
removed and replaced with medium. After a further 2hrs the supernatant was removed for 
analysis to give the probiotic stimulation. A reading was also taken for S. Enteritidis 
(SI400) stimulation after 2hrs independently of the probiotic reading. The S. Enteritidis
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reading was added to the response of the probiotic control treatment to produce a control 
cytokine response value. ELISA assays were performed as described below.
2.3.7 ELISA for RAW macrophage cytokine production
TNF-a, IL-6 and IL-10 production by RAW macrophages was determined using 
R&D systems Quantikine® sandwich ELISA kits. In brief supernatants of RAW 
macrophages were removed and centrifuged at 8000 rpm for lOmins to remove cellular 
debris. All reagents were brought to room temperature. Standards for TNF-a were 
reconstituted in calibrator diluents RD5Z whereas IL-6 and IL-10 standards were 
reconstituted in calibrator diluents RD5T. Serial 2 fold dilutions of the standards were 
prepared in the appropriate calibrator diluents. Fifty micro-litres of assay diluents (IL-6 and 
EL-10 assay diluents RDI-14 and TNF-a assay diluents RDIW) and 50pl of standard, 
control or sample was added to the centre of the ELISA plate. The plate was tapped gently 
for one minute, covered and incubated at room temperature. After 2hrs incubation the 
ELISA plate was washed in 400pl wash buffer five times, ensuring wash buffer was 
completely removed after each wash. One hundred micro-litres of conjugate were 
subsequently added to each well and the plate was incubated for a further 2hrs at room 
temperature. The ELISA plate was subsequently washed a further five times and lOOpl of 
substrate solution was added. The plate was incubated for a further 30 minutes at room 
temperature protected from light. After incubation lOOpl of stop solution was added and 
the plate was again tapped gently to ensure homogenous distribution of the stop solution. 
The optical density for each well was determined at 450nm using a Thermo Lab systems 
Multiskan Ascent ELISA plate reader. A calibration cure was plotted using the standards 
and the concentration of each sample and control was determined using the calculation y = 
m X + c, where y is the concentration of cytokine, m is the gradient of the line of best fit, x 
is the optical density and c is the x axis intercept.
2.3.8 Avian in vitro organ culture (IVOC)
L  salivarius 59 and E. faecium PXN-33 were grown for 16hrs, statically at 37°C in 
MRS broth and HIB broth respectively. Cultures were centrifuge at 1700g for 10 minutes.
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L  salivarius 59 and E. faecium PXN-33 were adjusted at 540nm in O.IM PBS (pH 7.2) to 
an optical density of 2.1 and 1.6 (±0.1) to give a final cfu/ml of 1x10 .^ Explant assays were 
performed as previously described with some modifications (Allen-Vercoe & Woodward, 
1999; La Ragione et ah, 2000). Day old SPF White Leghorn chicks (SPAFAS®) were 
culled by cervical dislocation. Approximately 2cm sections of tissue from the crop, 
duodenum, jejunum, ileum, ceaca and colon, were aseptically removed and stored in pre­
warmed sterile Ringer’s solution until use. The tissue loops were sliced down the 
longitudinal axis to expose approximately Icm^ of epithelial surface. Each explant was 
gently washed in sterile Ringer’s solution twice, added to 10ml of sterile Ringer’s solution 
and inoculated with a final concentration of 5x10  ^cfii/ml bacteria. Explants were incubated 
at 37°C with shaking for 2 hrs. The tissues were rinsed in pre-warmed sterile Ringer’s 
solution three times. The tissues were placed into 9mls O.IM PBS (pH 7.2) and 
homogenized using CAT S620® (SLS). Serial dilutions of suspension were plated out onto 
the appropriate medium and bacterial counts were determined.
2.4 In vivo methods
2.4.1 General in vivo methods
Mixed sex SPF White Leghorn chicks (SPAFAS®) were used in all in vivo studies. 
All chicks were hatched and transferred to Wey-isolators. Isolators were fumigated with 
formaldehyde before use and subsequently maintained under negative pressure. Feed and 
water were sterilized by irradiation and made available to the chicks ad libitum. Chicks 
were fed on a complete mash diet (chick crumbs) with a composition as described in 
Appendix 2. All procedures were carried out at the Veterinary Laboratories Agency 
(Weybridge) in accordance with Home Office guidelines.
2.4.2 Enumeration of persistence of Salmonella Enteritidis in chicks.
Shedding was assessed by a semi-quantative method as described previously with 
some modifications (Carroll et al, 2004). Cloacal swabs were plated onto brilliant green 
agar (BGA) with appropriate antibiotic in an 8 by 8 cross-hatching pattern. Swabs were 
inoculated into 9ml selenite broth. Plates and selenite broths were incubated at 37°C
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overnight. Where no Salmonella were recovered from initial culture, lOOpl of selenite 
broth enrichment were subsequently re-plated 1 and 7 days after initial incubation. 
Shedding results were recorded as negative, positive after enrichment, low (1-200 
colonies), moderate (>200 colonies) and high (confluent growth) from initial plates.
2.4.3 PAS staining and histology
Tissue samples fixed in 3% formalin were rinsed with tape water to remove any 
residual fixative and placed on slides. Samples were then stained with Alcian blue for 
5mins. Samples were rinsed under running tap water for a further 5mins and then rinsed 
twice with distilled water. Samples were subsequently washed twice with distilled water 
and then placed in 1% Aqueous Periodic Acid for a further 2mins. The sample was 
subsequently rinsed twice and the slide was flooded with Schiff s Reagent for 8mins. 
Samples were rinsed under tap water for a further 2mins and subsequently the cell nuclei 
were stained with Mayer’s Haematoxylin for one minute. Samples were then washed for 
5mins in tap water, dehydrated with alcohol and mounted using DPX. Acidic mucins were 
stained blue, neutral mucins were stained magenta and the nuclei were stained blue.
2.4.4 Probiotic feeding trial in SPF White Leghorns
Two equal groups of 18-day-old chicks were housed in negative pressure Wey- 
isolators. All chicks in the first group were dosed by oral gavage with 1x10  ^ cfu of 
probiotic preparation at age one and eleven days. The birds were dosed with a 50:50 
preparation of L. salivarius 59 and E. faecium PXN-33 suspended in 0.1ml of PBS. The 
remaining control group received 0.1ml of PBS by oral gavage. At five days of age 5 birds 
were humanely sacrificed for post mortem examination and circa 1 gram of the duodenum, 
jejunum, ileum, ceaca and colon were removed aseptically for histological examination. 
Samples were then placed in 9ml of 3% formalin. At 4, 14 and 21 days post-inoculation 
birds from each group were sacrificed and subsequently weighed.
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2.4.5 Direct oral contact competitive exclusion feeding trial
One hundred day old chicks were divided equally into 4 groups of 25 birds and 
were housed in Wey-isolators under negative pressure. The competitive exclusion feeding 
trial used in this study was performed as described previously with minor modifications 
(Pascual et al, 1999). Four equal groups of 25 day-old chicks were housed in negative 
pressure Wey-isolators. All chicks in three groups were dosed by oral gavage with 1x10  ^
cfu of probiotic preparation. The birds were dosed with L. salivarius, Enterococcus 
faecium or a 50:50 preparation of both probiotic strains suspended in 0.1ml of PBS. The 
remaining control group received 0.1ml of PBS by oral gavage. At two days old all the 
birds in the four treatments and control group were dosed by oral gavage with 5x10"^  cfu of 
Salmonella Enteritidis (S1400 NaF) suspended in 0.1ml of PBS. To determine Salmonella 
Enteritidis uptake and shedding profiles of the chicks, where possible, 10 birds were 
swabbed at 3, 6, 8, 10, 13, 16, 20, 23, 27, 30, 34, 37 and 41 days of age. After confirmation 
of Salmonella uptake (10 days of age) birds were swabbed twice weekly for Salmonella 
shedding patterns. All birds were marked to ensure the same birds were swabbed on the 
appropriate days. From day 27 the shedding profiles of 8 birds in the mixed group were 
recorded.
At 2, 3, 6, 24 and 43 days of age 3 to 4 birds were humanely sacrificed for post 
mortem examination. At days 2, 24 and 43 days of age circa 1 gram of the spleen, liver, 
crop, jejunum, duodenum, ileum, ceaca and colon were removed aseptically for bacterial 
examination. The removed tissues were placed into PBS to give a 10'^  dilution of tissue. 
Tissues were serially diluted and plated onto selective agar for the recovery of the probiotic 
strains. Recovered isolates were screened by PFGE in order to confirm that the isolates 
were those used for probiotic supplementation. At 3, 6, 24 and 43 days of age the liver, 
spleen, ileum, ceaca and colon were recovered and processed as described above. Tissue 
samples were plated onto selective agar for the recovery of S. Enteritidis. Where no 
Salmonella strains were recovered by direct plating, 1ml of homogenate was inoculated 
into 9mls of selenite broth and incubated at 37°C. Samples were re-plated onto selective 
media after 1 and 7 days. Approximately 10% of potentially recovered Salmonella isolates 
were tested by 09 agglutination. All selective medium plates were supplemented with 
15pg of naladixic acid.
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2.4.6 Competitive exclusion feeding trial with Salmonella infected seeder bird 
challenge
Ten groups of 14 birds and one group of 30 birds (seeder bird group) were housed 
in Wey-isolators. All birds in the seeder bird group were dosed with 5x10"^  cfu of 
Salmonella at 1 and 12 days of age. Seeder birds were tagged at 9 days of age and swabbed 
at 10 and 11 days of age to determine the shedding profiles of each bird. After Salmonella 
dosing at 12 days of age 3 birds from the seeder group were introduced to the remaining 10 
groups. Birds were divided and introduced to treatment groups based on shedding profiles 
to ensure similar seeder bird shedding in each group. Eight of the ten groups of 14 birds 
were dosed with 1x10  ^ cfu of a 50:50 preparation of Lactobacillus salivarius and 
Enterococcus faecium. Four duplicate dosing regimes were given to eight groups consisting 
of group A receiving a single probiotic dose at age 1 day, group B at age 1 and 12 days, 
group C at age 12 and 20 days and group D at age 12 days. The remaining two groups of 
14 birds were not dosed with the probiotic preparation and were treated as the control 
group. Five birds, that were not originally seeder birds, were swabbed at 15, 17, 19, 22, 24, 
26, 29, 31, 33, 36, 38, 40 and 43 days of age to determine Salmonella shedding profiles.
At 16, 23, 30 and 43 days of age 3 birds from each isolator (which were not 
originally seeder birds) were humanely sacrificed for post mortem examination. The liver, 
spleen, ileum, ceaca and colon were removed. Bacteriological enumeration of S. 
Enteritidis, E. faecium and L. salivarius was performed.
2.4.7 Animal Licensing
All licensed procedures were performed under the jurisdiction of project license 
70/6435 and 70/5282 and personal license 70/19421.
2.5 Statistical analysis
Statistical analysis of the data within this thesis was evaluated using GraphPad 
Prism 4 (GraphPad Software Inc.) software. Data comparisons for in vitro analysis were 
performed using an unpaired Students T-test assuming Gaussian distribution of the data. 
The null hypothesis assumed no significant differences between the means of the two
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compared sets data. To calculate the Probability (P) value using a Student’s T-test a t ratio 
was calculated. The t ratio was calculated by dividing the difference in the compared 
means by the total of the Standard Error of the Mean (SEM) for the two populations being 
analysed. The larger the difference in the two means as compared to the SEM the larger the 
t ratio and thus the smaller the P value.
In vivo colonisation data was analysed using a Two-way ANOVA General Linear 
Model (GLM) where the values of the control were compared to the probiotic treated 
group. The GLM model determines if there are differences between the mean values of the 
tissues, if there are differences between the mean values of the treated and control groups 
and also if the differences between the mean values of two groups are the same for all the 
tissues sampled. The logarithmic values were transformed into their logarithm base ten 
(logio) prior to analysis. The null hypothesis is that the differences observed in the three 
tissues were the same for the probiotic treated and control groups. Data comparisons were 
made between control and treatment groups at each day of chicken post-mortems. The 
values obtained for each of the treatment groups were treated as the dependent variables 
whereas the dosing regime and tissues were treated as the conditions for the dependent 
variables. The differences in the tissue condition were taken into account when comparing 
treatment to controls using Two-way ANOVA analysis.
The swabbing data from the in vivo studies was firstly rank ordered to allow 
statistical analysis using statistical test for continuous data. The data was initially analysed 
using a Kruskal-Wallis test to determine if there were any significant differences between 
all the groups within a data set. If significant differences were observed further analysis 
was conducted using Dunnett’s non-parametric post test to compare the treatment groups to 
the control group. Exact P values calculated using Kruskal-Wallis analysis were generated 
using StatXact software and post-test analysis was calculated using Unistat software. The 
null hypothesis for the Kruskal-Wallis test assumes that the data sets had the same 
distribution or from distributions that had the same median. The test was similar to a one­
way ANOVA but, as the data was ranked, median values were compared instead of mean 
values. The Dunnett’s post test is similar to the Students T-test but the t ratio is calculated 
using the median and the residual mean square calculated by the Kruskal-Wallis test.
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P values of <0.05 were considered statistically important. In addition further 
categorisation of the P values was applied and visualised on graphs using a star grading 
system (Table 2.4).
Table 2.4 P-value summary. P values are given for the star and wording summary used for representation on 
graphs.
P value Wording Summary
<0.001 Extremely Significant 1
0.001 to 0.01 Very Significant **
0.01 to 0.05 Significant
>0.05 Not Significant ns
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Chapter 3 - Characterisation of Lactobacillus salivarius and Enterococcus 
faecium
3.1 Introduction
Work described here and in subsequent Chapters was part of a collaborative 
program conducted with an industrial partner with the aim of using the probiotic products 
commercially within the EU. A commercial company supplied the putative probiotic 
bacteria used, based on preliminary studies performed by the company.
The specific aim of this work was to evaluate a putative probiotic product for the
reduction of Salmonella Enteritidis in poultry. The project had two principal aims; to 
determine firstly the appropriateness of the probiotic isolates for the European market and 
secondly the ability of the product to reduce Salmonella Enteritidis colonisation of poultry. 
The first objective can be split further into three sections:
1) Accurate and consistent characterisation and identification of probiotic strains to 
species and strain level using molecular and phenotypic methods.
2) The ability of the probiotic bacterial strains to survive transit in the GI tract of
poultry.
3) Evaluation of the products safety firstly to poultry but primarily human safety in 
case the product escaped into the human food chain.
Several authors have reported poor quality control of probiotic bacteria in the 
commercial sector (Yeung et al, 2002; Coeuret et al, 2004). This Chapter describes the 
characterization and identification of the Lactobacillus salivarius 59 and Enterococcus 
faecium PXN-33 as prospective probiotic products in poultry. The Chapter is separated into 
three sections. The first section aims to identify the probiotic bacteria to the species level 
using molecular and biochemical techniques. This section also describes some general 
properties of the probiotic strains, such as growth rates, that are required for handling them 
in the laboratory.
The second section of this Chapter investigates the use of molecular strain typing 
techniques to record and track the probiotic strains in vivo during the research and
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development stages. The final section of this Chapter investigates the ability of the 
probiotic strains to adhere to eukaryotic cells in general and avian derived epithelia 
specifically. The ability of bacteria to adhere to the host organism’s GI tract has been 
linked to the ability of the bacteria to induce a probiotic effect on the host (Conway et al, 
1987).
3.2 Results
3.2.1 Spéciation and phenotypic characterisation of probiotic strains
3.2.1.1 Molecular and biochemical spéciation
Gram staining, catalase and motility tests were performed on L. salivarius 59 and E. 
faecium PXN-33 and positive control organisms as described in sections 2.1.3, 2.1.4 and 
2.1.5. E. faecium PXN-33 was confirmed to be Gram positive, non-motile, catalase 
negative cocci and L. salivarius 59 was confirmed to be Gram positive, non-motile, 
catalase negative rods (Table 3.1 and 3.2).
Strain typing using API 20 Strep and API 50CH were performed as described in 
section 2.1.7 according to the manufacturers instruction. Profiles were recorded and 
compared to an online data base of API fermentation profiles. E. faecium PXN-33 was 
confirmed as E. faecium with 97.2% identity (Good identification). In contrast L. salivarius 
59 was identified as Leuconostoc lactis (76.6% identity) with a doubtful profile (data not 
shown).
In addition to API identification two species specific genes were detected using 
PGR. Lactobacillus and Enterococcus DNA was purified as described in section 2.2.1 and 
diagnostic PGR was performed as described in section 2.2.2 using the primers described in 
table 2.1. A diagnostic PGR based on the 16S rRNA gene was used to determine if L. 
salivarius 59 was a member of the L. salivarius species (Ehrmann et ai, 2002). A 
diagnostic PGR, based on the E. faecium specific D-alanine:D-alanine (D-Ala:D-Ala) ligase 
{ddl) gene, which is required for cell wall synthesis, was used to speciate E. faecium PXN- 
33 (Dutka-Malen gr a/., 1995).
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Table 3.1 Phenotypic characteristics ofh .  salivarius and E. faecium. Catalase test results given as positive 
(+) or negative (-). Positive (Staphylococcus aureus ATCC 5923) and negative (Enterococcus faecium NCTC 
12202) catalase test controls included. Gram stain results given as gram-positive cocci or bacillus.
Strain Catalase Gram stain
Staphylococcus aureus ATCC 5923 + Gram +ve cocci
Enterococcus faecium NCTC 12202 - Gram +ve cocci
Enterococcus faecium PXN-33 - Gram +ve cocci
Lactobacillus salivarius 59 - Gram +ve bacilli
Table 3.2 Motility test results o f  L. salivarius 59 and E. faecium PXN-33. Motility test results given as 
positive (+) or negative (-) at 22°C, 28°C, 37°C and 42°C. Positive (Escherichia coli 0127:H6 EC2348/69) 
and negative (Escherichia coli 0111:NM B171) controls included.
Motility
Strain 22°C 28°C 37°C 42°C
Escherichia coli 0127:H6 EC2348/69 + + + +
Escherichia coli 0111 :NM B171 - - - -
Enterococcus faecium PXN-33 - - - -
Lactobacillus salivarius 59 - - - -
L. salivarius 59 identity was confirmed by the amplification of the 90bp amplicon 
of the 16rRNA gene predictive of L. salivarius species (Figure 3.1). To confirm the API 20 
Step based spéciation of E. faecium PXN-33 amplification of the E. faecium species 
specific ddl gene produced the predicted 590bp product (Figure 3.1). Thus, L. salivarius 59 
and E. faecium PXN-33 were confirmed as L. salivarius and E. faecium strains, 
respectively.
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Figure 3.1 PCR spéciation results for L. salivarius and E. faecium. PCR of 16S rDNA (A) for spéciation of 
L. salivarius. M lOObp marker, lane 1 E. faecium NCTC 12202, lane 2 & 3 L. salivarius 59, lane 4 L. 
salivarius NCIMB 11975. PCR for species-specific E. faecium ddl ligase gene (B). M Ikb marker, lane 1 L. 
salivarius NCIMB 11975, lane 2 & 3 E. faecium PXN-33, lane 4 E. faecium NCTC 12202.
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3.2.1.2 Phenotypic characterization
Growth curves were determined as described in section 2.1.8. E. faecium PXN-33 
and L. salivarius 59 growth was assessed by bacterial counts performed in duplicate on 
three separate occasions. Visualisation of surface structures was conducted as described in 
section 2.2.7. Samples were prepared and visualised in duplicate.
L. salivarius 59 grew to stationary phase after ~8hrs yielding 2.9x10^ cfu/ml 
whereas E. faecium PXN-33 grew to 1.1x10  ^cfu/ml after 9 hrs (Figure 3.2). SEM was used 
to visualise cell surface structures on E. faecium PXN-33 and L. salivarius 59 grown in 
HIB and MRS broth respectively. No flagella were present on the surface of either strain 
(Figure 3.3). However, peritrichous ‘fimbrial’ like structures were observed on the surface 
of L. salivarius 59. Fimbriae-like structures were also observed on the surface on E. 
faecium PXN-33 but their elaboration and distribution was irregular; they were not seen on 
all the cells nor were they seen in regular numbers on these cells. The fimbriae extended 
out from the bacterial cell surface into tangled skeins of material.
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Figure 3.2 Growth curve results for  E. faecium and L. salivarius. Growth of (A) E. faecium PXN-33 when 
cultured in MRS broth and (B) L. salivarius MCIMB 31052 when cultured in HIB broth at 37°C in 5% CO2 
and shaking at 200rpm. Error bars indicate standard error of the mean (SEM).
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Figure 3.3 Scanning electron microscopy results for cell surface structures on E. faecium and L. 
salivarius. Scanning electron microscopy of E. faecium (A) grown in HIB and L. salivarius (B) grown in 
MRS at 37°C statically. Arrows indicate ‘fimbrial like’ structures.
B
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3.2.2 Strain typing of L. salivarius 59 and E. faecium PXN-33 using molecular typing 
methods
Bacterial DNA was extracted as described above and the BOX PCR was performed 
as described in section 2.2.2 (Versalovic et ah, 1994; Kim et al, 2002) and PFGE was 
performed as described in section 2.2.5. In addition to the probiotic bacteria five E. faecium 
and five L. salivarius strains were included to validate the ability of the PFGE technique to 
differentiate between strains.
L. salivarius 59, E. faecium PXN-33 and E. faecium NCTC 12202 were strain typed 
using BOX repetitive sequences. L. salivarius 59 generated four distinct profile bands, 
which were moderately reproducible using the BOX-PCR technique (Figure 3.4). E. 
faecium PXN-33 produced six clear reproducible bands using the BOX-PCR typing 
technique (Figure 3.4). The profiles produced by the control strain were less consistent than 
the profiles produced by E. faecium PXN-33 (Figure 3.4). Due to inconsistencies and the 
low number of profile bands produced for the probiotic strains PFGE was chosen for strain 
typing. PFGE profiles for L. salivarius produced 13 clear reproducible profile bands. The 
profile pattern produced by L  salivarius 59 was distinct from those produced by five 
reference strains of L. salivarius (Figure 3.5). E. faecium PXN-33 digests with Smal 
produced 17 clear and reproducible PFGE profile bands (Figure 3.6) and again these were 
different from the profiles of five other E. faecium strains.
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Figure 3.4 BOX-PCR for strain typing L. salivarius and E. faecium. Gel (A) lane 1 to 5 L. salivarius 
NCIMB 30152, gel (B) lane 1 to 5 E. faecium PXN-33 and gel (C) lane 1 to 5 E, faecium NCTC 12202, M 
Ikb plus ladder.
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Figure 3.5 PFGE profiles for  Lactobacillus and Enterococcus strains. Gel (A) lane 1 L. salivarius NCDO 
929, lane 2 L salivarius NCDO 5517, lane 3 L. salivarius A74, lane 4 L. salivarius NCDO 1555, lane 5 L. 
salivarius NCIMB 11975 and lane 6 L. salivarius NCIMB 30152. Gel (B) lane 1 E. faecium 216Va, lane 2 E. 
faecium 89Va, lane 3 E. faecium 10Va, lane 4 H6 E. faecium 360Va, lane 5 E. faecium 3Va H8 and lane 6 E. 
faecium PXN-33. M S. Braenderup marker.
B
M l  2 3 4 5 6 M M 1 2  3 4  5 6 M
1,135
668.9 
452.7
398.4
336.5
310.1
216.9
173.4
167.1
138.9
104.5
78.2
76.8
54.7
33.3
28.8
20.5
1,135
668.9
452.7
398.4
336.5
310.1
216.9
173.4
167.1
138.9
104.5
78.2
76.8
54.7
33.3
28.8
20.5
m m
m
83
University of Surrey Chapter 3
3.2.3 Adherence of L. salivarius 59 and E. faecium PXN-33 to tissue culture cell lines
3.2.3.1 Association to tissue culture cell lines
Association assays were performed as described in section 2.3.1 and described 
previously with some modifications (La Ragione et al, 2000; Best et al, 2005). Numerical 
data were statistically evaluated using a Student’s T-test as described in section 2.5. 
Association of the bacteria to the eukaryotic cells was visualised using EM as described in 
section 2.3.4.
E. faecium PXN-33 associated to HEp-2 cells at 3.87x10^ cfu (3.7% of input) and 
Caco-2 cells at 8.54x10^ cfu (4.8% of input) after 3hrs incubation (Figure 3.6). No 
significant difference was observed between the associations of strain PXN-33 to the two 
cell lines (P=0.1325). L. salivarius 59 associated to HEp-2 cells at 8.26x10^ cfu (1.2% of 
input) and Caco-2 cells at 5.77x10^ cfu (0.7% of input) (Figure 3.6). No significant 
difference was observed between the associations of strain 59 to the two cell lines 
(P=0.1534). E. faecium PXN-33 associated in greater numbers than L. salivarius 59 to both 
HEp-2 and Caco-2 cells (P<0.0001 and P=0.0016 respectively) (Figure 3.6).
The pattern of adhesion of L. salivarius 59 and E. faecium PXN-33 after 3hrs to 
HEp-2 cells was observed by electron microscopy (Figure 3.7). The control strain used in 
these studies was S. Enteritidis (S1400) which is known to adhere and invade and induce 
membrane ruffles on the HEp-2 cells (La Ragione et al, 2003). E. faecium PXN-33 
associated to the HEp-2 cell line in short chains whereas L. salivarius 59 associated to the 
HEp-2 cell lines in dense aggregates (Figure 3.7). No HEp-2 invasion processes, such as 
membrane ruffling or pedestal formation was observed by scanning electron microscopy.
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Figure 3.6 Association results of E. faecium and L. salivarius to tissue culture cells. Association of E. 
faecium PXN-33 (EF) and L. salivarius MCIMB 31052 (LS) and a mixture of E. faecium PXN-33 to HEp-2 
(A) and Caco-2 (B) cell lines after 3hrs incubation at 37°C and 5% CO2. The motile E.coli 0127 (0127) and 
non-motile E. coli G i l l  (G ill)  were included as controls.
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Figure 3.7 L. salivarius, E. faecium and S. Enteritidis HEp-2 association visualised using scanning 
electron microscopy results. Scanning electron microscopy of E. faecium (A), L. salivarius (B) and S. 
Enteritidis (C) association after 3hrs incubation at 37°C to HEp-2 cells. Arrows indicate membrane ruffling. 
Arrows in (A) show E. faecium short chain colonisation, in (B) L. salivarius aggregative colonisation and in 
(C) S. Enteritidis induced membrane ruffling.
B
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3.2.3.2 Association to poultry derived IVOC gut tissue
Explant assays were performed as previously described, with some modifications 
(Allen-Vercoe and Woodward 1999). Full methods are described in detail in section 2.3.7. 
Assays were performed using three chicks from which two duplicate gut sections were 
removed and adhesion evaluated. Experiments were repeated on two separate occasions. 
Adhesion of the bacteria to the chick gut was evaluated statistically using a One way 
ANOVA analysis to determine tissue tropism as described in section 2.5.
E. faecium PXN-33 associated to the crop at 4.42x10^ cfu/g of tissue (Figure 3.8). 
This was ~1 log higher than counts recovered from similar experiments performed with 
tissues from the duodenum, jejunum, ileum and colon (Figure 3.8). The difference 
observed between association to the crop and the duodenum, jejunum, ileum and colon was 
statistically significant (p values are tabulated in Figure 3.8). Also, association with the 
jejunum was significantly higher than association to the ileum (P =0.042). No significant 
difference was observed between numbers associating with the ceaca (2.31x10^ cfu/g) and 
the crop (P =0.2162).
For L  salivarius 59 IVOC studies, L. salivarius 59 associated to the crop at 
5.39x10^ cfu/g, which were ~2 logs higher than with the duodenum, jejunum, ileum and 
colon (Figure 3.9). Association to the caecal tissue (2.63x10^ cfu/ml) was less than that to 
the crop but higher than to the jejunum, ileum, or colon. L. salivarius 59 association to the 
crop tissue was significantly higher than the difference observed between the crop and 
ceaca (P =0.009). The difference observed between the crop and duodenum, jejunum, 
ileum and colon was statistically significant (P values tabulated in Figure 3.9). L. salivarius 
59 also adhered to the caecal tissue approximately half a log higher than the duodenum, 
jejunum, ileum and colon. The difference between the ceaca and these four tissues was 
again statistically significant.
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Figure 3.8 Association results ofE.  faecium to IVOC. Association of E. faecium PXN-33 to 1-day-old SPF 
chick derived IVOC tissue after explanation and subsequent incubation for 3hrs at 37°C and shaking at 
200rpm. Error bars indicate standard error of the mean.
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Statistical analysis of E. faecium PXN-33 association to avian IVOC tissue. Analysis was performed using 
unpaired student t-test; P values are given in the table.
Vs.
Tissue
Duodenum Jejunum Ileum Ceaca Colon
Crop 0.0087* 0.0096* 0.005* 0.2162 0.0123*
Duodenum - 0.75112 0.0733 0.1129 0.2823
Jejunum - - 0.042* 0.1259 0.1729
Ileum - - - 0.0614 0.3252
Tissue Ceaca - - - - 0.1101
Not Significant 
Significant
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Figure 3.9 Association results o f h .  salivarius to IVOC. Association of L. salivarius MCIMB 31052 to 1 
day old SPF chick derived IVOC tissue after explanation and subsequent incubation for 3hrs at 37°C and 
shaking at 200rpm. Error bars indicate standard error of the mean.
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Statistical analysis of L. salivarius 59 association to avian IVOC tissue. Analysis was performed using 
unpaired student t-test; P values are given in the table.
Vs.
Tissue
Duodenum Jejunum Ileum Ceaca Colon
Crop P<0.0001* P<0.0001* P<0.0001* 0.0009* P<0.0001*
Duodenum - 0.9000 0.5317 0.0006* 0.9165
Jejunum - - 0.6220 0.0147* 0.8676
Ileum - - - 0.0050* 0.6259
Tissue Ceaca - - - - 0.0023*
Not applicable 
Significant
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3.3 Discussion
The use of probiotic preparations for industrial and commercial purposes for 
stringent quality control. Strain typing, including molecular typing techniques, has become 
an important part of the quality control process in probiotic production. Several reports 
have indicated that commercial products are often misidentified. In a recent study 14 of 29 
probiotic strains obtained from commercial companies were misidentified at the species 
level when compared to partial 16sRNA sequencing (Yeung et al, 2002). A combination 
of classical microbiological techniques, such as Gram staining and molecular techniques, 
such as PCR, were used to speciate L. salivarius 59 and E. faecium PXN-33.
L. salivarius 59 was shown to be non-motile. Gram positive, catalase negative rods. 
No spore formation was observed and the isolate grew adequately in micro-aerophilic 
conditions. The general properties that were observed in our studies for L. salivarius 59 are 
the same as those previously described for the species (discussed in detail in Chapter I). E. 
faecium PXN-33 was a non-motile. Gram positive, catalase negative, coccus. As was 
observed previously with L. salivarius 59 no spore formation was observed and the isolate 
also grew adequately in micro-aerophilic conditions. The general properties that were 
observed in our studies for E. faecium PXN-33 are the same as those properties previously 
described for the species (discussed in detail in Chapter 1).
The spéciation of E. faecium PXN-33 was confirmed by the use of API 20 strep 
kits. API biochemical testing is often employed to confirm the species of enterococci 
isolates from clinical samples (Hsieh 2000; Ling et ai, 2002). API identification 
techniques are a relatively quick and accurate means of species identification. The identity 
of E. faecium PXN-33 was also confirmed using diagnostic primers to the ddl E. faecium 
spp. specific gene. L. salivarius 59 could not be confirmed as L. salivarius using an API 
50CH kit. It has been reported by several authors that the API 50CH are unreliable for the 
identification of a number of Lactobacillus species (Charteris et al, 2001; Boyd et al, 
2005). Woo et al, (2002) also used an API 20A kit, which failed to identify species of L. 
salivarius strains correctly. As was discussed in Chapter 1 Lactobacillus spp. are generally 
accepted as a heterogeneous group with unstable taxonomy making biochemical 
identification of the species difficult (Schleifer & Ludwig, 1995). It is therefore not 
surprising that biochemical species identification of L. salivarius 59 was unreliable. In
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order to confirm the identity of L. salivarius 59 a diagnostic 16S rRNA primer set was 
used. As the 168 rRNA sequence is thought to act as an evolutionary molecular clock this 
sequence was used to identify L. salivarius 59 to species level (Ludwig & Schleifer, 1994; 
Schloss & Handelsman, 2004). L. salivarius 59 was confirmed as L. salivarius species 
using this method.
Certain bacterial characteristics are important in the handling of the organisms for 
experimental work. The culture times and bacterial population density at stationary phase 
were determined. L. salivarius 59 and E. faecium PXN-33 grew to stationary phase within 
9hrs. L  salivarius 59 and E. faecium PXN-33 will, therefore, grow to stationary phase after 
overnight cultivation. Experiments requiring specific growth phase conditions and specific 
bacterial counts could be conducted in accordance with the demonstrated growth 
phenotype.
Surface structures such as fimbriae and flagella are often involved in adherence. A 
lack of flagella was observed in both strains which corresponded with the lack of motility 
noted for L. salivarius and E. faecium (Bergey et al., 2002). However, peritrichous 
‘fimbrial’ like structures were observed on the surface of L. salivarius 59. Fimbriae have 
been observed on the cell surface of many lactobacilli including L. acidophilus, L. jensenii, 
L. fermentum, L. rhamnosus and L. casei and these structures have been proposed to play a 
role in adherence and possibly motility (McGroarty, 1994). The fimbriae also extended into 
tangled skeins of material, an observation consistent with previous reports (Handley & 
Jacob, 1981). Although no definitive function has been proposed for these enterococcal 
fimbriae they may play a role in bacterial adherence.
As was mentioned above that accurate identification of probiotic bacteria is 
essential for quality control purposes. In previous studies it has been shown that four 
commercial milk products claiming to contain different probiotic strains actually all 
contained the same strain (Coeuret et al, 2004). With the importance of monitoring 
products on the commercial market the probiotic bacteria were strain typed. In addition to 
strain typing for quality control these methods can also be used to track strains during 
research and development. In the first instance a BOX PCR method was utilised for strain 
typing as this method is relatively quick and easy to use. Additionally the above repetitive 
sequences have been used extensively to strain type Gram-positives including pathogens
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such as Streptococcus pneumoniae and probiotic Bifidobacterium species (Hermans et al, 
1995; Masco et al, 2003). Although BOX-PCR has been used to strain type firmicutes 
previously E. faecium PXN-33 and L. salivarius 59 produced less than the 10 bands 
required for strain typing. Poor reproducibility (as observed by the banding patterns of the 
control enterococci) and the low number of profile bands produced using the BOX-PCR 
method indicated that this method was inadequate for true strain differentiation. 
Subsequently a PFGE method based on those described previously was used as this method 
is considered to be the gold standard for strain typing (Jacobsen et al, 1999; Turabelidze et 
al, 2000; Garcia-Migura et al, 2005). In contrast to the BOX-PCR method the PFGE 
typing method produced over 10 distinct bands for L. salivarius 59 and E. faecium PXN- 
33, which is thought to be the minimum number of bands required for strain typing 
(Tenover et al, 1995). On the basis of the inadequate banding patterns produced by the 
BOX-PCR method the PFGE method was adopted as the strain typing technique for in vivo 
studies.
The adhesion of organisms used as probiotics to the intestinal mucosa of target host 
animals is thought to be a major contributing factor for mediating probiotic effects (for a 
comprehensive review see Ouwehand et al, 1999). Adhesion to host intestinal mucosa is 
required for colonisation and contributes to long-term persistence within the gut. It can be 
surmised that adherence may increase the effect of competitive exclusion if the mechanism 
of exclusion is through competition for adherence sites, immunomodulation of host 
responses and production of inhibitory substances. Assessment of adherence to in vitro cell 
lines is often used to characterise the suitability of organisms to act as probiotics (Conway 
et al, 1987). In the first instance the ability of probiotic bacteria to adhere to eukaryotic 
cells was investigated.
E. faecium PXN-33 and L. salivarius 59 did not show any preference in association 
with either HEp-2 or Caco-2 cell lines, findings that agree with previous reports by 
Dwomiczek et al, (2005). There is scant literature describing comparisons between the 
associations of Lactobacillus to HEp-2 or Caco-2 cell lines. Adherence of E. faecium to 
HEp-2 and Caco-2 has been shown to vary depending upon the isolate being studied. E. 
faecium is known to form bio-films and binding to Caco-2 cells has been shown to be 
enhanced by the presence of factors such as enterococcal surface protein {Esp) (Lund &
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Edlund, 2003; Dwomiczek et al, 2005). At least four types of binding of E. faecium to 
HEp-2 cells have been described; aggregative, diffuse, localised and chain like adhesion 
(Dwomiczek et al, 2005). E. faecium PXN-33 associated in short chains with no 
aggregation (Figure 3.5). These findings correspond to previous observations by 
Dwomiczek et al, (2005). L. salivarius 59 adhered in aggregative clumps (Figure 3.5). 
Previous reports by Ocana et al, (2001) have shown vaginal L. salivarius readily self­
aggregate by a mechanism that is sensitive to trypsin suggesting that self-aggregation is 
mediated by a proteinaceous substance. Brooker & Fuller (1975) also demonstrated that the 
main adherence mechanism of L. salivarius 59 to crop tissue is dependent upon acidic 
carbohydrate interactions of the host and bacteria. These previous findings would indicate 
that the observed aggregative nature of L. salivarius 59 may depend upon proteinaceous 
substances for self-aggregation and acidic carbohydrates for association to host tissue, 
although this was not fully investigated in the work herein.
As was discussed in the previous section adhesion of probiotic bacteria to the 
mucosa of target host animals is thought to be a major factor for mediating probiotic 
effects. In order to reduce the number of animals used in in vivo experiments, ex vivo 
methods were used in order to evaluate probiotic adhesion to the chick gut. Assessment of 
adherence to ex vivo poultry gut tissue has also been used previously to evaluate adhesion 
of pathogens to the chick gut mucosa (Allen-Vercoe and Woodward 1999; La Ragione et 
al, 2000). Investigations of adhesion in this manner would allow evaluation of probiotic 
adherance to the gut mucosa more readily and also where the bacteria would be likely to 
colonise prior to in vivo experimentation
Both organisms showed tissue tropism to crop tissue compared to other tissues 
which corresponds to previous reports by Brooker & Fuller (1975). L. salivarius 59 also 
showed a tissue tropism to caecal tissue over the duodenum, jejunum, ileum and colon. 
Both the probiotic strains also showed a similar pattern of tissue tropism. The primary 
function of the crop is mastication of feed. The advantage of colonisation of the crop by 
probiotic organisms is a re-seeding of the rest of the gastro-intestinal tract of the chick. 
This will occur if the organism becomes stable within the natural flora of the bird and if the 
organism is able to survive the pH and bile activity of lower GI tract. L. salivarius 59 also 
showed a tropism to the caecal tissue. The caecum acts as a fermentation chamber for the
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digestion of feed. Colonisation of ceacal tissue by L. salivarius 59, if the IVOC findings 
are replicated in vivo, may be advantageous as the ceaca are partially protected from the 
flow of gut contents.
Bacterial phenotyping and genotyping of L. salivarius 59 and E. faecium PXN-33 
confirmed the strains were L. salivarius and E. faecium, respectively. Both strains adhered 
to various cell and tissues types but in different patterns and numbers. It was also possible 
to accurately and reproducibly type both probiotic strains using a PFGE method. The PFGE 
patterns of the probiotic strains were distinct from other strains belonging to the same 
species group. Electron microscopic (EM) ultra-structural studies indicated the presence of 
surface structures but there was no evidence that these factors were necessarily mediating 
adherence. It was demonstrated that L. salivarius 59 and E. faecium PXN-33 adhered to 
eukaryotic throat and gut tissue and also avian explanted tissue. In vitro data indicates that 
L. salivarius 59 and E. faecium PXN-33 are able to associate with eukaryotic cells. 
Association to host epithelia cells is considered an important factor in competitive 
exclusion. The initial data suggest that both strains may have the ability to adhere to avian 
tissue in vivo thus increasing the chance of the L. salivarius 59 and E. faecium PXN-33 
initiating competitive exclusion of S. Enteritidis S1400. Further in vivo and in vitro analysis 
is required to confirm this hypothesis.
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Chapter 4 - Evaluation of L, salivarius and E, faecium resistance to 
environmental stresses
4.1 Introduction
In the previous Chapter the probiotic bacteria were identified to species level and a 
PFGE technique was developed to strain type L. salivarius 59 and E. faecium PXN-33. 
IVOC studies indicated that both probiotic strains can adhere to the GI tract of poultry. 
Having fully characterized L. salivarius 59 and E. faecium PXN-33 the next stage was to 
evaluate the ability of the strains to survive transit through the GI tract of the target 
organism. Colonisation of poultry by probiotic organisms depends on many factors 
including the ability of the bacteria to survive the harsh environment of the GI tract. 
Pathogens and probiotic bacteria must have an adequate level of tolerance to resist gastric 
acidity, lysozyme, bile salts and the activity of pancreatic enzymes (Chateau et al, 1994). 
If the probiotic organism fails to colonise the target site in the GI it is assumed that the 
efficacy of the probiotic will be reduced if not eliminated.
The aim of this Chapter was to evaluate the ability of L. salivarius 59 and E. 
faecium PXN-33 to survive GI tract transit in vitro prior to in vivo studies to investigate the 
efficacy of the probiotic strains. Arguably the two predominant factors that affect bacterial 
survival in the GI are acid tolerance and bile tolerance thus the tolerance of the strains to 
acidic pH and Oxgall bile was investigated in vitro.
4.2 Results
4.2.1 Acid tolerance
Acid tolerance assays were performed as described in section 2.1.9. Briefly E. 
faecium PXN-33 and L. salivarius 59 were grown and subsequently inoculated into pH 
adjusted PBS. Bacterial counts were taken at the beginning of the assay and subsequently 
after incubation. Survival rates were calculated and presented as a percent of the original 
inocula. Survival was scored arbitrarily according to the criteria of Jin et al, (1998) (Table
4.1). Experiments were carried out in duplicate and repeated on five separate occasions.
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Table 4.1 Acid resistance survival: Correlation between numbers and low, moderate and good survival. 
Correlation of cfu/ml recovery after 3hrs incubation to survival rate. Starting levels were approximately 1x10* 
cfu/ml.
Bacterial counts (3hrs) Survival rate
f <lx 10^ Low 1
>1x10^ < 1x10^ Moderate
f> lx W Good 1
Table adapted from Jin et al, (1998).
E. faecium PXN-33 survived at all the pH levels tested although the number of 
survivors decreased with the pH. With an initial level of around 10^  cfu/ml, 83% of initial 
levels were recovered at pH 7.2 after 3 hrs incubation while only 0.004% survived at pH
2.0 (Table 4.3). Similar results were seen with L. salivarius 59 with 0.003% recovery at pH
2.0 after 3hrs (Table 4.3). E. coli O78:K80 Rpos mutant and wild type control strains 
behaved as anticipated with viable cells being undetectable after 3hrs at pH 2.0.
Table 4.2 Acid tolerance results o f  L. salivarius and E. faecium. Bacterial counts (cfu/ml) of L  salivarius 
and E. faecium survival after 3hrs at 37“C in PBS adjusted to various pH values. Values in brackets indicate 
the percent survival of bacteria after 3hrs as compared to the original inocula. Acid resistant {E. coli 
O78:K80) and sensitive (E. coli O78:K80 Rpos mutant) controls were included.
Bacterial counts cfu/ml
Time
(hrs) pH E. faecium PXN 33 L. salivarius 59 E.coli O78:K80
E. coli O78:K80 Rpos 
mutant
2 1.05x10* 1.14x10* 6.30x10’ 6.73x10’
2.5 1.18x10* 5.17x10’ 5.77x10’ 6.73x10’
3.2 1.31x10* 6.97x10’ 6.80x10’ 8.53x10’
0 7.2 1.26x10* 8.30x10’ 6.17x10’ 7.40x10’
2 3.90x10* (0.004%) 3.57x10* (0.003%) <1.00x10* (<0.001%) <1.00x10* (<0.001 %)
2.5 1.23x10* (0.104%) 1.94x10* (0.375%) 4.90x10^(0.085%) <1.00xl0*(<0.001%)
3.2 4.28x10^(32.672%) 3.74x10’ (53.659%) 4.90x10’ (72.059%) 2.50x10’ (29.308%)
3 7.2 1.05x10* (83.333%) 5.10x10’ (61.446%) 7.13x10’ (115.559%) 6.93x10’ (93.649%)
4.2.2 Bile tolerance
Bile tolerance assays were performed as described in section 2.1.10. Media 
containing bile were inoculated with L. salivarius 59 and E. faecium PXN-33. Optical
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density readings were taken periodically for 24hrs. The level of bile resistance was 
calculated as described by Chateau et al, (1994). The difference in time (minutes) for the 
culture to grow to an optical density of 0.08 at 600nm between the control and medium 
supplemented with 0.3% Oxgall bile was calculated. Bile tolerance was determined as 
resistant, tolerant, weakly tolerant or sensitive as outlined in Table 4.4. Assays were 
replicated four times and the experiment was repeated on three separate occasions.
Table 4.3 Correlation of bile tolerance/resistance to growth delay times. Table indicating criteria for the 
correlation of delay in growth to arbitrary bile tolerance/resistance as proposed by Chateau et al, (1994).
Bile tolerance/ 
resistance
Resistant Tolerant Weakly tolerant Sensitive
i  Delay in growth 
1 (min)
d < 15min 15min<d<40
min
40 min < d < 60 
min
D > 60 min i
Table adapted from Chateau et al, (1994).
E. faecium PXN-33 grew in the presence of 0%, 0.3%, 0.6% and 0.9% bile (Figure
4.1). L. salivarius 59 did not grow at 0.6% or 0.9% bile (Figure 4.1). Growth was observed 
in 0.3% bile but was substantially inhibited compared to growth in the MRS control. The 
growth delay value for E. faecium PXN 33 in 0.3% bile was 34 minutes whereas the 
growth delay value for L. salivarius 59 in 0.3% bile was 198 minutes (Figure 4.1). 
According to the criteria proposed by Chateau et al, (2004) E. faecium PXN-33 was bile 
tolerant and L. salivarius 59 was sensitive to bile.
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Figure 4.1 Bile tolerance assay results for L. salivarius and E. faecium. Bile tolerance of L. salivarius and 
E. faecium in 0, 0.3, 0.6 and 9% Oxgall bile over 24hr. Growth in appropriate media was determined by 
taking optical density readings every 15 minutes for 24hrs. Horizontal dashed line indicates an optical density 
of 0.08 units at 600nm.
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4.3 Discussion
Colonisation of poultry by probiotic organisms depends on many factors including 
the ability of the bacteria to survive the harsh environment of the gastro-intestinal (GI) 
tract. Pathogens and probiotic bacteria must have an adequate level of tolerance to resist 
gastric acidity, lysozyme, bile salts and the activity of pancreatic enzymes (Chateau et al, 
1994). The transition time of food through the avian GI tract is significantly shorter than in 
the mammalian gut; passage of feed through the GI tract can take as little as two and a half 
hours in poultry in comparison with human colonic transit of 30-42 hours (Meier et al, 
1995; Jin et al, 1998). Although feed transition is quicker and, therefore, exposure to 
gastric acidity reduced for any potential probiotic, colonisation of tissue like the lower GI 
tract still requires resistance to acidic environments and bile salts. Famer et al, (1942) 
demonstrated that the gizzard of year old chickens had a pH of 2.6 whereas the crop had a 
pH of 4.51. The pH of the lower GI track of the same chickens ranged from pH 5.71 to pH 
6.42 (Table 4.1) (Famer et al, 1942).
Table 4.4 pH in the digestive tract o f SPF White Leghorn Chickens. The pH of the gastral intestinal tract of 
year old SPF White Leghorn Chickens. The GI tract of mature chickens ranges from pH 2.60 to 6.42.
Organ Crop Proventriculus Gizzard Duodenum Upper
ileum
Lower
ileum
Large int.- 
cloaca
Ceaca
pH 4.51 4.40 2.60 5.76-6.01 5.78-
5.90
6.27-
6.42
6.26 :5/71 1
Table adapted from Famer (1942).
A standard method described by Jin et al, (1998) was used to evaluate the acid 
tolerance of L. salivarius 59 and E.faecium PXN-33. Acid tolerance was evaluated in vitro 
prior to in vivo studies in order to adhere to the ethical use of animals. This in vitro method 
of evaluation was chosen as it simulated the extremes of the poultry GI tract acidity. 
Survival in PBS at pH 2.5 was used to model transit through the gizzard which is 
approximately pH 2.6. A three-hour exposure time was also used to simulate GI tract 
transit that typically takes approximately two and a half hours.
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L. salivarius 59 and E. faecium PXN-33 were acid tolerant according to the criteria 
stipulated by Jin et al, (1998) (see Table 4.3). Both strains showed moderate tolerance to 
pH 2 and good tolerance to pH 2.5 and pH 3.2. Moderate survival (as defined by Jin et al,
1998) at pH 2 by both strains would suggest that they would be able to survive passage 
through the gizzard into the lower GI tract. The pH of the lower GI tract of poultry 
generally does not drop below pH 5.76, suggesting that both strains would survive in the 
lower GI tract (Table 4.3). Previous studies by Ehrmann et al, (2002) showed that L. 
salivarius strains are able to survive at pH 1 for 1 hour and for up to 4hrs at pH 2 and pH 3. 
Tsai et al, (2004) previously reported a similar level of resistance in E. faecium TM39. 
After 3 hrs at pH 2.5 approximately 1x10  ^cfu/ml bacteria were recovered and at pH 3.2 
approximately 1x10  ^cfu/ml was recovered (Tsai et al, 2004). These values are consistent 
with 1.23x10  ^ and 4.28x10^ cfu/ml recovered at pH 2.5 and pH 3.2 respectively for E. 
faecium PXN 33 after 3 hrs incubation (Table 4.2). The acid tolerance exhibited by L. 
salivarius 59 and E. faecium PXN 33 indicates that these strains would survive in the avian 
GI tract.
Bile is secreted into the duodenal section of the small intestine. The major 
constituent of poultry bile salts is taurocholic acid and taurochenodeoxycholic acid (Cole & 
Fuller, 1984). Lindsay et al, (1969) showed that SPF White Leghorn cockerels fed on a 
basal diet produced 3.42mg of bile/lOOg body mass every 24hrs. Bile salts, like taurocholic 
acid and taurochenodeoxycholic acid, are thought to disrupt the lipids and fatty acids of 
bacterial cell membranes leading to cellular destruction. In order to survive transit through 
the GI tract L  salivarius 59 and E. faecium PXN-33 would need to be resistant to poultry 
derived bile salts. To date no poultry specific bile tolerance assays have been developed so 
the standard bile test used for probiotic evaluation as described by Chateau et al, (1994) 
was chosen.
According to the arbitrary bile resistance classification proposed by Chateau et al, 
(1994) (Table 4.4), E. faecium PXN 33 would be considered bile tolerant whereas L. 
salivarius 59 would be classified as sensitive to bile (Chateau et al, 1994). This is 
consistent with previous reports by Ehrmann and colleagues demonstrating growth 
inhibition of L. salivarius strains by Oxgall bile (Ehrmann et al, 2002). Oxgall bile is 
composed mainly of taurocholic acid and glycocholic acid in contrast to chick bile which is
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composed of taurocholic acid and taurochenodeoxycholic acid (Cole & Fuller, 1984); Cole 
and Fuller used L. salivarius 59 in their bile experiments. Cole & Fuller (1984) 
demonstrated that 7 strains of E. faecium were able to deconjugate taurocholic acid, 
taurochenodeoxycholic acid and glycocholic acid in contrast to L. salivarius 59, which was 
unable to deconjugate glycocholic acid (Cole & Fuller, 1984). This would suggest that 
while Oxgall bile resistance is low in L. salivarius 59, in the avian GI tract, L. salivarius 59 
could still be resistant to poultry bile. These results also indicate that E. faecium PXN 33 is 
bile tolerant and would be able to survive in the lower GI tract in poultry but as above these 
results could be misleading as the composition of Oxgall bile is different from poultry 
derived. Further experiments are required to test L. salivarius 59 specific resistance to 
poultry bile and thus whether the sensitivity to Oxgall bile is representative of bile 
resistance in the bird.
It has been demonstrated that L. salivarius 59 and E. faecium PXN-33 are tolerant 
to artificial acidic environments similar to those found in the poultry GI tract. E. faecium 
PXN-33 has been shown to be tolerant to Oxgall bile whereas E. faecium PXN-33 has been 
shown to be sensitive to Oxgall bile. Poultry-derived bile and Oxgall bile have different 
bile acid compositions thus the results observed here are only crude measures of bile 
tolerance. Further experimentation is required to determine the ability of L. salivarius 59 
and E.faecium PXN-33 to tolerate poultry derived bile.
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Chapter 5 - Assessment of the safety of L. salivarius and E, faecium for 
use as probiotic supplements
5.1 Introduction
Having shown in the previous Chapter that L. salivarius 59 and E. faecium PXN-33 
were able to survive transit through the GI tract of poultry and are capable of adhering to 
the epithelium of the chick GI, it was necessary to evaluate their safety. This Chapter is 
divided into two sections: the first investigates the carriage of virulence factors and 
cytotoxicity whereas the second investigates the presence of transferable antibiotic 
resistance.
As the probiotic strains have the ability to survive GI tract transit and colonise the 
chick gut mucosa it can be assumed that they will enter the human food chain. Virulence 
factors of human medical importance and cellular cytotoxicity on human cell lines are an 
important aspect of agricultural feed supplement safety. To date no virulence factors have 
been associated with lactobacilli, although several have been identified and studied in E. 
faecium (Kayaoglu and Orstavik 2004) (Table 5.1). Here the presence of enterococcal 
virulence factor determinants was investigated in L. salivarius 59 and E. faecium PXN-33 
using PGR. Cellular cytotoxicity was also investigated using human derived tissue culture 
cell lines. The cell lines were exposed to probiotic bacteria and cellular toxicity was 
evaluated using chemical staining.
Another consideration is the effect the animal feed supplements have on the host 
organism. Toxicity to the animal may affect feed conversion rates and subsequently reduce 
commercial productivity but would also be inhumane. Thus the effect of the probiotic 
preparations on the host organism was also investigated. Their effect on weight gain was 
recorded as this is a commercially important aspect of poultry production and 
histopathology with appropriate staining was used to evaluate any damage caused to the 
gut mucosa.
The second section of this Chapter investigated the presence of antibiotic resistance 
genes of clinical importance. In recent years the escalation in antibiotic resistance in human 
pathogens has become a major concern. Recent studies have implicated agricultural 
practices as a reservoir for these antibiotic resistance gene determinants. Probiotic bacteria
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that are being used in agriculture as food supplements are now required to be free of 
transferable antibiotic resistance genes of human clinical importance (Wright 2005). Herein 
phenotypic MIC’s to investigate antibiotic resistance and nano-array technology to 
investigate the presence of possible transferable resistance genes in L. salivarius 59 and E. 
faecium PXN-33 has been utilised.
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Table 5.1 Enterococcus virulence factors. Summary of common enterococcal virulence factors and their 
mode of action. Table adapted from Kayaoglu & Orstavik (2004).
Virulence
Factor
Description Mode of action Reference
i Aggregation Adhesin encoded Shown to facilitate attachment to renal (Kreft e/a/., 1992;
i substance: by sex pheromone tubular cells and induce enterococcal Olmsted er fl/., 1994) gi Asal, AsclO, 
i Asa373 plasmids such as
enterocyte invasion.
pAM373________
Surfece High molecular weight Esp shown to be common in clinical (Rich era/., 1999;
adhesins: Esp, surface adhesin endocarditis isolates. EfaA Proposed to Low et al, 2003;
EfaA, Ace facilitates biofilm aid survival in low magnesium Vankerckhoven et al,
formation (Esp), environment of the blood. Ace allows 2004)
magnesium scavenging binding of enterococci to extra-cellular
(EfaA) and collagen matrix.
binding protein (Ace)
rGeiatinase Extracellular zinc- Hydrolyse gelatin, collagen, fibrinogen. (Bleiweis & |
1 containing casein and insulin. Zimmerman 1964; j
f metalloproteinase Makinen et «/., 1989) }
Hyaluronidase Break down of Breakdown of mucopolysaccharide (Kostyukova et al.
mucopolysaccharide to connective tissue and thus increases 1995; Hynes &
disaccharide for invasiveness. Walton 2000)
nutrients
Î Cytolysin Cellular toxin active Cytolysin targets macrophages, PMNs (Kayaoglu & j
against host cells and and erythrocytes as well as Gram Orstavik 2004) i
other Gram positive positive organisms
organisms.
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5.2 Results
Chapter 5
5.2.1 Evaluation of the presence of virulence factors and toxicity
5.2.1.1 PCR evaluation of the presence of virulence factors
Investigations were conducted to determine if L. salivarius 59 and E.faecium PXN- 
33 encoded several virulence factors using a modified PCR based method previously 
described by Vankerckhoven et. al, (2004). DNA was isolated from L. salivarius 59, E. 
faecium PXN-33 and enterococcal control strains as described in section 2,2.1. Extracted 
samples were amplified using a HotstarTaq PCR technique as in section 2.2.3 and the 
samples were subsequently separated and visualised as in section 2.24.
The two probiotic bacteria were screened for the virulence factors Asal and 
aggregation protein, GelE a gelatinase enzyme, CylA a cytolysin, Esp a surface adhesion 
and Hyl a hyaluronidase enzyme. L. salivarius 59 and E. faecium PXN-33 were shown not 
to possess any of the virulence factors screened (Table 5.2).
Table 5.2 PCR results for enterococcal virulence factors. Results for strains given as positive (+) or 
negative (-) for all strains. L. salivarius, E. faecium and control strains were included as described in the table.
Strains
Virulence factors
asa\ gelE cylA Esp hyl
E. faecium PXN-33 - - - - -
L. salivarius 59 - - - - -
E.faecalis MMH 594* + + + + N
E. faecium C68* N N N N +
E.feacalis 219** - - - - N
E.faecium C38** N N N N -
*= positive control strain 
**=negative control strain 
N=Not applicable
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5.2.1.2 In vitro evaluation of cellular toxicity
HEp-2 and mucus secreting HT29 cells were maintained as described in section 
2.3.1. The toxicity assay was performed essentially as described in section 2.3.1 but with 
slight modifications. The cells were incubated with the probiotic preparation and 
subsequently stained with Giemsa stain as described in section 2.3.4. Cytotoxicity was 
evaluated visually using a light microscope and compared with uninfected cells (data not 
shown). Cellular detachment, nuclear condensation and vacuolation was recorded where 
observed. Assays were performed in duplicate on three separate occasions.
It was observed that both probiotic bacteria, individually and in combination, 
adhered to HEp-2 and HT29 cells (Figure 5.1). Giemsa staining of bacterial association to 
HEp-2 cell lines indicated L. salivarius 59 and E. faecium PXN-33 induced cellular cyto- 
pathology (Figure 5.1). E.faecium PXN-33 induced pronounced vacuolation of the HEp-2 
cells while L. salivarius 59 induced nuclear condensation (Figure 5.1). When both 
probiotics were inoculated onto the HEp-2 cell lines vacuolation and nuclear condensation 
were both observed (Figure 5.1). In contrast adhesion of L. salivarius 59 and E. faecium 
PXN-33 did not induce any cyto-pathic effect upon the HT29 cell line (Figure 5.1).
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Figure 5.1 Giemsa staining of HEp-2 and HT29 cells after inoculation with probiotic bacteria. Giemsa 
staining of E. faecium (A) L salivarius (B) and 50:50 inocula of E. faecium and L. salivarius (C) association 
after 3 hrs incubation at 37°C to HEp-2 cells. Giemsa staining of E.faecium (D) L. salivarius (E) and medium 
control (F) association after 3hrs incubation at 37°C to mucus producing HT-29 cells. Bacterial colonies (B), 
vacuolation (V) and nuclear condensation (N) are indicated by the arrows.
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5.2.1.3 In vivo evaluation of weight gain by SPF White Leghorn chicks dosed with a 
probiotic preparation
Weights of birds in the probiotic treated group and control group were determined 
as described in section 2.4.4. All chicks in the first group were dosed by oral gavage with 
the probiotic preparation on two separate occasions. The remaining control group received 
a placebo treatment. At five days of age 5 birds were humanely sacrificed for post mortem 
examination. Birds in the treatment and control group were weighed on three occasions. 
Student’s T-test was used to compare the control and treatment groups as described in 
section 2.5.
No significant difference in the weights of birds in the control group and probiotic 
treated group was observed at age 5, 15 or 22 days (P=0.4889, P=0.2890 and P=0.2264, 
respectively). At age 5, 15 and 22 days the average weight of the birds in the control group 
was 53.3g, 144.7g and 232.2g respectively (Figure 5.2). The average weights of birds in the 
control group at age 5, 15 and 22 days was 52.0g, 139.5g and 186.5g respectively (Figure
5.2). Birds were observed at regular intervals throughout the study and no morbidity or 
mortality was observed in the control and probiotic treated group.
Figure 5.2 Weight gain of SPF chicks treated with probiotic bacteria compared to control chicks. Six birds 
were randomly weighed at age 5, 15 and 22 days of age. The probiotic treated group was dosed with a 50:50 
preparation of L. salivarius 59 and E. faecium PXN-33 at age 1 and 11 days of age. The error bars indicate 
the standard error of the mean. Note no significant differences were observed between the two groups.
Effect of probiotic dosing on weight gain in birds 
25(H —
Probiotic treated group 
Control group
5 15 22
Age of birds (days old)
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5.2.1.3 In vivo evaluation of toxicity to SPF White Leghorn Chicks
Chicks in the first group were dosed as described above. At five days of age birds 
from both groups were humanely sacrificed for post mortem examination. Samples were 
taken from the duodenum, jejunum, ileum, ceaca and colon for histological examination. 
Tissues were Alcian blue and PAS stained for acidic and neutral mucins as described in 
section 2.4.3; probiotic treated birds were compared to the untreated control group.
Tissue preservation of samples from the duodenum, jejunum and ileum were sub- 
optimal but were considered to be of a quality to observe severe pathological changes. It 
was not possible to observe subtle changes, including changes in the epithelial cells such as 
goblet cell hyperplasia or alteration in the mucin layer in the lumen. Mild disruption 
shortening and blunting of the villi were observed in the probiotic and control group but no 
significant difference in pathology between the two groups was observed. Whilst subtle 
changes in the integrity of the small intestine could not be observed no significant 
inflammatory response was present in the animals dosed with L. salivarius and E. faecium 
at the moment of euthanasia compared to the control group (Figure 5.2). Lymphoid tissue 
activation in response to major inflammation was not observed in the small intestine. The 
preservation of samples from the caecum and colon was significantly better than in those 
from the small intestine. All sections taken from the caecum of probiotic treated and 
control group had morphology within the normal limits expected for healthy chicks. Two 
chicks in the control group had abundant goblet cells as visualised using PAS staining 
although this was within the normal limits expected for healthy chicks. In addition to this, 
one bird in the control group also presented visible lymphoid structures but again within 
the normal limits for healthy chicks. All the chicks treated with the probiotic also presented 
morphology within the normal limits of healthy tissue though two chicks presented mild 
distension of the lumen and sloughed epithelial cells.
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Figure 5.3 Histology sections for investigation of epithelial damage from in vivo study. PAS stained 
sectioned tissues from 5 day old chicks dosed with the probiotic bacteria. Jejunum sections from the (A) 
control group and (B) the probiotic treated group. Colon sections from (C) control group and (D) the 
probiotic treated group. Mucosa appeared to be unaffected by probiotic treatment.
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5.2.2 Assessment of antibiotic resistance safety
5.2.2.1 Evaluation of minimum inhibitory concentrations for clinically relevant 
antibiotics
MICs were performed as described in section 2.1.13. Recommended British Society 
for Antimicrobial Chemotherapy (BSAC) control strains S. aureus ATCC 25923 and E. 
faecalis NCTC 29212 were included to ensure that antibiotic failure did not occur. Target 
MICs of control strains are given in Table 5.3 as the expected values; one 10-fold-dilution 
error was allowed for the control strains. Assays were performed with at least three 
experimental repeats on two occasions.
Nalidixic acid was tested for use as an antibiotic marker. L. salivarius 59 and E. 
faecium PXN-33 were resistant to this antibiotic (Table 5.3). As recommended by 
Scientific Committee for Animal Nutrition (SCAN) L. salivarius 59 and E. faecium PXN- 
33 were tested for resistance to ampicillin, chloramphenicol, enrofloxacin, erythromycin, 
gentamicin, neomycin, rifampicin, streptomycin, tetracycline, trimethoprim and 
vancomycin. In addition to testing the resistance of L. salivarius 59 and E. faecium PXN- 
33 to the antibiotics suggested by SCAN they were also tested for the presence of the 
clinically relevant antibiotics amoxycillin, cefoperazone, clindamycin, doxycycline, 
penicillin G and teicoplanin.
According to the SCAN MIC breakpoints L. salivarius 59 was sensitive to 
ampicillin, chloramphenicol, erythromycin, gentamycin, neomycin, rifampicin, 
streptomycin and tetracycline (Table 5.3). L. salivarius 59 was also sensitive to the 
additional antibiotics for which the BSAC values were published. L. salivarius 59 was 
sensitive to clinically relevant concentrations of amoxycillin, cefoperazone, clindamycin, 
doxycycline and penicillin G if the MIC breakpoints of enterococci are used as a guide. 
The MIC for L. salivarius to vancomycin was greater than >128 ng/pl. This would indicate 
that L. salivarius 59 is resistant to clinically relevant concentrations of vancomycin (the 
recommended MIC by SCAN is 4 ng/pl).
E. faecium PXN-33 was clinically resistant to cefoperazone, chloramphenicol, 
clindamycin, enrofloxacin, erythromycin, gentamycin and penicillin G; MICs were above 
those recommended for clinical resistance (Table 5.3). Clinical resistance of E. faecium
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PXN-33 to gentamycin, penicillin G, chloramphenicol and erythromycin is unlikely to be 
transferable because the MIC’s were below SCAN recommended breakpoints. E. faecium 
PXN-33 MIC to rifampicin was above the BSAC and SCAN MIC breakpoints suggesting 
clinical resistance due to possible transferable resistance elements.
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Table 5.3 MIC results for  E. faecium and L. salivarius. BSAC control strains, S. aureus ATCC 25923 and 
E. faecium NCTC 29212, included. MIC results given in ng/pl. BSAC and SCAN MIC breakpoints given in 
table.
Antibiotic
S. a u r e u s  ATCC 25923 
Expected Actual
E. fa e c a lis  n C ï C  2 9 2 1 2  
Expected Actual
E. fa e c iu m  
PXN 33
L. s a liv a r iu s  
5 9
MIC break point
E n te r o c o c c i ,Lactobacillus
Amoxycillin^ 0.25 0.25 0.5 1 1 0.5 8
Ampicillin - 0.25 1 2 2 0.5 8/8 2*
Cefoperazone^ - 2 - 32 16 4 4
Chloramphenicol - 16 4 8 8 4 16/2 16
Clindamycin^ 0.12 0.06 8 4 4 <0.03 0 .5
Doxycycline^ - 1 - 16 1 1 1
Enrofloxacin 0.5® 0.12 1® 0.5 4 1 4/7® 4*
Erythromycin 0.5 0.5 4 2 4 0.06 4/0.5 4
Gentamicin^ 0.25 0.25 2 2 16 1 500/7 1
Nalidixic acid®’^ 128 64 - >128 >128 >128
Neomycin® - 0.25 - 2 8 0.12 1024 32
Penicillin 0.03 0.06 2 2 2 0.12 0 .1 2
Rifampicin 0.015 0.06 2 2 32 2 4/7 32
Streptomycin® - 2 - 16 64 2 1024 16
Teicoplanin^ 0.5 1 0.25 0.5 2 >128 4
Tetracycline - 1 16 32 1 2 16/7 16
Trimethoprim - 2 0.25 0.12 0.5 0.5 8/0.5 32
Vancomycin 0.5 2 2 4 2 >128 4/4 4*
*=certain species are inherently resistant.
MIC break point= those determined by SCAN as categorizing bacterial species as resistant. 
MIC break points in italics= clinical break points as described by BSAC.
A= high level resistance is 512mg/l susceptible
B= BSAC MIC value not published for enterococci
C= SCAN MIC value not published
D=BSAC MIC value for human equivalent ciprofloxacin
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S.2.2.2 Molecular evaluation of antibiotic resistance genes
DNA extraction was performed as described in section 2.2.1. The microarray 
analysis was performed by Vincent Perreten at the Institute of Veterinary Bacteriology, 
University of Berne, Switzerland as described previously (Perreten et al, 2005). 
Microarray controls were included; the internal controls included genes for a transferase, 
ATP-binding transporter, hydrolase and lactonase. The array controls used for array 
alignment consisted of biotin-labelled oligonucleotides. Resistance genes identified using 
hybridisation were confirmed subsequently by PCR.
L. salivarius 59 and E. faecium PXN-33 were both positive for all five biotin- 
labelled oligonucleotide array controls. L. salivarius 59 was negative for the internal 
controls whereas E. faecium PXN-33 was positive for the lactonase internal control. L. 
salivarius 59 was negative for all 90 Gram positive resistance genes tested. E. faecium 59 
was positive by microarray hybridisation, for acc(6’)-Ii encoding a acetyltransferase which 
is associated with aminoglycoside resistance. E.faecium PXN-33 was positive for msr(C) 
encoding for an efflux pump protein which is associated with macrolide resistance. E. 
faecium PXN-33 was also positive for tet(M), a protein related to ribosomal protection 
conferring tetracycline resistance, although the presence of this gene could not be 
confirmed by PCR.
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Figure 5.3 Microarray analysis of 90 antibiotic resistance genes. L. salivarius (A) was negative for all 
antibiotic resistance genes. In contrast E. faecium (B) was positive for 37-38: aac(6')-Ii encoding 
aminoglycoside resistance and 164-165: msr(C) encoding macrolide resistance. 205-206: tet(W) (could not 
be confirmed by PCR, tet(W)-negative ),264-265: internal control and C: control.
B
264 265 c.
205 206 s
164 165
. 37 38
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5.3 Discussion
As the use of probiotics in both man and animals has become more widespread over 
the past decade, concern with the safety of these bacterial food supplements has risen. The 
two major areas of concern in relation to probiotics are: bacterial virulence leading to 
disease in the host organism and possession of resistance genes that could be transferred to 
bacterial pathogens. The EU tightly controls the use of animal probiotic feed supplements 
within Europe (Wright, 2005). Several recommendations have been made by SCAN, a 
committee formed to recommend scientific policies to the EU on animal feed supplements 
within Europe. To determine the safety of L. salivarius 59 and E. faecium PXN-33 the 
presence of several virulence factors isolated from virulent enterococcal strains was 
investigated. To date no virulence factors have been isolated from lactobacilli. The use a 
simple PCR method was chosen due to the rapid and simple nature of the technique. A 
modified PCR based method was used as previously described by (Vankerckhoven et. al., 
2004). E. faecalis MMH 594 and E. faecalis 219 was used as a positive and negative 
control for the presence of asal, gelE, cylA, esp respectively. E. faecium C68 and E. 
faecium C38 was used as a positive and negative control for hyl gene respectively. As only 
very tentative links have been made between virulence factors and E. faecium 
pathogenicity more detailed investigations would be inappropriate.
E. faecium and members of the Lactobacillus genus are generally considered to be 
safe organisms for man and animals but have been reported to cause opportunistic infection 
such as endocarditis and bacteriaemia (for comprehensive case reviews see Wade, 1997 
and Cannon et al, 2005). Only two clinical cases of disease have been attributed to the use 
of lactobacilli as probiotic supplements. Both of these (a case of endocarditis and a case 
resulting in a liver abscess) were due to L. rhamnosus (Mackay et al, 1999; Rautio et al,
1999). To date no virulence factors have been associated with lactobacilli and as such it is 
likely that L. salivarius 59 is non-pathogenic to man and host. In contrast several virulence 
factors have been identified and studied in E. faecium and there is a possibility that E. 
faecium PXN-33 may contain virulence factors. The problematic nature of Enterococcal 
virulence in humans is due, in part, to the prevalence of E. faecalis as a cause of 
nosocomial infection but also because of the rising incidence in vancomycin resistant 
enterococci (VRE) resulting in increased persitance of pathogenic strains. Enterococcal
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pathogenicity is important particularly in hospital environments. Over a three-year period 
in US hospitals enterococci accounted for 11% of nosocomial bloodstream infections 
(Edmond et al, 1999). An estimated 10-20% of enterococcal associated nosocomial 
infections are attributed to E. faecium (Murray, 1990). The success of E. faecium as a 
nosocomial pathogen is thought to be due to its virulence factors. The array of enterococcal 
virulence factors include aggregation substances (AS), surface adhesins such as Esp, 
lipoteichoic acid (LTA), extracellular superoxide production, gelatinase, hyaluronidase and 
cytolysins (for a comprehensive review read Kayaoglu & Orstavik, 2004).
E. faecium PXN 33 and L. salivarius 59 were negative by PCR for the presence of 
asal, gelE, cylA, esp and hyl virulence determinants. No p-haemolysis was observed when 
the cultures were grown on blood agar. The lack of virulence factors shown by E. faecium 
PXN-33 correlates with previous finding by several authors; aggregating substances, such 
as ace and asal, gelatinase, cytolysin and haemolysin are predominantly found in isolates 
from clinical or food samples (Eisner et al, 2000; Franz et al, 2001; Dupre et al, 2003; 
Vankerckhoven et al, 2004). Importantly clinical E. faecium isolates have been shown to 
possess hyaluronidase and Esp gene markers. Vankerckhoven et al, (2004) reported the 
presence of hyaluronidase in both clinical (27%) and faecal (17%) samples. There was no 
significant difference between the clinical and faecal samples indicating that the presence 
of hyaluronidase does not correlate with the virulence of E. faecium (Vankerckhoven et al, 
2004). Isolates from the UK which had the hyaluronidase gene correlated with the presence 
of ampicillin and vancomycin resistance (Vankerckhoven et al, 2004). As E. faecium 
PXN-33 is sensitive to both ampicillin and vancomycin (see MIC data above) the lack of 
hyaluronidase would be expected (Vankerckhoven et al, 2004). Esp was identified in 
significantly more of clinical isolates (92%) than faecal isolates (73%). This indicated that 
the difference observed between clinical and faecal isolates was significant (P=0.04) 
(Vankerckhoven et al, 2004). Dupre et al, (2003) also observed that Esp was present in 
nearly three quarters (71.9%) of clinical isolates from Italian studies. Again vancomycin 
and ampicillin resistance was related to the presence of Esp in E. faecium. As E. faecium 
PXN-33 was sensitive to both these antibiotics the lack of Esp correlates with previous 
findings by Vankerckhoven and colleagues. Importantly, out of all the virulence factors 
screened for in the probiotic bacteria, Esp appears to be the most significant in relation to
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clinical pathology. The lack of Esp in both probiotic bacteria suggests they are unlikely to 
be associated with human infection.
Although virulence factors were not observed in either probiotic strain it was 
thought prudent to investigate the effect the organisms had upon eukaryotic cells in vitro 
prior to in vivo experimentation. Currently no immortalised gut derived avian epithelial 
cells exist which are suitable for in vitro experimentation. Two characterized cell lines 
were chosen to investigate the cellular toxicity of the probiotic bacteria upon eukaryotic 
cells. The first cell line that was used to evaluate cellular toxicity was a human epithelial 
carcinoma cell line HEp-2. The HEp-2 cell line has been extensively characterised 
previously particularly in the evaluation of pathogenic bacterial adhesion studies (La 
Ragione et al, 2000; Best et al, 2005). The second cell line that was selected (HT29 cell 
line) was a human mucus secreting carcinoma cell line previously isolated from the ileum. 
As this cell line is derived from intestinal tissue and also produces protective mucus it was 
thought that it would provide a cytotoxicity model that was more akin to that of the GI tract 
of poultry. This cell line has also been well characterized previously and has been used in 
the evaluation of bacterial pathogenicity (Lesuffleur et al, 1995; La Ragione et al, 2000). 
The standard model developed for use with the HEp-2 cells was applied to the HT29 cell 
line with some modifications (Best et al, 2005).
Cellular damage to the HEp-2 cells was observed for both probiotic bacteria as 
individual preparations and also in combination. EMEM medium has a phenol red pH 
indicator system. E. faecium PXN-33, when inoculated onto both cell lines, maintained the 
red colour of EMEM indicating the pH of the inoculation medium was buffered and 
maintained at around pH 7.4. L. salivarius 59, in contrast, resulted in the EMEM medium 
turning yellow. This indicated a drop in pH below 6.7. Thus L. salivarius 59 substantially 
reduced the medium pH. The cause of cellular damage observed with L. salivarius 59 could 
be due to a reduction in pH of the tissue culture media. It is unlikely that reduced pH of the 
tissue culture media is the cause of the vacuolation observed with the E. faecium PXN-33 
inoculation. E. faecium species are known to produce hydrogen peroxide from the 
reduction of oxygen. Exposure of mammalian cells to hydrogen peroxide causes cellular 
damage. Moy et al, (2004) established that hydrogen peroxide production by various 
strains of E. faecium was induced by aeration of cultures (Moy et al, 2004). The
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vacuolation observed by Giemsa staining of HEp-2 cells could be caused by the production 
of hydrogen peroxide by E. faecium PXN-33 (Moy et al, 2004). As the intestines of 
poultry are anaerobic if the vacuolation observed was due to hydrogen peroxide production 
then this maybe art factual due to the aerobic conditions in the tissue culture assay. The 
nuclear condensation observed when L. salivarius 59 was administered to the HEp-2 cells 
may simply be a result of the reduction in medium pH. It should also be noted that the pH 
of poultry intestines is significantly lower than the observed pH reduction in the HEp-2 
cells.
Mucus lining the gut may also protect the gut epithelium from hydrogen peroxide 
production and a reduction in intestinal pH. To simulate the protective effect of mucus 
production in the GI tract, mucus producing HT29 cells were inoculated with the probiotic 
preparations. No cellular cytotoxicity was observed and thus it can be surmised that the 
production of mucus protected the cell line. Further in vivo studies were required to assess 
if cellular toxicity would be observed in the chick.
According to SCAN it is of particular importance to demonstrate that the probiotic 
does not adversely affect the host organism by causing pathology. Safety of the probiotic 
preparation was evaluated in vivo using an SPF chick model. SPF chicks were used as they 
would be free of potentially pathogenic bacteria, in particular Salmonella species that may 
bias the experiment. Damage to the mucosa in immature chicks was evaluated after a single 
high dose of the probiotic preparations. Immature chicks were evaluated as the 
undeveloped chick gut is more likely to be damaged by exposure to bacteria than 
developed mucosa in the adult bird. Production of mucus was evaluated by histological 
staining in order to determine if the probiotic bacteria affect the integrity of the mucus 
barrier. Histological examination also allowed the assessment of disruption and blunting of 
villi.
As predicted by the in vitro assays, no damage to the epithelia was observed in the 
chicks even when approximately 1x10  ^cfu of the probiotic was given per bird. The doses 
used in the study were relatively high and the lack of pathology within the chick gut would 
suggest tolerance to the probiotic bacteria. Whilst histo-pathological preparations of the 
chick gut was less than optimal any serious pathology detrimental to the chicks would have
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been observed. Furthermore no morbidity or increased mortality was observed throughout 
the study.
Although no enhancement of growth was observed when chicks were given the 
probiotic preparation no significant reduction in growth was seen. It should be noted that a 
trend in reduction in bird weights was observed in the probiotic treated group and that the 
reduction in weight gain may be significant in a larger scale study. The poultry industry is 
what is termed “vertically” integrated i.e. the birds, farm and feed are owned by a company 
or integrator. The farmer is hired by the integrator and is paid relative to the weight of live 
birds produced. If a reduction in weight gain was observed in further studies it would 
therefore be of concern.
Inhibition of bird growth may be due to the action of the probiotic bacteria 
deconjugating poultry bile acids resulting in reduced digestion of lipids. Previous reports 
have linked a reduction of L. salivarius spp. in poultry to the administration of antibiotics. 
The reduction in L. salivarius spp. was subsequently linked with reduced bile salt 
deconjugation and increased lipid absorption which, in turn, was thought to have resulted 
in increased chick weight gain (Cuban et al, 2006). This suggests that L. salivarius spp. 
may inhibit optimal weight gain in poultry by interference with lipid digestion and thus the 
use of L. salivarius 59 may have caused the observed trend in reduced chick weight gain. 
No definitive evidence of chick pathology was observed and tolerance of the chicks to the 
probiotic preparation was shown.
As was discussed in the introduction there are currently stringent controls on the 
use of probiotics within the EU as animal feed supplements. One aspect of probiotic safety 
is the acquisition of transferable resistance genes and resistance to clinically important 
antibiotics. SCAN has recommended the testing of probiotic feed supplements for 
antibiotic resistance (Wright, 2005). The BSAC method for MIC determination of 
antibiotic resistance was chosen as this method is commonly used in the UK (Andrews, 
2001). In order to determine the presence of transferable antibiotic resistance and resistance 
to clinically important antibiotics SCAN has published antibiotic MIC breakpoints for 
several probiotic bacteria (Wright, 2005). The antibiotic MIC values of L. salivarius 59 and 
E. faecium PXN-33 recommended by SCAN were determined. In addition to the SCAN
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recommended list of antibiotics several other antibiotics of human clinical importance were 
also screened.
Antibiotic resistance can be divided into two groups, acquired and innate resistance. 
Innate resistance is when the bacterial cell processes either prevent interference by 
antibiotics or are naturally refractive to the antibiotic. Acquired resistance is where the 
bacteria either acquire resistance genes from neighbouring resistant isolates (transferable 
resistance) or selective pressure promotes growth of strains where mutational changes have 
produced resistance. Of concern with L. salivarius 59 and E. faecium PXN-33 is resistance 
to antibiotics that are of clinical importance as these antibiotics may be used to eradicate 
the probiotics in the event of an opportunistic infection from the probiotics. Secondly if the 
probiotic bacteria carry antibiotic resistance genes these could also be transferred to 
pathogenic bacteria.
The BSAC MIC breakpoints are used routinely to determine the clinical resistance 
of an isolate to a given antibiotic (MacGowan & Wise, 2004). The BSAC MIC points are 
usually specific to humans and, in some cases, to the site of infection. These break points 
are also species or genus specific to the bacteria isolated (MacGowan & Wise, 2004). This 
means that only isolates of clinical importance have specified MIC break points. The 
advisory body, BSAC, has not produced any break points for members of the Lactobacillus 
genus because they very rarely cause disease. BSAC has produced a large number of MIC 
breakpoints for enterococci as they are human pathogens (e.g. E. faecalis). SCAN MIC 
breakpoints, in contrast to those described by BSAC, are for the identification of antibiotic 
resistance that maybe due to transferable resistance elements and thus SCAN has published 
MIC break-points for Lactobacillus species.
Nalidixic acid was tested for use as an antibiotic marker. L. salivarius 59 and E. 
faecium PXN-33 were resistant to this antibiotic (Table 5.2). Nalidixic acid is 
predominantly used to treat Gram-negative bacterial infections as resistance occurs more 
frequently in Gram-positive bacteria (Brisse et al, 1999). By supplementing the growth 
medium with naladixic acid there should be a reduction in background growth of 
problematic Gram-negative contaminants such as Proteus and Klebsiella species during in 
vivo trials.
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Transferable resistance has been shown to occur by three mechanisms in 
Enterococcus faecium, conjugative transformation, conjugative sex pheromone dependent 
transformation and transposon mediated transformation (Heaton & Handwerger, 1995; 
Takeuchi et al, 2005). Gentamycin, erythromycin and vancomycin resistance are all 
transferable (Heaton & Handwerger, 1995; Takeuchi et at., 2005). Of particular concern is 
the rising occurrence of VRE in hospitals. Vancomycin was the antibiotic of choice when 
treating serious infections by Gram positive bacteria, although resistance to this antibiotic 
is becoming more prevalent. As resistance to p-lactam, especially extended spectrum 13- 
lactams (ESBLs), and glycopeptide antibiotics increases, the ability to treat patients quickly 
and effectively becomes increasingly difficult (Dutka-Malen et al, 1995).
E. faecium has been shown to have low-level resistance to various antibiotics 
including a range of p-lactams, aminoglycosides and lincosamides (for a comprehensive 
review see Murray, 1990). Although E. faecium PXN-33 was resistant to gentamycin, 
penicillin G, chloramphenicol and erythromycin according to BSAC MIC breakpoints this 
is unlikely to be transferable resistance because the MIC’s were below SCAN 
recommended breakpoints. E. faecium PXN-33 MIC to rifampicin was above the BSAC 
and SCAN MIC breakpoints. This indicates that the resistance to rifampicin is above the 
acceptable limit for clinical resistance and may be due to transferable elements; although 
previous reports by Enne et al, (2004) indicated that rifampicin acquired resistance in E. 
faecium is likely to be due to mutations of the DNA-dependent RNA polymerase. Other 
mechanisms of resistance are rarely seen and have been limited to species such as Bacillus 
and Mycobacterium (Dabbs et al, 1995). It is therefore likely that rifampicin resistance in 
E. faecium PXN-33 is due to point mutations in DNA dependent RNA polymerase but 
should be further investigated to ensure transferable resistance is absent.
Lactobacilli other than L. salivarius such as strains of L. reuteri have been shown to 
harbour erythromycin resistance on a 6.9kb plasmid (Axelsson et al, 1988) and a 7kb 
plasmid conferring chloramphenicol resistance (Lin et al, 1996). The structural cat-TC 
gene, which is the determinant protein of chloramphenicol resistance, showed 95% 
homology to the cat-gene from Staphylococcus aureus pC194 plasmid (Lin et al, 1996). 
The similarity of the cat-genes from S. aureus and L. reuteri would suggest that transfer.
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presumably by transformation, is possible between lactobacilli and distantly related Gram 
positive bacteria. Although transferable resistance has been seen in lactobacilli no 
transferable resistance has been seen in L. salivarius species.
The MIC for L. salivarius 59 to vancomycin was greater than >128 ng/pl indicating 
that it is resistant to clinically relevant concentrations of vancomycin (the recommended 
MIC by SCAN is 4 ng/pl). Lactobacillus species are however, naturally resistant to 
vancomycin. Previous work by Elisha & Courvalin (1995) demonstrated that several 
Lactobacillus isolates, including L. salivarius CIP103140T, posses a chromosomal D- 
alanineiD-alanine ligase. This enzyme was significantly different from transmissible 
elements found in enterococci and suggests that whilst L. salivarius is clinically resistant to 
vancomycin, this is not readily transmissible to potential pathogens. L salivarius 59 
resistance phenotype suggests that it does not carry transmissible resistance elements to the 
tested antibiotics recommended by SCAN. It is resistant to naladixic acid and vancomycin 
but this is likely to be due to chromosomal resistance determinants.
In addition to determining MICs a micro-array was also used in order to fully 
investigate the possible carriage of transferable antibiotic resistance genes. The array used 
screens for the carriage of 90 antibiotic resistance genes including three resistance genes 
found in lactobacilli and twenty eight enterococci resistance genes including fifteen from 
E. faecium species. Phenotypic characterisation is preferred to genotypic because genes 
maybe inactive through truncation or mutation. Although phenotypic characterisation is 
preferred use of the microarray was thought to be quicker for screening numerous 
antibiotic resistance genes.
L  salivarius 59 appeared to have no Gram positive resistance genes which 
correspond to the MIC levels and literature discussed above. In contrast two resistance 
gene determinants were observed and their presence confirmed by PCR in E. faecium 
PXN-33. The msr(C) gene detected using the antibiotic nano-array is common among E. 
faecium species and was suggested as a species specific identifying gene (Singh et al, 
2001). Further research has indicated that this gene is not found in every member of the 
species E. faecium and thus is not a species specific identifying gene (Werner et al, 2000; 
Werner et al, 2001). Whilst this resistance gene is not found in every isolate it should be 
noted that this gene is distributed widely within the E. faecium species. This would suggest
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that the resistance gene was acquired very early in the species evolution or that this was an 
endogenous gene lost by certain members of the species. Whichever is true, as the gene is 
distributed so widely among the species it should be considered either endogenous to the 
species or non-transferable to pathogenic bacteria. The efflux pump encoded by the msr(C) 
confers, among others, erythromycin resistance. The MIC of E. faecium PXN-33 to 
erythromycin was 4pig/ml which is below the SCAN MIC break point suggesting that the 
resistance is non-transferable. Whilst the msr(C) gene was observed in E. faecium PXN-33 
the literature suggests that it is not transferable.
The second resistance gene detected in E. faecium PXN-33 using the nano-array 
was the aminoglycoside resistance gene aac(6')-Ii. The aminoglycoside resistance gene 
encodes a 6’-N-aminoglycoside acetyltransferase which catalyses the acétylation of the 
amino groups of various aminoglycoside antibiotics (Costa, et al, 1993). This is a 
chromosomally encoded gene that does not appear to be on a mobile genetic element 
(Costa et al, 1993; Wright & Ladak, 1997). In addition to being chromosomally encoded 
the resistance gene appears to be ubiquitous within the E. faecium species (Chow, 2000). 
The fact that aac(6’)-Ii is a none mobile gene and common within the E. faecium spp. 
indicates that this resistance element is unlikely to be transferable between species. Also 
the gene is common within the E. faecium species and thus intra-species transfer of the 
gene is irrelevant. Although E. faecium PXN-33 was positive for acc{6’)-Ii this gene’s 
presence is not a safety concern.
It is unlikely that either of the two probiotic strains studied would be harmful to 
poultry. Cytotoxicity was observed in HEp-2 cells but further in vitro investigations using 
HT-29 mucus secreting cells showed no cellular cytotoxicity induced. Birds dosed with 
high numbers of probiotic bacteria did not show any pathology, morbidity or mortality 
compared to controls. No significant reduction in weight gain was observed although a 
trend of reduced weight gain was observed. Future studies should be conducted in order to 
confirm that the probiotic preparation had no adverse effects on chick weight gain. The 
resistance to antibiotics observed in E. faecium PXN-33 and L. salivarius 59 is almost 
certainly due to chromosomal elements and are not therefore transferable. Further 
investigations should be conducted to confirm that rifampicin resistance of E. faecium 
PXN-33 is not transmissible. Two resistance genes were detected in E. faecium PXN-33 by
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nano-array analysis. Although these genes appear to confer resistance to clinically 
important antibiotics the literature suggests that these resistance genes are common in E. 
faecium species and are not transferable between different species. From the evidence 
presented in this Chapter E. faecium PXN-33 and L. salivarius 59 are safe for animal use 
although certain aspects of probiotic safety should be investigated further.
125
University of Surrey Chapter 6
Chapter 6 - Evaluation of inhibitory effects of L. salivarius and E, faecium 
on Salmonella Enteritidis in vitro
6.1 Introduction
In the previous Chapters the ability of the probiotic strains to survive GI tract transit 
in poultry was demonstrated. It has also been demonstrated that the probiotic strains are 
safe for use as a commercial agricultural feed supplement. S. Enteritidis poses a major 
social and economic problem (discussed in Chapter 1). This Chapter describes an 
investigation into the ability of the probiotics to inhibit S. Enteritidis in vitro. In order to 
adhere to principles of the three R’s i.e. reduction of the number of animals used, 
replacement of animal experimentation and refinement of current techniques to maximize 
the data obtained from animal experimentation, it was thought prudent to demonstrate 
inhibition of S. Enteritidis by the probiotic strains in vitro prior to in vivo studies. Probiotic 
pre-conditioned media assays were utilised to assess whether the probiotic bacteria secreted 
inhibitory substances and an assay based on the antibiotic disc diffusion method to evaluate 
the ability of live bacteria to inhibit Salmonella growth on solid medium. In addition to this 
competition assays on tissue culture cells were utilised to investigate competition for 
epithelial cell binding sites. It was demonstrated that the probiotic strains were capable of 
inhibiting Salmonella growth in vitro using the conditioned medium assay and plate 
diffusion assay but no competition for receptor sites was demonstrated. As inhibition of 
Salmonella was observed in vitro it was decided to investigate these inhibitory properties in 
vivo.
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6.2 Results
6.2.1 In vitro inhibition of Salmonella Enteritidis
6.2.1.1 Disc diffusion and conditioned medium assays
The live bacteria plate diffusion assays were conducted as described in section 
2.1.12. The assay was performed in triplicate and a Student’s unpaired T-test was used to 
compare the results from L. salivarius 59 and E. faecium PXN-33 inhibition of Salmonella. 
In order to determine the presence of inhibitory substances produced by the probiotics 
conditioned medium assays were conducted as described in section 2.1.11. The inhibitory 
effect of the probiotic culture on S. Enteritidis was determined as either none, mild, strong 
or very strong using the size of the zone of inhibition as described in Table 6.1. 
Experiments were conducted on three separate occasions with four experimental repeats. 
Error bars were included to show the 95% confidence intervals for each reading taken at 15 
minute intervals.
Table 6.1 Correlation o f S. Enteritidis tolerance/resistance to probiotic conditioned medium to growth 
delay times. Table indication criteria for the correlation of delay in growth to arbitrary bile 
tolerance/resistance as proposed by Tsai et al., (2005). Where d=diameter of the zone of inhibition in 
millimetres.
Grade of Salmonella None Mild Strong Very strong
inhibition
1 Size of zone of 
! inhibition (nun)
< 11mm 11mm <d< 16 mm 16 mm < d < 22 mm D > 22 mm I
1
Table adapted from Tsai et al, (2005).
In the disc diffusion inhibition assays L. salivarius 59 and E. faecium PXN-33 
inhibited S. Enteritidis growth on solid media. No inhibition was observed with the MRS 
negative control or the blank disc on either probiotic treated plate. The mean sizes of S. 
Enteritidis zone inhibition from L. salivarius 59 was 13.7mm, 12.7mm and 10.7mm when 
20iil, 15[xl and lOpl of overnight cultures were inoculated onto the plate on blank discs 
respectively. E. faecium PXN-33 produced 12mm, 11.3mm and 10.0mm zones of S. 
Enteritidis inhibition when 20fxl, 15[xl and lOpl of culture was inoculated onto S.
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Enteritidis seeded plates respectively. Both L. salivarius 59 and E. faecium PXN-33 mildly 
inhibited S. Enteritidis growth on solid media when 20(xl or 15pl of the organism was 
inoculated on to the plates according to the proposed criteria by Tsai et al, (2005). The S. 
Enteritidis zones of inhibition produced by L  salivarius 59 and E. faecium PXN-33 were 
compared statistically using Student’s T-test; no significant differences were observed 
between the zones of inhibition produced by the two probiotic cultures. Additionally the 
ability of CFCS to inhibit S. Enteritidis using the same technique was determined. No 
inhibition was observed by L. salivarius 59 or E. faecium PXN-33 CFCS.
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Figure 6.1 Disc diffusion assays to determine the ability of the probiotic bacteria to inhibit S. Enteritidis.
Competitive exclusion of S. Enteritidis S1400 with either E. faecium (A) or L. salivarius (B). Internal 
antibiotic positive control (1), blank disc negative control (2), MRS negative control (3), lOpl of probiotic 
conditioned medium (4), 15pl of probiotic conditioned medium (5) and 20pl of probiotic conditioned medium 
(6).
B
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To determine the tolerance of S. Enteritidis to the probiotic pre-conditioned 
medium, a criterion based on that used for bile tolerance, as described in section 4.2.2, was 
developed, based on that previously described by Chateau et al, (1994). The difference in 
time (minutes) for the culture to grow to an optical density of 0.08 at 600nm between the 
control medium and the probiotic treated medium was calculated. S. Enteritidis tolerance to 
probiotic conditioned medium was determined as either resistant, tolerant, weakly tolerant 
or sensitive using the time delays described in Table 6.1. Assays were performed using four 
experimental repeats on three separate occasions.
Table 6.1 Correlation o f S. Enteritidis tolerance/resistance to probiotic conditioned medium to growth 
delay times. Table indication criteria for the correlation of delay in growth to arbitrary bile 
tolerance/resistance as proposed by Chateau et al, (1994). Where d=delay in Salmonella growth compared to 
the control.
Tolerance to 
conditioned medium
Resistant Tolerant Weakly tolerant Sensitive
Delay in growth 
1 (min)
d < 15min 15min < d < 40 min 40 min < d < 60 
min
D > 60 min |
j
Table adapted from Chateau et al, (1994).
For spent media assays S. Enteritidis grew in E. faecium PXN-33 and L. salivarius 
59 pre-conditioned medium adjusted to pH 7.2 and control medium (Figure 6.2). Growth 
was also observed in the L. salivarius 59 unadjusted conditioned medium but not in E. 
faecium PXN-33 unadjusted conditioned medium. The average pH of L. salivarius 59 and 
E. faecium PXN-33 unadjusted pre-conditioned medium assay was pH 5.4 for both isolates. 
In the control medium S. Enteritidis grew to an optical density of 0.08 at 600nm in 4hrs 
43mins in both experiments (+/- Imins). When S. Enteritidis was grown in L. salivarius 59 
and E. faecium PXN-33 pH adjusted pre-conditioned medium, S. Enteritidis grew to an 
optical density of 0.08 at 600nm in 5hrs 17mins and 6hrs and 16mins respectively. When S. 
Enteritidis was grown in L. salivarius 59 unadjusted pre-conditioned medium, S. Enteritidis 
grew to an optical density of 0.08 at 600nm in 3hrs 1 Imins. S. Enteritidis did not grow to 
an optical density of 0.08 at 600nm when cultured in the unadjusted E. faecium PXN-33
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pre-conditioned medium. The growth delay value for S. Enteritidis in L  salivarius 59 pre­
conditioned medium adjusted to pH 7.2 was 35 minutes whereas the growth delay value for 
growth in L. salivarius 59 pre-conditioned medium adjusted to pH 7.2 was 93 minutes 
(Figure 4.1). In the unadjusted pre-conditioned medium assay L. salivarius 59 delay in 
growth was 191 minutes and the delay in growth caused by E. faecium PXN-33 could not 
be determined. According to the criteria proposed by Chateau et al, (2004) S. Enteritidis 
was tolerant to L. salivarius 59 pre-conditioned medium adjusted to pH 7.2. In contrast S. 
Enteritidis was sensitive to L. salivarius 59 unadjusted pre-conditioned medium, E. faecium 
PXN-33 unadjusted pre-conditioned medium and E. faecium PXN-33 adjusted pre­
conditioned medium.
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Figure 6.2 Conditioned medium assays. Optical density of the medium was measured at regular time 
intervals. Growth of S. Enteritidis was recorded in BHIB medium preconditioned with L. salivarius (A) and 
E. faecium (B). Triangle points indicate the growth of Salmonella in unconditioned medium, circular points 
show the growth in conditioned medium at pH 7.2 and triangular points show growth in unadjusted 
conditioned medium. Horizontal dashed line indicates an optical density of 0.08 units at 600nm.
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6.2.1.2 Tissue culture competition assays
Competition assays were performed as described in section 2.3.2, as described 
previously with modifications (La Ragione et al, 2000; Best et al, 2005). S. Enteritidis 
association to the cell lines was determined after cells were either pre-treated with the 
probiotic preparation or inoculated with medium only. Assays were performed in 
quadruplicate on three separate occasions. Student T-test was used to compare probiotic 
interference of Salmonella adhesion as compared to the control as described in section 2.5.
The mean number of S. Enteritidis recovered when mucus secreting HT29 cells 
were pre-treated with E. faecium PXN-33, L. salivarius 59, a 50:50 preparation of the two 
probiotics and negative control were 4.17x10^ cfu/cell, 3.21x10^ cfu/cell, 5.03x10^ cfu/cell 
and 4.97x10^ cfu/cell respectively. The number of S. Enteritidis recovered after each 
probiotic treatment was compared to the control treatment; no significant difference was 
observed between the control and probiotic treated cells.
The mean number of S. Enteritidis recovered when Caco-2 cells were pre-treated 
with E. faecium PXN-33, L. salivarius 59, a 50:50 preparation of the two probiotics and 
negative control were 2.28x10^ cfu/cell, 2.34x10^ cfu/cell, 2.91x10^ cfu/cell and 2.84x10^ 
cfu/cell respectively. The number of S. Enteritidis recovered from after each probiotic 
treatment was compared to the control treatment; no significant difference was observed 
between the control and probiotic treated cells.
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Figure 6.3 Tissue culture competition assays. Competitive exclusion of S. Enteritidis SI400 with either E. 
faecium (EF), L. salivarius (LS), 50:50 inoculum of L. salivarius and E faecium (MP) on mucus secreting 
HT29 cells (A) and Caco-2 cells (B) after 3hrs incubation with probiotic and 2hr incubation with S. 
Enteritidis (SI400) at 37°C and 5% CO2. Error bars indicate the standard error of the mean.
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6.2.3 Discussion
In order to test the inhibitory effects of probiotic organisms on Salmonella and to 
adhere to principles of the three R’s (reduction, replacement and refinement) of animal 
experimentation, in vitro assays were conducted. Furthermore, demonstration of possible 
probiotic mechanisms by L. salivarius 59 and E. faecium PXN-33 in vitro may aid in 
elucidating the mechanisms by which competitive exclusion of S. Enteritidis (81400) may 
occur. The ability of the probiotic bacteria to inhibit Salmonella Enteritidis in vitro was 
evaluated using a plate diffusion technique. Plate diffusion techniques have been described 
previously by several authors and are considered quick and easy screens for inhibition. 
These assays have also been used to evaluate inhibitory effects of probiotic lactobacilli and 
Bacillus spp. on E. coli and Act. pyogenes (Guo et al., 2006; Otero et al, 2006).
Whilst the technique is rapid at describing inhibition from probiotic cell free culture 
supernatant (CFCS), the technique cannot be used to evaluate the effect of live probiotic 
bacteria on live pathogenic bacteria. The diffusion method was modified to allow the 
evaluation of inhibition from live probiotic bacteria on live pathogenic bacteria.
To assess the inhibition of probiotic cell free culture supernatant a conditioned 
medium assay was employed. Several authors have described the evaluation of CFCS to 
determine if probiotic bacteria produce pathogen specific inhibitory metabolites (Hudault et 
al, 1997; Fayol-Messaoudi et al, 2007). Here an assay was developed to determine 
inhibition, independent of pH, produced extracellularly by the probiotic organism. The 
assay was similar to that described by Tsai et al, (2004) where live bacteria were inoculated 
onto paper discs which were placed on MRS agar and subsequently overlaid with media 
containing Salmonella Typhimuiium. As the assays were similar to Tsai et al, (2004) this 
inhibition classification system was adopted for our investigations. The assay allows the 
evaluation of inhibitory metabolites in solution which is more akin to what is found in vivo, 
rather than those produced on solid media.
E. faecium PXN-33 and L. salivarius 59 exhibited similar inhibition patterns on S. 
Enteritidis in plate diffusion assays. The inhibitory effect of both probiotics was mild when 
live bacteria were inoculated onto the plates, but no inhibition was observed when CFCS 
were assessed. This indicated that the inhibition presented by the bacteria towards S.
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Enteritidis required the probiotic bacteria to be metabolically active to cause inhibition. It 
should be noted that CFCS assays showed inhibition of S. Enteritidis. It is likely that the 
inhibitory substances are present in the CFCS on both the plates and broth medium but due 
to the diffusion dynamics of solid agar the concentration of these at the point of contact 
with S. Enteritidis may have been reduced in the solid medium. Furthermore metabolically 
active bacteria would be capable of maintaining a higher concentration of inhibitory 
substance and thus on the solid media the observed inhibition of live bacteria compared to 
the CFCS would suggest constant production and greater inhibition from live L. salivarius 
59 and E. faecium PXN-33.
It was observed that S. Enteritidis was sensitive to L. salivarius 59 pre-conditioned 
medium, which had an approximate pH of 5.4. The inhibitory effect of L. salivarius 59 pre­
condition medium on S. Enteritidis was almost totally neutralized by the adjustment of the 
medium to pH 7.2. L. salivarius 59 inhibition is thus almost entirely pH dependent and 
maybe due to the neutralization of lactic acid produced by the organism, which corresponds 
to previous observations cited in the literature. In vivo studies by Fuller (1977) with L. 
salivarius 59 demonstrated a substantial reduction in the crop pH of poultry (pH 5.70 
reduced to pH 4.00). The reduction in pH correlated with a significant drop in the total 
numbers of E. coli in the crop. Previous experiments have shown that inhibition of E. coli 
in vivo by L. salivarius 59 is directly dependent upon inhibitory substances such as lactic 
acid (Fuller, 1977). Additionally previous studies have indicated that the inhibition of S. 
Enteritidis by L. salivarius spp. is entirely pH dependent and that the effect could not be 
neutralized by the addition of catalase (Garriga et al, 1998). Furthermore van Coillie et al, 
(2007) correlated lactic acid production with the inhibitory effect of L. salivarius spp. on 
Salmonella enterica isolates in a spot on in vitro assay. A similar observation by Makras et 
al, (2006) showed four Lactobacillus spp. inhibit Salmonella Typhimurium invasion of 
Caco-2 cells by the production of between 150 to 190nM of lactic acid. The effect of 
inhibition also reduced over the 24hr period and although 5. Enteritidis growth did not 
entirely recover to normal levels of growth a reduction in inhibitory activity was observed.
E. faecium PXN-33 CFCS also had an approximate pH of 5.4 and almost entirely 
eliminated S. Enteritidis growth for the duration of the experiment. When the E. faecium 
PXN-33 CFCS was pH adjusted to pH 7.2 the observed S. Enteritidis inhibition was
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reduced, although in the initial growth phase S. Enteritidis remained sensitive to the CFCS. 
The growth of S. Enteritidis in the CFCS at pH 7.2 recovered to the same levels observed 
in the control towards the end of the incubation period. This could suggest a pH 
independent type of inhibition such as the production of bacteriocins, coupled with pH 
dependent inhibition. E. faecium spp. has been shown to produce bacteriocins active 
against Gram positive bacteria that are expressed in the exponential growth phase and also 
during the stationary phase of growth (Leroy et al, 2003; Marekova et al, 2003). Previous 
reports by Carina et al, (1999) demonstrated the production of bacteriocins by E. faecium 
J96 that antagonize the growth of S. Gallinarum and S. Pullorum. Furthermore Laukova et 
al, (2003) has suggested significant reduction in the colonisation of Japanese quails by S. 
Düsseldorf was due to the production of Enterocin A by E. faecium EK13. It is also 
possible the inhibition of Salmonella by E. faecium PXN-33 could be by the production of 
inhibitory metabolites that are not bacteriocins. Previous studies have shown inhibition of 
Salmonella Typhimurium by lactobacilli mechanisms independent of lactic acid production 
due to unstable substances that lose their activity after 24hrs (Fayol-Messaoudi et al, 
2005). Furthermore L. johnsonni Lai and L. plantarum ACA-DC 287 were shown to 
inhibit Salmonella Typhimurium by the production of a non-proteinaceous, heat-stable 
substance that required lactic acid concentrations above 125mM and pH below pH4.5 in 
CFCS (Makras et al, 2006). The observation in CFCS and the similar pattern of inhibition 
observed with L. salivarius 59 coincides with the plate diffusion results suggesting that the 
constant production of inhibitory substances is required to maintain Salmonella inhibition.
Several authors have used in vitro culture competition assays to determine the 
ability of probiotics to inhibit pathogens. Forestier et al, (2001) showed that Caco-2 
competition assays could be used to describe L. rhamnosus inhibition of E. coli and K. 
pneumoniae (Forestier et al, 2001). A similar assay has been used to determine reductions 
in S. Typhimurium invasion of Caco-2 cells by L. casei GG (Hudault et al, 1997). To 
maintain experimental consistency the adherence assays were adapted (as described in 
section 2.3.1 and 3.2.3.1) to determine the ability of the probiotic cultures to reduce or 
eliminate adherence of S. Enteritidis to Caco-2 cell and HT29 cell lines. HEp-2 cell lines 
were not used since, as described in section 3.2.3.1, the probiotic bacteria damaged the 
integrity of the cell line which was derived from the oesophagus rather than the intestine.
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The hypothesis was that L. salivarius 59, E. faecium PXN-33 and S. Enteritidis (S1400) 
adhered and thus competed for similar receptor sites. No significant protective effects 
against S. Enteritidis association to HT-29 cells or Caco-2 cells by L  salivarius 59 and E. 
faecium PXN-33 was observed.
From the plate inhibition and CFCS studies it was suggested that S. Enteritidis 
inhibition by L. salivarius 59 was dependent upon a pH of at least 5.4 and that an increase 
in pH to pH 7.2 neutralizes this effect. In contrast inhibition of S. Enteritidis by E. faecium 
PXN-33 was not entirely dependent on a low pH, although this effect was substantially 
enhanced by a reduced pH therefore the effect was enough to inhibit S. Enteritidis growth 
entirely. The results also indicate that metabolically active E. faecium PXN-33 and L. 
salivarius 59 are able to induce better inhibition than CFCS. No inhibition of S. Enteritidis 
binding to the human derived gut cell lines was observed suggesting that L. salivarius 59 
and E. faecium PXN-33 did not compete for the same binding receptor sites.
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Chapter 7 - Evaluation of Salmonella Enteritidis colonisation and 
persistence in a direct oral contact model and seeder bird model.
7.1 Introduction
Several authors have demonstrated the ability of probiotic cultures to competitively 
exclude Salmonella colonisation of poultry. Fuller (1977) previously demonstrated that L. 
salivarius 59 reduces E. coli colonisation of the avian crop by 2 logs and that the higher the 
initial dose the greater the reduction in E. coli crop numbers. In contrast to this, no previous 
reports in the published literature have shown E. faecium PXN-33 to be inhibitory towards 
GI derived bacteria. In this Chapter the ability of L. salivarius 59 and E. faecium PXN-33 
to competitively exclude S. Enteritidis will be investigated.
This Chapter describes two in vivo studies investigating different aspects of 
probiotic inhibition of Salmonella. The first in vivo study of this Chapter demonstrated the 
ability of the probiotics strains to inhibit Salmonella Enteritidis in vivo. The ability of a 
single dose of the probiotics to inhibit Salmonella Enteritidis in SPF White Leghorns using 
L. salivarius 59 and E. faecium PXN-33, both as individual cultures and in combination, 
was investigated. Firstly the persistence of the probiotic strains in the GI tract of the birds 
was determined and then the ability of the probiotics to reduce Salmonella shedding from 
the cloaca and colonisation of the birds’ GI tract compared to a control group was 
investigated.
In the first in vivo study of this Chapter the ability of the combined probiotic 
preparation to inhibit S. Enteritidis in vivo was demonstrated. It was observed that dosing 
SPF chicks on day one with the probiotic preparation and then dosing them subsequently 
with S. Enteritidis on day two resulted in a significant reduction in Salmonella at the end of 
the study. In the second in vivo study the effect of altering the probiotic-dosing regime on 
the ability of the probiotic strains to inhibit S. Enteritidis in poultry was investigated. The 
method by which the birds were dosed with S. Enteritidis was also refined; a sentinel bird 
model to simulate the natural colonisation of the birds by S. Enteritidis was utilised.
Additionally the effect of dosing the SPF chicks with the probiotic preparation at 
different ages and the subsequent ability of L. salivarius 59 and E. faecium PXN-33 to 
inhibit S. Enteritidis colonisation of the birds was investigated. The effect of giving single
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or dual doses of the probiotic preparations to chicks and the effect this had on S. Enteritidis 
colonisation and carriage in the birds was again also investigated.
The aim of this Chapter was to firstly show inhibition of Salmonella by the 
probiotic preparation and secondly to evaluate the effect of altering the probiotic dosing 
regimes had on the competitive exclusion properties of the probiotic preparation. After 
proof of principle of Salmonella inhibition in the first in vivo study the aim was to 
determine the optimal dosing regime of the probiotic preparation for reduction of 
Salmonella.
7.2 Results
7.2.1 In vivo inhibition of Salmonella Enteritidis using a direct oral contact infection 
model
7.2.2.1 Recovery of isolates from SPF White Leghorns at 43 days of age
The in vivo model described here was conducted as described in sections 2.4.1,
2.4.2, 2.4.5 and 2.4.7. Probiotic isolates were recovered as described in section 2.4.5 and 
PFGE was performed as described in section 2.2.6. At the end of the study isolates were 
recovered and screened by PFGE in order to confirm colonisation of the birds by the 
probiotic bacteria. Six isolates were recovered from plates and compared to the original 
probiotic strains.
At age forty three days five distinct strains of enterococci were recovered from the 
ileum and caecum of birds dosed with E. faecium PXN-33 only (Figure 7.1). None of the 
recovered isolates had the same PFGE pattern as E. faecium PXN-33. Two banding 
patterns of recovered isolates were common in the ileum and caecum. In the L. salivarius 
59 probiotic treated group all the isolates recovered on MRS agar had identical PFGE 
banding patterns (Figure 7.1). Additionally all the isolates recovered from the ileum and 
caecum had identical banding patterns to those presented by L. salivarius 59. One isolate 
recovered from the caecum presented very weak banding but the pattern seen did match 
that of L. salivarius 59 (Figure 7.1).
All the enterococci isolates recovered from the group treated with a combination of 
the two probiotics were identical (Figure 7.2). Although all the enterococci isolates
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recovered from the dual treated group were identical, the PFGE profiles of the recovered 
isolates did not match the patterns seen for E. faecium PXN-33. In contrast all the 
Lactobacillus isolates recovered from the dual probiotic group matched the PFGE profile 
described for L. salivarius 59 (Figure 7.2). One of the isolates from the ceaca presented 
very weak banding patterns but again these matched the banding pattern unique to L. 
salivarius 59 (Figure 7.2).
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Figure 7.1 PFGE gels of bacteria isolated from birds receiving an E. faecium or L. salivarius probiotic 
preparation from the in vivo completive exclusion trial. PFGE profiles of bacteria isolated from the ileum 
(lanes 1 to 6) and caecum (lanes 7 to 12) of probiotic treated groups. Salmonella Braenderup was used as the 
marker (M). Enterococci were isolated from the E. faecium probiotic dosed group (A); lane 13 shows the 
PFGE profile of E. faecium PXN-33. Lactobacilli were isolated from the L. salivarius probiotic group (B); 
lane 13 shows the PFGE profile of L. salivarius 59.
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Figure 7.2 PFGE gels of bacteria isolated from birds receiving a combined E. faecium and L. salivarius 
probiotic preparation from the in vivo completive exclusion trial. PFGE profiles of bacteria isolated from 
the ileum (lanes 1 to 6) and caecum (lanes 7 to 12). Salmonella Braenderup was used as the marker (M). 
Enterococci were isolated from the E. faecium probiotic dosed the mixed dosed group (A); lane 13 shows the 
PFGE profile of E. faecium PXN-33. Lactobacilli were isolated from the mixed dosed group (B); lane 13 
shows the PFGE profile of L. salivarius 59.
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1,12.1 Evaluation of the reduction in Salmonella colonisation in the ileum, caecum 
and colon after treatment with prohiotic bacteria
The in vivo study was conducted as previously described in sections 2.4.1, 2.4.2, 
2.4.5 and 2.4.7. Briefly the competitive exclusion feeding trial used in this study was 
performed as described previously with minor modifications (Pascual gr at., 1999). Four 
groups of chicks received either a probiotic preparation or placebo and all the birds were 
subsequently dosed with Salmonella Enteritidis (S1400). At various points during the study 
tissues from the GI tract were removed and S. Enteritidis colonisation was determined. 
Licensed procedures were performed under the jurisdiction of project license 70/6435 and 
70/5282 and personal license 70/19421. Three to four birds were removed for analysis and 
the probiotic treated and control group were compared statistically using a two-way 
ANOVA as described in section 2.5.
At age six days colonisation of the ileum and colon by S. Enteritidis was 
approximately 1 log higher in the probiotic treated groups than the control group. This was 
observed in the L. salivarius 59, E. faecium PXN-33 and mixed probiotic treated groups. In 
the ileum S. Enteritidis colonisation observed in the probiotic treated and control group was 
approximately 3.00x10^ cfu/g and 3.09x10^ cfu/g respectively. Colonisation of the caecum 
in the probiotic treated and control groups were approximately the same at age six days 
(1.00x10^ cfu/g). In the colon colonisation by S. Enteritidis of birds treated with the 
probiotic preparations and the control group were approximately 1.00x10^ cfu/g and 
1.42x10  ^ cfu/g respectively. Probiotic treated groups were compared statistically to the 
control group using two way ANOVA analyses. No significant difference was observed 
between the E. faecium PXN-33 (p=0.7162), L. salivarius 59 (p=0.7241), mixed probiotic 
group (p=0.7117) and the control group.
At age twenty four days colonisation of the ileum and caecum by S. Enteritidis was 
approximately the same for all the probiotic treated groups and the control group (Figure 
7.3). Colonisation by S. Enteritidis to the ileum of the chicks in the probiotic treated and 
control groups was approximately 2.00x10^ cfu/g. Colonisation by S. Enteritidis of the 
caecum in the probiotic treated and control groups was approximately 2.00x10^ cfu/g. S. 
Enteritidis colonisation of the colon by the E. faecium PXN-33, L. salivarius 59 and control 
group was approximately 4.00x10^ cfu/g (Figure 7.3). The group treated with a
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combination of the two probiotics reduced S. Enteritidis colonisation in the colon by 
approximately 1 log; 3.04x10^ cfu/g of S. Enteritidis was recovered from the tissue in the 
mixed probiotic treatment group. As before the probiotic treated groups were compared 
statistically to the control group using two way ANOVA analyses. No significant 
difference was observed between the E. faecium PXN-33 (p=0.1617), L. salivarius 59 
(p=0.2069), mixed probiotic group (p=0.3591) and the control group (Figure 7.3).
At age 43 days colonisation of the ileum by S. Enteritidis was reduced by all the 
probiotic treated groups compared to the control group (Figure 7.3). Colonisation by S. 
Enteritidis to the ileum in the E. faecium PXN-33, L. salivarius 59, mixed treated group 
and control groups was 1.37x10  ^cfii/g, 1.61x10  ^cfu/g, 9.44x10^ cfu/g and 6.33x10^ cfu/g 
respectivley. Colonisation by S. Enteritidis of the caecum in the E. faecium PXN-33, L. 
salivarius 59 and control treated groups was approximately 5.00x10^ cfu/g. S. Enteritidis 
colonisation was reduced by approximately 2 logs in the caecum when birds were treated 
with a combination of the two probiotics (2.09x10^ cfu/g) as compared to the control group 
(2.99x10^ cfu/g) (Figure 7.3). Colonisation by S. Enteritidis of the colon in the E. faecium 
PXN-33, L. salivarius 59 and control treated groups was approximately 9.00x10^ cfu/g. S. 
Enteritidis colonisation was reduced by approximately 2 logs in the colon when birds were 
treated with a combination of the two probiotics (8.34x10"^  cfu/g) as compared to the 
control group (4.47x10^ cfu/g). As above the probiotic treated groups were compared 
statistically to the control group using two way ANOVA analyses. No significant 
difference was observed between the E. faecium PXN-33 (p=0.9036) and L. salivarius 59 
(p=0.4596) compared to the control group. In contrast the differences between the mixed 
probiotic treated group compared to the control group at age forty three days was 
significant (p=<0.001) (Figure 7.3).
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Figure 7.3 Colonisation results from competitive exclusion feeding trial. The cfu/g of Salmonella was 
recorded for the ileum, caecum and colon at age six (A), twenty four (B) and forty three (C) days of age. 
Samples were removed from birds exposed to S. Enteritidis taken from four experimental groups; E. faecium 
treated birds (EF), L. salivarius treated birds (LS), birds treated with L salivarius and E. faecium (MP) and a 
negative control group that was only exposed o the S. Enteritidis challenge (C).Error bars indicate the 
standard error of the mean.
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1,2.23 Evaluation of the reduction in Salmonella shedding after treatment with 
probiotic bacteria
The competitive exclusion feeding trial used in this study was performed as 
described above (Pascual et al, 1999); detailed methods can be found in sections 2.4.1,
2.4.2, 2.4.5 and 2.4.7. To determine Salmonella Enteritidis uptake and shedding profiles, 
chicks were swabbed regularly during the study and shedding was assessed by a semi- 
quantative method as described previously with some modifications (Carroll et al, 2004).
No significant differences in S. Enteritidis shedding was observed between any of 
the groups using Kruskall-Wallis test at age three to thirty seven days (P=>0.050 for 
probiotic treatment groups compared to the control group) (Figure 7.4). A significant 
difference between the groups was observed using the Kruskall-Wallis test at age forty one 
days of age (P=0.010). Further analysis at age forty one days using Dunn’s test showed no 
significant differences between the L. salivarius 59 treated group, E. faecium PXN-33 
treated group and the mixed probiotic treated as compared to the control group (P=1.000, 
P=0.540 and P=0.136 respectively). It should be noted however, that there was a general 
downward trend in the level of S. Enteritidis shedding in the group treated with the mixed 
probiotic as compared to the control group after the age of twenty three days (Figure 7.4). 
At the age of twenty three days approximately 60% of the birds that were swabbed in the 
control and mixed probiotic group were medium or high S. Enteritidis shedding birds. 
During the subsequent eighteen days the percent of Salmonella high and low shedding 
birds did not fall below 30% of the birds swabbed and on the final sampling point 60% of 
the birds were medium or high Salmonella shedding chickens (Figure 7.4). In contrast the 
birds in the group that received the mixed probiotic treatment did not fluctuate in the 
numbers of medium and high shedding chickens and the numbers of birds that were high or 
medium Salmonella shedders steadily reduced to just over 10% at age forty one days. This 
would explain the significant difference in shedding profiles observed using the Krustall- 
Wallis test (Figure 7.4).
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Figure 7.4 Faecal shedding results from the competitive exclusion feeding trial. Shedding was 
evaluated by swabbing birds from each group at several intervals. Swabs were plated and Salmonella 
growth was evaluated by a semi-quantitive method; results were presented as percent of birds Salmonella 
shedding at various intensities. Samples were removed from birds exposed to S. Enteritidis taken from 
four experimental groups; E. faecium treated birds (A), L. salivarius treated birds (B), birds treated with 
L. salivarius and E. faecium (C) and a negative control group that was only exposed to the 5. Enteritidis 
challenge (D).
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Figure 7.4 Faecal shedding results from the competitive exclusion feeding trial continued. Shedding 
was evaluated by swabbing birds from each group at several intervals. Swabs were plated and Salmonella 
growth was evaluated by a semi-quantitive method; results were presented as percent of birds Salmonella 
shedding at various intensities. Samples were removed from birds exposed to S. Enteritidis taken from 
four experimental groups; E. faecium treated birds (A), L. salivarius treated birds (B), birds treated with 
L. salivarius and E. faecium (C) and a negative control group that was only exposed o the S. Enteritidis 
challenge (D).
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7.2.2 In vivo inhibition of Salmonella Enteritidis using a seeder infection model
7.2.2.1 Evaluation of Salmonella colonisation of the ileum, caecum and colon after 
treatment with a combined L. salivarius and E. faecium  preparation
In the previous Chapter it was observed that S. Enteritidis inhibition occurred 
after dosing chicks with a combination of L. salivarius 59 and E. faecium PXN-33. In 
this Chapter the effect of dosing the chicks with the combined probiotic preparation on 
one or two occasions was evaluated. Experiments were also conducted to evaluate the 
effectiveness of dosing immature or more mature chicks with the probiotic preparation 
and the age related changes in S. Enteritidis inhibition. A seeder bird model similar to 
those described previously by Clifton-Hadley et al, (2002) was also used. In this model 
the shedding profiles of the seeder birds were tracked until their introduction to the 
experimental groups at age eleven days. The trial was conducted in this way in order to 
firstly control the experiment better and ensure an even distribution of seeder birds 
(shedding similar amounts of Salmonella) throughout the treated and control groups. In 
addition to greater control of the experimental model infection of commercial birds 
often occurs after hatching from horizontal transmission and thus infection of the flock 
is often delayed.
The seeder bird trial was conducted as described in sections 2.4.1, 2.4.6 and 
2.4.7. Briefly the seeder bird group was dosed twice with Salmonella prior to 
introduction to the control and treatment groups. Four dosing regimes of the probiotic 
inocula were used in the experimental groups in addition to the control group. At 
various stages through-out the study experimental birds were removed from the 
isolators and sacrificed for post mortem examination. Tissues were removed and 
colonisation of the birds by S. Enteritidis was determined. Five to six birds were 
removed for analysis and the colonisation of the probiotic treated groups was compared 
to the control group using a Two-way ANOVA as described in section 2.5.
At age sixteen days birds dosed at age one & twelve days, twelve & twenty days 
and twelve days only showed no significant reduction in S. Enteritidis numbers as 
compared to the control group (P=0.5984, P=0.0928 and P=0.0936 respectively). In 
addition there were no significant differences between the groups treated with one 
probiotic preparation and the groups receiving two doses of the probiotic preparation 
compared to the control group (P=0.3555 and P=0.0533 respectively). In contrast the 
group treated with the probiotic at one day of age showed significant differences as
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compared to the control group (P=0.0357). In the ileum there was approximately a half 
log reduction in S. Enteritidis colonisation from the probiotic treated group compared to 
the control group; 8.66x10^ cfu/g of S. Enteritidis was recovered from this probiotic 
treatment group (Figure 7.5). In the caecum and colon of birds treated at age one day 
approximately a one log reduction was observed compared to S. Enteritidis recovered 
from the caecum and colon of the control group; approximately 3.45x10^ cfu/g and 
2.19x10^ cfii/g of S. Enteritidis was recovered from the birds treated with the probiotic 
preparation at age one day from the caecum and colon respectively (Figure 7.5).
At twenty three days of age 2.13x10^ cfu/g, 9.94x10^ cfu/g and 2.12x10^ cfu/g 
of S. Enteritidis was recovered from the ileum, caecum and colon of the control group 
respectively (Figure 7.5). The birds dosed with the probiotic preparation at age twelve 
days was the only group not to show a significant reduction in S. Enteritidis compared 
to the control group (P=0.7178). There was a significant reduction in S. Enteritidis 
colonisation in the group dosed with the probiotic preparation on day one & twelve 
(P=0.0373) compared to the control group. The probiotic treated group showed very 
slight reductions in S. Enteritidis numbers from the caecum and colon i.e. less than a 
half log reduction in S. Enteritidis colonisation as compared to the control group (Figure 
7.5). Approximately a log reduction in S. Enteritidis colonisation of the ileum (2.43x10"  ^
cfu/g of S. Enteritidis was recovered from this site in the probiotic treated group) was 
observed in the group treated with the probiotics on days one & twelve as compared to 
the control treated group. A significant reduction in S. Enteritidis colonisation was also 
observed in the groups treated with the probiotic preparation at age one day and at age 
twelve & twenty days as compared to the control group (P=0.0041 and P=0.0012 
respectively). In both probiotic treated groups a two log reduction in S. Enteritidis 
colonisation was observed; on average 2.95x10^ cfii/g of S. Enteritidis was recovered 
from the probiotic treated groups (Figure 7.5). In the caecum and colon approximately a 
log reduction in S. Enteritidis colonisation was observed in the two probiotic groups as 
compared to the control group. A significant difference in the groups dosed twice with 
the probiotic preparation compared to the control group was observed (P=0.0022). No 
significant difference between the groups treated on one occasion with the probiotic 
preparation compared to the control group was observed (P=0.1377). There was also a 
significant difference between those groups treated with a single or dual dose of the 
probiotic preparation (P=0.0437).
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At age thirty days no significant difference was observed between the groups 
treated with the probiotic preparation at age one day, age twelve days, age one & twelve 
days and twelve & twenty days compared to the control group (P=0.3368, P=0.5608, 
P=0.3816 and P=0.4510 respectively). In addition no significant difference in S. 
Enteritidis recovery was observed between the groups receiving a single or dual dose of 
the probiotic compared to the control group (P=0.3734 and P=0.3473 respectively).
At age forty three days no significant reduction in S. Enteritidis numbers was 
observed between the groups dosed with the probiotic preparation at age one day and at 
age one & twelve days compared to the control group (P=0.5593 and P=0.1404 
respectively). In the birds treated at age twelve days a two log reduction was observed 
as compared to the control group; 2.61x10^ cfu/g of S. Enteritidis was recovered from 
this probiotic treated group (Figure 7.5). Although a reduction of S. Enteritidis was 
observed in the colons of probiotic treated groups compared to the control group only 
the groups treated at age twelve days and age twelve & twenty days were significantly 
different from the control group (P=0.0166 and P=0.0021 respectively). Both the 
groups showing significant reductions in S. Enteritidis numbers also presented a log 
reduction in the S. Enteritidis numbers from the caecum; on average, approximately 
1.23x10^ cfu/g was recovered from the probiotic treated groups (Figure 7.5). In the 
birds treated with the probiotic preparation at age twelve days the number of S. 
Enteritidis isolates recovered from the ileum was equivalent to those recovered from the 
control group (1.89x10^ cfu/g of S. Enteritidis was recovered from the probiotic treated 
group). In contrast the birds treated at age twelve & twenty days showed just under a 
log reduction in the ileum as compared to the control group (3.75x10"  ^ cfu/g of S. 
Enteritidis was recovered from the probiotic treated group) (Figure 7.5). Both the single 
and double dosing regimes showed significant differences in the reduction of S. 
Enteritidis numbers (P=0.0835 and P=0.0085 respectively). No significant reduction 
was observed between the single and dual dosing regimes (P=0.2485).
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Figure 7.5 Colonisation results from the seeder bird competitive exclusion feeding trial. The cfu/g of 
Salmonella was recorded for the ileum (A), caecum (B) and colon (C) over forty three days. Samples 
were removed from birds exposed to S. Enteritidis taken from the five experimental groups dosed with 
both probiotic strains; group A was dosed on day one, group B was dosed on day one and twelve, group 
C was dosed on day twelve and twenty, group D was dosed on day twelve and group E the negative 
control group, that was only exposed to a S. Enteritidis challenge.
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1,1,1,1 Evaluation of Salmonella shedding after treatment with a combined L. 
salivarius said E, faecium  preparation
In addition to the evaluation of S. Enteritidis colonisation determined using 
direct plate counting described in section 7.2.2 the faecal shedding of S. Enteritidis from 
infected birds, as described in the previous Chapter, was also evaluated. The semi- 
quantitive method previously described by Carroll et al, (2004) was utilised. The 
competitive exclusion feeding trial used in this study was performed as described above 
and in sections 2.4.1, 2.4.2, 2.4.6 and 2.4.7. To determine Salmonella Enteritidis uptake 
and shedding profiles, chicks were swabbed regularly during the study. Shedding was 
assessed by the semi-quantitive method as described in the previous section.
No significant differences in S. Enteritidis shedding was observed between any 
of the groups using Kruskall-Wallis test at age fifteen to twenty six days (P=>0.05 for 
group comparisons). A significant difference between the groups was observed using 
the Kruskall-Wallis test at age twenty nine, thirty three, thirty eight and forty three days 
of age (P=0.020, P=0.035, P=0.033 and P=0.040 respectively). After further analysis 
using Dunn’s test no significant differences were observed between the probiotic 
treated groups and the control (P=>0.050 for the probiotic treatment groups compared 
to the control group). Furthermore clear trends in the reduction of high and medium 
Salmonella shedding birds was not observed in the probiotic treated groups as 
compared to the control group (Figure 7.6).
At age thirty eight days birds treated with the probiotic at age one day only 
showed a significant reduction in Salmonella shedding as compared to the control group 
as observed using Dunn’s test (P=0.027). At thirty eight days of age chicks dosed with 
the probiotic at one day of age had 60% of the birds shedding low levels of Salmonella 
and the remaining 40% were only positive after enrichment (Figure 7.6). In contrast the 
control group had 30% of the birds shedding Salmonella at moderate levels with the 
remaining 70% of the chickens shedding S. Enteritidis at low levels at age thirty eight 
days of age (Figure 7.6).
At age forty three days birds treated with the probiotic at twelve and twenty 
days showed a significant reduction in Salmonella shedding as compared to the control 
group using Dunn’s test (P=0.045). In the group dosed with the probiotic preparation at 
age twelve and twenty days 65% of the birds were low Salmonella shedders with the 
remaining 35% of the birds being S. Enteritidis positive after enrichment (Figure 7.6).
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In contrast in the control group 20% of the birds were moderate Salmonella shedders 
with the remaining 80% of the birds shedding 5. Enteritidis at low levels (Figure 7.6).
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Figure 7.6 Colonisation results from the seeder bird competitive exclusion feeding trial. Shedding was 
evaluated by swabbing birds from each group at several intervals. Swabs were plated and Salmonella 
growth was evaluated by a semi-quantitive method; results were presented as percent of birds Salmonella 
shedding at various intensities. Samples were removed from birds exposed to S. Enteritidis taken from 
five experimental groups; group A was dosed on day one, group B was dosed on day one and twelve, 
group C was dosed on day twelve and twenty, group D was dosed on day twelve and group E the 
negative control group, that was only exposed to a S. Enteritidis challenge.
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Figure 7.6 Colonisation results from the seeder bird competitive exclusion feeding trial. Shedding was 
evaluated by swabbing birds from each group at several intervals. Swabs were plated and Salmonella 
growth was evaluated by a semi-quantitive method; results were presented as percent of birds Salmonella 
shedding at various intensities. Samples were removed from birds exposed to S. Enteritidis taken from 
five experimental groups; group A was dosed on day one, group B was dosed on day one and twelve, 
group C was dosed on day twelve and twenty, group D was dosed on day twelve and group E the 
negative control group, that was only exposed to a S. Enteritidis challenge.
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7.3 Discussion
In order to evaluate the ability of the probiotics to inhibit S. Enteritidis in vivo a 
direct oral contact in vivo model was utilised based on that previously described by 
Pascual et al., (1999). To evaluate the ability of the probiotics to inhibit S. Enteritidis 
birds were given a preventative dose of the three probiotic preparations at one day old. 
Subsequently birds were dosed with S. Enteritidis when the birds were two days old. 
Salmonella shedding and persistence was monitored over 45 days as this is 
approximately the age at which commercial broilers are slaughtered in industry. The 
ability of E. faecium PXN-33 and L. salivarius 59 to competitively exclude S. 
Enteritidis as individual preparations or in combination was evaluated. The probiotics 
as individual or combined preparations were investigated in order to determine if one of 
the probiotics was more effective than the other at competitive exclusion of S. 
Enteritidis. This was also done to determine if this action was more effective when the 
probiotics were used in combination. It is generally assumed that the higher the 
probiotic dose the more effective the probiotic effect, this has been shown previously by 
several authors. A relatively high dose of probiotic was used to demonstrate proof of 
principle. Previous evaluations of Salmonella colonisation have used the specific dose 
of 1x10"^  cfu/dose and thus in these studies this standard method was followed. In order 
to maintain a controlled methodology for the in vivo model, SEP White leghorns were 
chosen as it was possible to certify the lack of Salmonella colonisation prior to the 
experiments.
In addition to the evaluation of S. Enteritidis colonisation using direct plate 
counting described in section 6.2.2.2, the faecal shedding of S. Enteritidis from infected 
birds was also determined. Shedding is important in Salmonella dissemination in 
commercial flocks particularly due to the high chicken stocking density. The shedding 
profiles of the probiotic treated group compared to the control treated group were also 
investigated. A semi-quantitative method was used as previously described by Carroll et 
ah, (2004) which were originally used to evaluate the persistence of Salmonella flagella 
mutants in poultry. A similar method was used by Best et al, (2005) to evaluate 
shedding profiles of chicks infected with E. coli 0157:H7 flagella mutants. This method 
was chosen to allow tracking of specific bird shedding profiles during the study.
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It was observed that at age six days old the administration of the probiotic 
bacteria resulted in an increased trend of recovery of S. Enteritidis in the ileum and 
colon. This would suggest that the administration of the probiotic in young chicks 
initially increased Salmonella association to the bird’s GI tract. At age twenty four days 
no significant reduction in Salmonella colonisation was observed after probiotic 
administration in any of the tissues sampled. It was noted however that a reduction 
trend was observed in the group administered the combined probiotic inoculation.
Significant reductions in Salmonella colonisation of the chick GI tract was 
observed in birds at age forty three days when the probiotics were used in combination. 
No reduction was observed when the probiotic bacteria were used as single 
preparations. This suggests that the inhibition of Salmonella is dependent upon the 
activity of both probiotic bacteria. The majority of studies in the literature investigating 
probiotic inhibition of Salmonella in poultry are short term studies where pathogen 
suppression is measured within a few days of probiotic administration. Few studies 
have indicated delayed inhibition of Salmonella by probiotic bacteria in poultry 
although several authors have demonstrated the ability of probiotic cultures to 
competitively inhibit Salmonella colonisation of poultry. Carina et ah, (2000) showed 
that pre-treatment of broilers with E. faecium J96 reduced mortality caused by S. 
Pullorum from 50% to 25%. A significant 1 log fold reduction in S. Düsseldorf isolated 
from the ceaca of Japanese quails was also observed 168hrs post inoculation with E. 
faecium J96 (Laukova et al, 2003). However it has been shown that L. salivarius 
CTC2197 has been shown to clear caecal colonisation of S. Enteritidis C-114 by day 21 
post-infection (Pascula et al, 1999). It should be noted that Pascula and colleagues used 
a non-invasive strain of S. Enteritidis. Fuller (1977) previously demonstrated L. 
salivarius 59 reduces E. coli colonisation of the avian crop by 2 logs and that the higher 
the initial dose the greater the reduction in E. coli crop numbers.
In order to determine if the probiotic cultures persisted to the end of the study 
PFGE was performed on a selection of recovered isolates. As was previously discussed 
in the introduction and Chapter 3, colonisation of the host by probiotics organisms is 
thought to enhance probiotic effects including competitive exclusion. Probiotic bacteria 
are often selected based on the presence of antibiotic resistance in order to isolate the 
strain from the micro-flora. Previous studies by Pascual et al, (1999) specifically 
selected Lactobacillus salivarius strains based on rifampicin resistance so that the 
organism could be monitored in vivo (Pascual et al, 1999). L. salivarius 59 had no
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unique antibiotic resistance genes, as discussed in Chapter 5. E. faecium PXN-33 had 
low level resistance to several antibiotics but not at a level useful for isolating the strain 
from background enterococci, as discussed in section 5.2.2. Plates containing the 
antibiotic naladixic acid were used to reduce the background noise from gram negative 
bacteria such as Klebisella species, though the antibiotic resistance was not selective for 
the probiotic organisms. It was not possible to use the rapid BOX-PCR strain typing 
technique for high throughput evaluation of recovered isolates as the profiles produced 
were not discriminatory for the strains investigated (see section 3.2.2). PFGE was used 
to determine if the recovered isolates were the probiotic isolates used in the study, as 
described in section 3.2.2. Six lactobacilli and enterococci isolates were recovered from 
the probiotic treated birds at age 43 days.
At age forty three days it was possible to recover L. salivarius 59 isolates from 
the ileum and caecum from birds dosed with the probiotic individually or in 
combination with E. faecium PXN-33. This would suggest that the birds were colonised 
with L. salivarius 59 from the single dose received at age one day. Furthermore it was 
not possible to recover E. faecium PXN-33 from birds treated with bacteria individually 
or combined with L. salivarius 59. It is possible that E. faecium PXN-33 did colonise 
the chicks but was not detected using the methods described herein due to low detection 
sensitivity. E. faecium PXN-33 was unlikely to be the predominant Enterococcus 
species within the bird’s caecum and ileum. The most likely scenario is that the birds 
were not colonised with E. faecium PXN-33 due to it being out competed by other 
enterococci and may have cleared shortly after administration. As Salmonella clearance 
is dependent upon both probiotic bacteria being administered it maybe that E. faecium 
PXN-33 induces a strong inflammatory response that primes the immune system for 
Salmonella inhibition but which subsequently also results in its own clearance from the 
chick’s GI tract.
Interestingly enterococci isolates recovered from the birds dosed with both 
probiotic bacteria were the same. In contrast the enterococci isolated from birds that 
were only dosed with E. faecium PXN-33 only were not the same. This observation 
suggests a possible stabilisation of the micro-flora by the administration of both 
probiotic bacteria as compared to the birds receiving only single probiotic organisms. It 
is possible that the combination of the two probiotic bacteria enrich the bird’s micro­
flora resulting in inhibition of Salmonella. Several authors have described the 
administration of natural chicken micro-flora for inhibition of Salmonella in poultry
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(Rantala & Nurmi 1973; Corner et al, 1994; Filho et al, 2003). The administration of 
caecal contents as competitive exclusion products is essentially an artificial replacement 
of the host micro-flora. As the development of host immune systems effects host 
tolerance to endogenous bacteria it is also possible that the probiotic bacteria modulated 
the immune system and subsequently stabilisation of the micro-flora was observed. 
Furthermore the administration of probiotic bacteria with the prebiotic inulin has been 
shown to diversify the bacterial populations in rat colons as determined by DGGE 
profiles (Schultz et al, 2004). In addition Schultz et al, (2004) showed that this 
treatment also resulted in reduced colitis and the suppression of inflammation although 
it was not clear whether the probiotic or prebiotic caused the change in micro-flora and 
immune modulation. It can be surmised that administration of feed supplements can 
influence the micro-flora and the immune system of the host. It should also be noted 
that the probiotic bacteria were administered to the chicks at an early age and that the 
probiotics efficacy appeared to be dependent upon host maturation. It was observed that 
there was an increased trend of Salmonella inhibition at age twenty three days in the 
mixed probiotic group compared to the control as observed in colonisation studies. The 
administration of the probiotic bacteria in combination appears to enhance this natural 
Salmonella suppression in shedding. It was also observed that there was a reduction 
trend in S. Enteritidis shedding in the mixed probiotic treated group as compared to the 
control group after the age of twenty three days as determined by cloacal swabbing. 
Additionally a natural pattern of inhibition was observed by evaluation of shedding data 
in the control and treatment groups at age twenty three days. This natural burst of 
inhibition by the chicks at around age twenty days is most likely due to host maturation. 
It should also be noted that the development of the chick’s immune system corresponds 
to this burst in inhibition. Previous studies have indicated that chicks T-cell 
development, determined by the pattern of expression of cytokines by CD3+ cells, 
occurs within the first two weeks after hatching (Bar-Shira et al, 2003). Furthermore 
previous studies have indicated prolonged CD3+, CD8+ and B cell proliferation occurrs 
after dosing with Salmonella between 7 and 21 days of age (Asheg et al, 2002). This 
indicates that immune responses to early Salmonella challenge develop and progress to 
optimal levels within the first twenty day period. Host/probiotic interactions, such as 
immunomodulation, may also play a significant role in S. Enteritidis (S1400) clearance. 
Previous reports by Maassen et al, (2000) have shown well-characterised probiotic 
strains such as L. reuteri induced pro-inflammatory cytokines such as TNF-a and IL-2.
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The response to L. reuteri was coupled with increased IgG production. Cytokines that 
promote humoral responses, such as IL-10, may induce enhanced antibody production 
to pathogens. In addition immunomodulation of the host response to pathogenic 
challenge has been suggested as a possible mechanism of competitive exclusion.
In the second in vivo study it was decided to use a seeder bird model in order to 
simulate natural Salmonella colonisation in chickens. Several authors have modelled 
Salmonella CE by probiotic bacteria in poultry using similar models (Weinack et ah, 
1979; Soeijadi et al, 1981; Bailey et al, 1998). It was observed that the biggest trend in 
reduction of Salmonella colonisation after treatment with the probiotic bacteria was the 
colon. It was also observed that the smallest trend in reduction of Salmonella was in the 
caecum. This correlates with the preference of Salmonella to persist in the caecum of 
chickens. Previous reports have shown that chick’s dosed age one day with 7.5x10^ cfu 
of Salmonella Enteritidis carry the pathogen in the caecum of chickens for at least 
sixteen days post inoculation (Gast & Holt, 1998). Furthermore Salmonella spp. show a 
preference of invasion of M cells located predominately in the ileum thus S. Enteritidis 
would show a tropism for this tissue; for a comprehensive review read Jepson & Clark 
(2001). It was observed that there were significant differences between single and 
double dosing of the probiotic preparation and the subsequent recovery of Salmonella at 
age twenty three days of age. The birds that received two doses of the probiotic 
preparation reduced Salmonella colonisation significantly more than birds dosed with a 
single preparation of the probiotic preparation. Previous reports in the literature have 
suggested that dosing the host with greater numbers of probiotic bacteria increase 
probiotic effects. The induction of Bcl2 protein, which is required for the activation of 
macrophages and dendritic cells, was dependent upon the length of time lactic acid 
bacteria were given to mice (Perdigon et al, 2002). It should be noted, however that 
this significant difference between single and double probiotic dosing was not observed 
at any other time point during the study.
Dosing of birds at age one day resulted in significant inhibition of Salmonella at 
age sixteen and twenty three days old. Additionally the birds dosed with the probiotic at 
age one and twelve days also showed significant reduction of Salmonella colonisation. 
No significant inhibition of Salmonella was observed at forty three days of age in the 
two groups dosed at age one day. None of the groups, except the group dosed at age one 
day only, showed Salmonella inhibition at age sixteen days. In contrast birds that did 
not receive a probiotic dose at age one showed significant inhibition of Salmonella at
162
University of Surrey Chapter 7
forty three days of age. Furthermore the birds that were dosed with the probiotic at age 
twelve and twenty days of age showed significant reductions of Salmonella at age 
twenty three and forty three days of age.
As no inhibition was observed at age forty three days in groups dosed with 
probiotic at age one day and age one and twelve days it would suggest that the probiotic 
effect diminishes over time. From these observations it suggests that early dosing of 
probiotic bacteria results in greater inhibition of Salmonella earlier in the study. It 
should be noted thdLt Salmonella shedding was significantly reduced at age thirty eight 
days in the group receiving the probiotic preparation at age one day as compared to the 
control group. Additionally late administration of the probiotic results in greater 
inhibition later in the study. Salmonella inhibition appears to increase when birds are 
dosed near to post-mortem time points. This burst of inhibition could be explained by 
an increase in the inflammatory response induced by the probiotic bacteria. Clearance 
of Salmonella has been shown to be dependent upon the induction of pro-inflammatory 
cytokines such as TNF-a and IL-1 (Eckmann & Kagnoff, 2001) thus a burst in pro- 
infianunatory cytokines may increase clearance of S. Enteritidis. The inability of E. 
faecium PXN-33 to colonise chicks also indicates that as E. faecium PXN-33 is cleared 
the inhibitory effect of the probiotic preparation reduces.
The colonisation data from the ileum, caecum and colon obtained from the 
control group in the two in vivo studies were similar. Salmonella colonisation observed 
from the control group in the two studies was predominately within one log recovery of 
each other. Furthermore the cyclic shedding patterns of Salmonella within the two 
studies were also similar. It should be noted however, that birds receiving a single dose 
of probiotic in the direct oral contact model showed inhibition of Salmonella at age 
forty three days whereas in the second in vivo study birds that were dosed at age one 
day did not present Salmonella inhibition at age forty three days. Previous reports 
suggest that seeder bird models for Salmonella inhibition by probiotic preparations are 
less sensitive than direct oral contact studies (Weinack et al, 1979). The authors 
suggested that the seeder bird model was less sensitive to the observed probiotic 
inhibition of Salmonella when compared to the direct oral contact model. The 
similarities in the pattern of Salmonella colonisation in the control groups of the two 
studies and also the similar cyclic shedding patterns suggest that the direct oral contact 
and seeder bird models correlate to a certain degree. The discrepancies in the pattern of 
probiotic inhibition maybe due to the route of Salmonella transmission i.e. natural
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horizontal transmission versus orally challenged birds. As was mentioned the 
differences between the two models may also be due to experimental sensitivity.
Whilst the production of inhibitory compounds towards Salmonella in this in 
vivo study cannot be ruled out the delayed S. Enteritidis suppression from the probiotic 
bacteria suggests a host modifying dependant inhibition mechanism. Furthermore the 
inhibitory pattern observed within this study corresponds to host immune system 
maturation that has been described in the literature (see Chapter 1). It can be surmised 
from the above observations and those made in Chapter 6 that the probiotic bacteria can 
inhibit Salmonella in vitro by a direct probiotic mechanism i.e. the production of 
inhibitory metabolites. In vivo, however, Salmonella inhibition appears to be dependent 
upon the probiotic bacteria affecting host responses. This host modulation also appears 
to be dependent upon age related chick maturation. It has been suggested above that the 
probiotic bacteria inhibit S. Enteritidis by modulating the immune responses of the 
chicks. Furthermore probiotic inhibition of Salmonella appears to be dose and age 
dependent. Observations made in the direct oral contact and seeder models appear to 
suggest firstly that the inhibition observed can be correlated between the two models 
and secondly that Salmonella inhibition by the probiotic bacteria is reproducible.
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Chapter 8 - Evaluation of the effect of L, salivarius and E, faecium  on 
inflammatory cytokine responses in vitro
8.1 Introduction
In the previous Chapter it was demonstrated that S. Enteritidis carriage could be 
reduced prior to slaughter age. It was observed that using dual probiotic doses was more 
effective at reducing Salmonella carriage than single probiotic doses. In addition it was 
also observed that dosing the birds with the probiotic preparation preceded a reduction 
in Salmonella colonisation. In order to improve the competitive exclusion properties of 
the probiotic preparation further the mechanistic basis of this inhibitory effect was 
investigated.
Previous work had shown that inhibition of Salmonella occurred in adult birds. 
Inhibition was dependent on both probiotic bacteria being given to the birds yet only L. 
salivarius 59 was recovered at the end of the study. E. faecium PXN-33 was not the 
predominant enterococcal strain and thus was unlikely to have colonised the birds. It 
was also observed that, in the sentinel bird model, the most dramatic reduction in S. 
Enteritidis occurred directly after probiotic dosing. The late effect observed in this first 
study indicated that clearance of Salmonella was dependent upon the maturity of the 
bird’s immune system. From these observations it was hypothesized that the reduction 
in Salmonella was dependent upon the effect of the probiotic preparations on the birds’ 
immune system. It was also hypothesized that the effect elicited by the probiotic 
preparation, specifically E. faecium PXN-33, was upon the immediate inflammatory 
immune response.
In this Chapter the effect that the probiotic isolates have on the pro- 
inflammatory response of the immune systems was investigated. This was done by 
observing the effect of the probiotic isolates on mammalian and chick-derived 
macrophages and changes in pro-inflammatory cytokine expression and production. 
The synergistic effect of stimulating macrophages with the probiotic bacteria and with 
S. Enteritidis was also determined.
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8.2 Results
8.2.1 Evaluation of acute phase response cytokine production in a standard 
mammalian model
8.2.1.1 Evaluation of pro-inflammatory cytokines TNF-alpha and 11-6 and anti­
inflammatory cytokine 11-10 after stimulation with probiotic bacterial 
preparations.
Assays were performed as described in sections 2.3.1, 2.3.6 and 2.3.7. In brief 
RAW macrophages were maintained as described (Fritsche et al, 2003). The probiotic 
preparation or S. Enteritidis were inoculated onto the macrophages. Cells inoculated 
with the probiotic positive control and negative control were incubated for 5hrs before 
cytokine production was analysed. Assays were performed in quadruplicate on three 
separate occasions. Probiotic treatments were compared statistically to the Salmonella 
treated cells as described in section 2.5 using a Student’s T-test.
L. salivarius 59 induced 221.1 pg/pl, E. faecium PXN-33 induced 506.9 pg/pl 
and the combined inocula induced 476.7 pg/pl of TNF-a after 5hrs; no significant 
differences between the S. Enteritidis positive control or the probiotic treatments were 
observed (P = 0.7284, P=0.1019 and P=0.9519 respectively) (Figure 8.1). L. salivarius 
59 induced 0.4 pg/pl, E. faecium PXN-33 induced 1.5 pg/pl and the combined probiotic 
inocula induced 6.9 pg/pl of IL-6 after 5hrs (Figure 8.1). The results obtained were 
significantly lower for E. faecium PXN-33 and L. salivarius 59 but not the combined 
probiotic inocula when compared to S. Enteritidis (S1400) (P = 0.0396, P=0.0139 and 
P=0.5528 respectively). L. salivarius 59 induced 4.1 pg/pl, E. faecium PXN-33 induced 
7.6 pg/pl and the combined probiotic inocula induced 1.1 pg/pl of IL-10, which was 
again lower than S. Enteritidis. In the case of L. salivarius 59 and the combined 
probiotic inocula IL-10 production was significantly lower than S. Enteritidis (S1400) 
(P = 0.0208 and P=0.0045). This was not the case with E. faecium PXN-33 (P = 
0.0775).
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Figure 8.1 Cytokine responses o f RAW macrophages after exposure to probiotic bacteria. TNF-a A), 
IL-6 B) and IL-10 cytokine C) response of RAW macrophages after 5hrs inoculation with either E. 
faecium (EF), L. salivarius (LS), 50:50 inoculum of L. salivarius and E. faecium (MP), medium control 
(MC) and S. Enteritidis (SE) at 37°C and 5% CO2. Error bars indicate the standard error of the mean.
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8.2.1.2 Evaluation of pro-inflammatory cytokine production by poultry derived 
macrophages after stimulation with probiotic bacteria.
HD 11 stimulation assays were conducted as described in sections 2.2.2, 2.2.7 
and 2.3.5. For stimulation assays avian macrophages were inoculated with control 
medium or medium inoculated with the probiotic and incubated. RNA was extracted 
from the macrophages and cytokine mRNA levels were determined using qRT-PCR. 
Assays were performed in duplicate on three separate occasions. The log-2 value of the 
CT-40 was calculated for the probiotic stimulation and compared to the control log-2 
CT-40 value of the Salmonella treated cells using a Student’s T-test as described in 
section 2.5.
The results are presented as fold change in mRNA of the stimulated cells 
compared to the un-stimulated cells. S. Enteritidis positive control induced a 1988, 2068 
and 59 fold increase in mRNA for IL-lp, IL-6 and IL-10, respectively. L. salivarius 59 
induced a 641 fold increase, E. faecium PXN-33 induced a 1832 fold increase and the 
combined inocula induced a 1178 fold increase in IL-ip mRNA expression; no 
significant differences between the S. Enteritidis positive control or the probiotic 
treatments were observed (P = 0.4509, P=0.8831 and P=0.7725 respectively) (Figure 
8.2). L. salivarius 59 induced a 531 fold increase, E. faecium PXN-33 induced an 1826 
fold increase and the combined probiotic inocula induced a 964 fold increase in IL-6 
mRNA expression (Figure 8.2). There was no significant difference between E. faecium 
PXN-33, L. salivarius 59 and the combined probiotic inocula as compared to S. 
Enteritidis (S1400) (P = 0.0900, P=0.4143 and P=0.2631 respectively). L. salivarius 59 
induced a 23 fold increase, E. faecium PXN-33 induced a 44 fold increase and the 
combined probiotic inocula induced a 42 fold increase in IL-10 mRNA expression. No 
significant difference was observed between E. faecium PXN-33 and mixed probiotic 
inocula compared to S. Enteritidis (S1400) (P = 0.0857 and P=0.2126). In contrast IL- 
10 production induced by L. salivarius 59 was significantly lower than S. Enteritidis 
(S1400)(P = 0.0208).
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Figure 8.2 H D ll macrophage cytokine responses after exposure to probiotic bacteria. IL-1P (A ), IL-6 
(B) and IL-10 (C) cytokine response of H D ll macrophages after 3hrs treatment with E. faecium (EF), L. 
salivarius (LS), 50:50 L. salivarius and E. faecium (MP) and S. Enteritidis (SE). All plates were 
incubated at 37°C and 5% CO2. Error bars indicate the standard error of the mean.
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8.2.1.3 Determination of combined probiotic and Salmonella Enteritidis synergistic 
stimulation of pro-inflammatory cytokines
Synergy assays were performed as described in section 2.3.1, 2.3.6 and 2.3.7. 
Briefly probiotic preparations were inoculated onto the cells and the supernatant was 
then replaced with a S. Enteritidis preparation and subsequently analysed. For the 
probiotic control values the probiotic preparations were inoculated onto the RAW 
macrophages the medium was removed and replaced with medium only. After a further 
incubation the medium was analysed. A reading was also taken for S. Enteritidis 
stimulation and was added to the response of the probiotic control treatment to produce 
a control cytokine response value. The control and treatment values were compared 
using a two-tailed Student’s T-test as described in section 2.5.
Pre-treatment with E. faecium PXN-33 and subsequent infection with S. 
Enteritidis (S1400) induced RAW macrophages to produce 524.0 pg/pl of TNF-a, 7.3 
pg/pl of IL-6 and 7.0 pg/pl of IL-10 (Figure 8.3). Pre-treatment with L. salivarius 59 
and subsequent infection with S. Enteritidis (S1400) induced RAW macrophages to 
produce 220.9 pg/fil of TNF-a, 6.4 pg/jxl of IL-6 and 9.4 pg/|il of IL-10. Pre-treatment 
with a combination of the two probiotic bacteria and subsequent infection with S. 
Enteritidis induced raw macrophages to produce 396.3 pg/|il of TNF-a, 13.8 pg/|il of 
IL-6 and 5.7 pg/|Lil of IL-10.
E. faecium PXN-33 and S. Enteritidis treatment of RAW macrophages induced 
351.7 pg/pl more TNF-a than the control; the difference between the control and 
treatment values was significant (P=0.0054). In addition to this, the E. faecium PXN-33 
treatment group also induced 6.7 pg/pl more IL-6 than the controls although this 
difference was not significant (P=0.0893) (Figure 8.3). Similarly significant change of 
IL-10 compared to the control were not induced (P=0.9784) (Figure 8.3).
L. salivarius 59 and S. Enteritidis treatment of RAW macrophages did not 
induce any significant change in TNF-a, IL-6 or IL-10 when compared to the control 
(P=0.9679, P=0.5651 and P=0.3757 respectively) (Figure 8.3). The combined probiotic 
treatment group induced 13.6 pg/pl more IL-6 than the control group and the difference 
compared to the control was significant (P=0.0008) (Figure 8.3). The combined 
probiotic and S. Enteritidis treatment of RAW macrophages did not induce a significant 
change of IL-10 compared to the control (P=0.4633) (Figure 8.3).
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Figure 8.3 Cytokine responses o f RAW macrophages after exposure to Salmonella and probiotic 
bacteria. TNF-a A ) , IL-6 B) and IL-10 C) cytokine response of RAW macrophages after 3hrs treatment 
with E. faecium (EF), L. salivarius (LS), 50:50 L. salivarius and E. faecium (MP) or Medium. This was 
followed by a 2hr inoculation with Medium (Probiotic medium control) or S. Enteritidis (Probiotic 
treatment and S. Enteritidis medium control). All plates were incubated at 37°C and 5% CO2. Error 
bars indicate the standard error of the mean.
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8.3 Discussion
As was seen in the first in vivo study in Chapter 7 the significant inhibition of S. 
Enteritidis by the probiotic preparation in chicks was only observed at age 43 days. 
From this it was hypothesised that the probiotics were not directly inhibiting S. 
Enteritidis but were improving host responses to the pathogen. In the second in vivo 
study in Chapter 7 it was also observed that inhibition occurred at age 16 days. As chick 
T-cell dependent immune responses do not mature until at least one week of age it was 
hypothesised that the probiotic bacteria were enhancing the immune responses 
(Lowenthal er a/., 1994).
Previous studies into host modifications by vaccination against Salmonella spp. 
suggest the importance and enhancement of acute phase immune responses and cell 
mediated immune responses in pathogen clearance (Babu et al, 2003). In this section 
the evaluation of inflammatory immune responses of mammalian and avian 
macrophages to the probiotic stimulations compared to those produced by S. Enteritidis 
was investigated. The production of pro-inflammatory cytokines by macrophages plays 
a role in the assistance of specific immunity, the coordination of non-specific immunity, 
the protection of the host from damage and the isolation of pathogens (Klasing, 1998). 
Murine RAW macrophages were used as commercial ELISA assay kits were available 
for a range of cytokines of interest. HDll avian macrophages were utilised to evaluate 
the induction of pro-inflammatory cytokine responses in a separate in vitro model. 
Avian macrophages have been used previously to determine responses to pathogens 
such as Campylobacter (Smith et ah, 2005). H D ll cells have also been used to 
determine the induction of nitric oxide production by Salmonella species (Babu et ah,
2006). Due to limited availability of monoclonal antibodies to avian cytokines qRT- 
PCR was used to determine the induction of pro-inflammatory cytokines by the 
macrophages after probiotic bacterial stimulation. TNF-a and IL-6 were chosen for 
study in the RAW macrophages as these cytokines play an important role in the acute 
phase response (Lalmanach & Lantier, 1999). Whilst at the time of experimentation 
TNF-a had not been isolated in chicks, homologues of TNF-a receptors had been 
identified suggesting the presence of a TNF-a type cytokine (Abdalla et al, 2004). The 
induction of IL-1 p and IL-6 in HDll cells was investigated. IL-10 was also chosen for 
investigation in both macrophage cell lines as this cytokine plays an important in the 
anti-inflammatory response.
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Although the method used to determine cytokine production in the H D ll 
macrophages was different to that used in RAW macrophages similar patterns were 
seen in both cell lines when stimulated using the probiotic bacteria as compared to the 
S. Enteritidis positive control. In both cell lines IL-10 induction by L  salivarius 59 was 
significantly lower than the levels induced by S. Enteritidis and also lower than the 
levels induced by E. faecium PXN-33. It was also noted that the levels of cytokines 
induced by L. salivarius 59 were lower than those induced by all the other probiotic and 
positive control treatments with the exception of RAW macrophage IL-10 production.
In addition the pro-inflammatory cytokine (TNF-a, IL-6 and IL-lp) levels 
induced by the mixed probiotic inocula in both cell lines were consistently around those 
induced by S. Enteritidis. Furthermore E. faecium PXN-33, as an individual inoculum, 
consistently induced pro-inflammatory cytokines at approximately the same levels as S. 
Enteritidis in both cell lines. The only pro-inflammatory cytokine that was not induced 
at the levels of S. Enteritidis was IL-6 in RAW macrophages.
The similar cytokine induction patterns observed in the RAW macrophages 
compared to the HDl 1 macrophages would suggest that the cell line is a good substitute 
for the HDll cells. From the lower levels of cytokines produced by L. salivarius 59 in 
the 5hr stimulation assays, L. salivarius 59 was probably less able to induce pro- and 
anti-inflammatory cytokines than E. faecium PXN-33. Previous reports have shown that 
E. faecium species induce inflammatory cytokine responses in conjunction with yeast 
supplementation, although it should be noted that the hosts were feedlot steers 
(Emmanuel et al, 2007). Investigations into inflammatory responses induced by L. 
salivarius species have indicated either no effect (Feighery et al, 2007) or a reduction 
in inflammatory responses (Peran et al, 2005; O'Hara et al, 2006). The consistent 
induction of cytokines by the combined probiotic inoculum is almost certainly due to 
the E. faecium PXN-33 strain. It should be noted that the mixed probiotic inoculum 
generally induced slightly lower levels of cytokine than E. faecium PXN-33 and this 
could be explained by the fact that in the combined inoculum there was half the 
concentration of E. faecium PXN-33. Cytokine levels induced by the mixed probiotic 
inocula were greater than those produced by L. salivarius 59 and E. faecium PXN-33 as 
individual inocula when IL-6 concentrations were measured in RAW macrophages. 
This would suggest that IL-6 induction in high levels would require both probiotic 
bacteria although this observation could not be replicated in HDl 1 macrophages.
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Whilst S. Enteiitidis and E. faecium species have been shown to induce 
inflammatory cytokine responses the cumulative responses of probiotic and pathogen 
have to date not been studied in vitro. The ability of the probiotic bacteria to prime 
murine macrophages prior to infection was investigated and thus priming would result 
in a synergistic response greater than that observed with the pathogen and probiotic 
individually.
In the synergistic cytokine assays the ability of probiotic bacteria to prime RAW 
macrophages to produce an enhanced cytokine response to S. Enteritidis was 
investigated. To determine whether there was a synergistic response, individual 
stimulations by the probiotic bacteria and S. Enteritidis were added together to give the 
cytokine production expected when the macrophages were exposed to them in 
combination. Subsequently the assay was performed and compared to the values 
obtained for the combined individual exposure. No synergy in XL-10 cytokine induction 
was seen with any of the probiotic inocula. A significant synergistic induction of TNF-a 
was observed when E. faecium PXN-33 was used to prime the macrophages and the 
macrophages were subsequently infected with S. Enteritidis; this was not seen with the 
other probiotic pre-treatments. Previous reports by Maassen et al, (2000) have shown 
that administration of L. reuteri and L. brevis increased TNF-a producing cells to 
Chikungunya virus in mice. It was suggested that this increase could lead to a Th-1 
biased immune response resulting in preferential expression of IgG2a; Th-1 biased 
immune response induce IgG2a immunoglobulin (Maassen et al, 2000). Interestingly 
preferential induction of Th-1 dependent cytokine responses is important in clearance of 
intercellular pathogens such as Salmonella.
In addition to this, a significant synergistic induction of IL-6 was observed when 
the mixed probiotic product was used to prime the macrophages which were 
subsequently exposed to S. Enteritidis. It should also be noted that small, but not 
significant, synergistic IL-6 responses were observed when L. salivarius 59 and E. 
faecium PXN-33 were used as individual preparations. This is consistent with previous 
studies showing the induction of IL-6 and TNF-a production in in vitro macrophage 
assays by the LAB S. thermophilus strain 133 (Marin et al, 1998).
The results indicate that macrophages can be primed by E. faecium PXN-33 
prior to S. Enteritidis exposure to produce a greater TNF-a response than would be 
predicted by measurements taken from individual exposures added together. This would 
also suggest that E. faecium PXN-33 is a potent inducer of pro-inflammatory cytokines
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which is consistent with the previous findings in this Chapter. Interestingly it was also 
observed that an IL-6 synergistic response was only induced when the two probiotics 
were used in combination and not as individual preparations. This would suggest that in 
vivo IL-6 induction would require exposure to both probiotics as was observed in the 
first in vivo study in Chapter 7. Several reports have indicated that the inhibition and 
neutralisation of pro-inflammatory cytokines such as TNF-a in poultry has led to 
increased levels of Salmonella infection and increased mortality. Furthermore the 
administration of IL-1 has also been shown increased resistance by the host to 
Salmonella Typhimurium; for a comprehensive review see (Eckmann & Kagnoff, 
2001). The role of IL-1 and TNF-a in reduced host pathogenicity and Salmonella 
clearance is important.
If a similar effect was elicited by the dual probiotic preparation in vivo it would 
be expected that exposure to the probiotic stimulus on its own would not necessarily 
induce an inflammatory response equivalent to that observed by Salmonella exposure. 
In Chapter 4 detrimental inflammatory responses in birds exposed to the probiotic were 
not observed. Furthermore it would be expected that if the birds were primed with the 
probiotic and then subsequently infected with Salmonella that the subsequent 
inflammatory response to Salmonella would be more aggressive than that seen in birds 
not treated with the probiotic; this is consistent with the reduction in Salmonella 
colonisation in Chapter 7. As was discussed above the acute phase response is required 
for the progression of Th-1 type inunune response which is required for the clearance of 
intracellular pathogens (Maassen et al, 2000). Previous reports by Mohamadzadeh et 
al, (2005) have also demonstrated the ability of L. gasseri, L. johnsonii and L. reuteri 
to induce the production of pro-inflammatory cytokines IL-12 and IL-18, moving 
macrophages responses towards a Th-1 response. They suggested that the production of 
pro-inflammatory cytokine could promote a ‘robust’ inflammatory response directed 
towards pathogens. In addition Babu et al, (2003) demonstrated that enhanced 
clearance of S. Enteritidis required induction of Th-1 cell-mediated immune response. 
Thus the induction of pro-inflammatory response by the probiotic preparations may 
direct the avian immune system to clear S. Enteritidis (S1400) infection. IL-6 is also 
known to play a role in the maturation of activated B cells to fully differentiated 
immunoglobulin producing plasma cells, thus IL-6 plays a role in humoral responses 
(Nishimichi et al, 2005).
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Only resident monocytes or macrophages exposed to the probiotic would be 
able to elicit an enhanced inflammatory response, thus the greatest increase in 
inflammation would be observed immediately after the initial exposure of the birds to 
Salmonella. Also as Salmonella infected macrophages often systemically disseminate, 
macrophages that had been primed would reduce in number at the site of infection and a 
subsequent reduction in probiotic effect would be observed after the initial inhibition. It 
has been previously reported that avian HD 11 macrophages could kill 80% of 
internalised S. Enteritidis PT4 that the remaining 20% persisted for at least 48hrs 
(Kramer, et al, 2003). Salmonella has been shown to cause the movement of CD18+ 
cells from the gut lumen to the spleen and liver through manipulation of macrophage 
dissemination using the expression of SrfH (Worley et al, 2006). In conjunction with 
the reduction of macrophages due to dissemination it was also observed in the seeder 
bird model in Chapter 7 that the greatest reduction in Salmonella numbers was often 
observed in birds that received the probiotic preparation at age twelve days and above; 
birds dosed at age one day did not produce such pronounced inhibition. Finally if the 
acute phase response was enhanced by probiotic stimulation the subsequent recruitment 
and maturation of leukocytes would enhance the humoral and cell mediated inunune 
response and would result in a prolonged reduction in Salmonella. In Chapter 7 it was 
noted that at 43 days of age, when the birds and their immune systems were fully 
mature, a reduction in Salmonella was also observed. Although the data shown in this 
Chapter does not definitively demonstrate that the probiotic mechanism of Salmonella 
inhibition is due to induction of the pro-inflanunatory immune response the results are 
consistent with the inhibition patterns observed in vivo in Chapters 4 and 7. Further 
research is required to demonstrate the putative link observed between the results in this 
Chapter and those observed in the in vivo studies observed in the previous Chapters.
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Chapter 9 -  General discussion
9.1 Summary
S. Enteritidis infection of commercial poultry flocks remains an economic and 
public health problem (discussed in Chapter 1). The use of antibiotic feed supplements 
for agricultural purposes within the EU has been banned and thus the development of 
alternative control strategies, such as the use of probiotics, has become a priority for the 
poultry farming industry. The corporate sponsors of this project have suggested that the 
two probiotic strains L. salivarius 59 and F. faecium PXN-33 are good candidates for 
Salmonella control in poultry on the basis of small scale preliminary in vivo studies. In 
order to determine the viability of the product for commercial use, the ability of L. 
salivarius 59 and E. faecium PXN-33 to inhibit S. Enteritidis S1400 was evaluated in 
vivo and in vitro. Additionally the probiotic bacteria’s antibiotic and microbiological 
safety were determined to standards required for use of the product within EU.
Previous reports have indicated that commercial probiotic bacteria are often 
misidentified due to poor quality control (Yeung et al, 2002; Coeuret et al, 2004). This 
is of particular concern with regard to the possible use of pathogenic bacteria as 
probiotic supplements. In Chapter 3 a selection of classical bacteriological methods 
were used to describe basic properties of the probiotic bacteria. It was possible to 
demonstrate that L. salivarius 59 and E. faecium PXN-33 exhibited the same properties 
as organisms belonging to the same species. L. salivarius 59 and E. faecium PXN-33 
were both identified to the species level using molecular techniques. They were also 
strain typed for quality control purposes and in order to track the organisms in vivo. 
Their growth kinetics were elucidated and the strains were shown to adhere to 
eukaryotic cell lines. L. salivarius 59 was shown to have tissue tropism to the ceaca and 
crop in studies using poultry-derived tissue. E. faecium PXN-33 was also shown to 
preferentially adhere to poultry caecal tissue. S. Enteritidis resides in caecal tissue and 
thus the ability of the probiotics to adhere to these tissues would suggest increased 
probiotic activity due to increased localised inhibition (Gast & Holt, 1998).
The ability of probiotic bacteria to withstand the harsh environment of the GI 
tract is important if they are to persist in the host. Increased persistence is generally 
thought to improve the activity of probiotic bacteria on the host (Klaenhammer & 
Kullen, 1999). In Chapter 4 L. salivarius 59 and E. faecium PXN-33 were evaluated for
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their ability to withstand pH and bile in vitro. Both organisms showed good tolerance to 
pH 2.5 in vitro suggesting that they would be able to survive transit through the gizzard. 
E. faecium PXN-33 was also tolerant to Oxgall bile at standard experimental 
concentrations. L. salivarius 59 was classed as Oxgall bile sensitive and would suggest 
the organism would not survive transit through the chick’s GI tract. It was noted that the 
composition of chick-derived bile is significantly different from that of Oxgall bile and 
that these results may not refiect the ability of the organism to survive transit through 
the bird’s GI tract (Cole & Fuller, 1984). Additionally persistence of L. salivarius 59 
was observed in vivo as determined by PFGE during the competitive exclusion studies 
in Chapter 7. This indicates that L. salivarius 59 is able to survive GI tract transit and 
colonise the host for at least six weeks.
In addition to strain typing the bacteria for quality control and tracking purposes 
it was necessary to establish the safety of the organisms for commercial use. In Chapter 
5 L. salivarius 59 and E. faecium PXN-33 were shown not to posses any of the common 
enterococcal virulence factors. Limited cytotoxicity was observed in vitro and this 
observed cytotoxicity was eliminated when mucus secreting cell lines were used (no 
pathology was observed). The presence of pathological damage to the chick GI tract 
was evaluated in vivo using a combined probiotic inoculation. No significant 
macroscopic or microscopic changes to the GI tract by the probiotic bacteria were 
observed. Additionally no significant reduction in bird weight gain was observed when 
treated with the probiotic preparation as compared to un-treated control chicks; it 
should be noted that a reduction trend was noted and that this should be investigated in 
more detail.
As no significant pathological damage to the host was observed in vivo the 
antibiotic safety of the probiotic bacteria was evaluated. As described in Chapter 5 L. 
salivarius 59 did not show any antibiotic resistance that would be considered unsafe. 
MIC levels for the antibiotics evaluated were below the recommended safety 
breakpoints except for vancomycin resistance. L. salivarius 59 resistance to 
vancomycin has previously been shown to be intrinsic and non transferable (Elisha & 
Courvalin, 1995). E. faecium PXN-33 did not exhibit antibiotic resistance above those 
recommended by SCAN except for rifampicin resistance. Although rifampicin is used 
clinically, all be it infrequently, antibiotic resistance is generated through chromosomal 
point mutations of the DNA-dependent RNA-polymerase gene therefore it is unlikely 
that the resistance presented by E. faecium PXN-33 is transferable (Enne et al., 2004).
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Nano-array analysis of E. faecium PXN-33 also detected aminoglycoside and macrolide 
resistance genes but from the literature these appear to be endemic non-transferable 
resistance genes (Costa et al, 1993; Wright & Ladak, 1997; Werner et al, 2000; Singh 
et al, 2001). In vitro analysis of antibiotic resistance for E. faecium PXN-33 and L. 
salivarius 59 did not indicate the presence of transferable antibiotic resistance genes. 
From a conunercial perspective this would suggest that the two probiotic organisms are 
safe for use in a commercial environment.
As the probiotic bacteria were considered safe for use in vivo their ability to 
inhibit S. Enteritidis was elucidated in vitro. Inhibition of S. Enteritidis adhesion to 
eukaryotic cell lines by both probiotic bacteria was not observed in vitro as described in 
Chapter 6. Both probiotic bacteria were able to inhibit S. Enteritidis growth in plate 
diffusion and CFCS assays. Plate diffusion assay results indicated that inhibition was 
dependent upon viable probiotic organisms as no inhibition was observed when CFCS 
were inoculated onto Salmonella lawns. Inhibition was observed with probiotic CFCS 
in broth culture assays. CFCS from E. faecium PXN-33 consistently inhibited S. 
Enteritidis more readily than CFCS from L. salivarius 59 in broth culture assays. E. 
faecium PXN-33 totally repressed S. Enteritidis growth when the CFCS was not 
neutralised. The inhibition appeared to be a combination of a pH dependent mechanism 
and a pH independent mechanism which may have been due to the production of 
inhibitory substances such as bacteriocins. In contrast L. salivarius 59 inhibition of S. 
Enteritidis could be negated by the neutralisation of the CFCS. This supports previous 
reports that have indicated that inhibition of Salmonella by L. salivarius spp. is 
predominately due to the production of lactic acid (Fuller, 1977; van Coillie et al,
2007).
As inhibition of S. Enteritidis was observed by the probiotic bacteria in vitro 
further in vivo analysis of these CE properties was thought prudent. In Chapter 7 the 
ability of the probiotic bacteria to inhibit S. Enteritidis was investigated utilising an in 
vivo an established SPF White Leghorn chick model. In addition to the control group, 
the probiotic bacteria were evaluated individually or in combination for their ability to 
inhibit S. Enteritidis. L. salivarius 59 was isolated from chicks at age six weeks when 
administered individually or in combination with E. faecium PXN-33 suggesting that 
the organism is able to persist in the host organism. In contrast E. faecium PXN-33 was 
not recovered from any of the birds treated with the probiotic as individual or combined 
inocula. The lack of persistence suggests that E. faecium PXN-33 is a transient
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organism unable to colonise the host. Despite this inability to colonise the host E. 
faecium PXN-33 was required, in combination with L. salivarius 59, for significant 
inhibition of S. Enteritidis. It was also observed that S. Enteritidis inhibition only 
occurred at the end of the study suggesting that inhibition of Salmonella is dependent 
on host maturation. Furthermore S. Enteritidis shedding was also reduced in the group 
treated with the combined probiotic preparation as compared to the control. The 
inhibition patterns observed in this first study paralleled chick immune maturation and 
thus it was suggest that the observed probiotic inhibition maybe due to immuno- 
modulation (Asheg et al, 2002).
As inhibition of S. Enteritidis was observed in a direct oral contact in vivo chick 
model using the combined probiotic inoculum further investigations (Chapter 7) were 
conducted to evaluate inhibition in a more natural seeder bird model. The combined 
probiotic inoculum was investigated as this was the preparation to show significant 
reduction of S. Enteritidis colonisation of chicks. Several dosing regimes were used in 
order to determine the effect of dosing the birds at different ages and with one or two 
doses. Dosing the birds twice only exhibited significantly greater inhibition of S. 
Enteritidis compared to the single dosage midway through the study. Although a dose 
dependent effect was observed the significance of this to Salmonella inhibition during 
the entirety of study remains uncertain. It was observed that greater inhibition of S. 
Enteritidis towards the end of the study occurred when birds were dosed with the 
probiotic later in the study. Additionally early dosing of the chicks resulted in greater 
inhibition at the early stages of the study. Therefore chicks dosed with the probiotic 
close to the post mortem point showed greater inhibition of S. Enteritidis. It was 
suggested that the chicks displayed a burst of inhibition after probiotic dosing and that 
this may be related to the lack of persistence of E. faecium PXN-33. It was further 
hypothesised that this burst of inhibition maybe due to a short burst of activity by the 
host inflammatory response.
Due to the dynamics of 5. Enteritidis inhibition observed in vivo it was 
suggested that the probiotic bacteria were modulating the immune response of the 
chicks by induction of the acute phase response. To investigate this hypothesis a series 
of in vitro experiments were conducted as described in Chapter 8. Previous reports have 
suggested an important role for acute phase response cytokines for the clearance of 
Salmonella infections (Eckmann & Kagnoff, 2001). It was observed that E. faecium 
PXN-33 induced pro-inflammatory cytokines at levels observed with S. Enteritidis in
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avian and murine derived macrophages. L. salivarius 59 also induced pro-inflammatory 
cytokines but the levels produced were less than those observed with E. faecium PXN- 
33. It was also noted that the patterns of cytokine induction were similar for avian and 
murine macrophages and thus the murine macrophage would be a suitable model for 
avian inununo-modulation. Synergistic cytokine assays were subsequently performed 
on murine macrophages in order to determine the ability of the probiotic bacteria to 
prime APC prior to Salmonella stimulation. As predicted stimulation with L. salivarius 
59, E. faecium PXN-33 and the combined inocula induced pro-inflammatory cytokines. 
Interestingly it was observed that priming macrophages with E. faecium PXN-33 
resulted in a synergistic response to Salmonella which was greater than would be 
observed with single inoculations added together. A similar effect was observed with 
IL-6 when macrophages were primed with the combined probiotic inocula. This would 
indicate that the E. faecium PXN-33 and the combined inocula are able to prime 
macrophages to produce pro-inflammatory cytokine in response to S. Enteritidis and 
that these responses are greater than would be seen with probiotic and Salmonella 
stimulation individually.
9.2 Future work
Although the main objectives of the project were met, further research is 
required to determine the full potential of the product commercially and also the 
mechanistic basis of Salmonella inhibition. Future research should ultimately focus on 
transferring the product from the proof of principle experiments presented in this thesis 
to a commercially viable product with proven efficacy on an industrial scale. 
Investigations into the mechanism of competitive exclusion would also yield further 
understanding of the basis of inhibition which would allow refinement of the product 
for maximal efficacy.
In Chapter 7 evidence was presented that suggested a role for host maturation in 
the probiotic inhibition of Salmonella. Further evidence in Chapter 8 suggested that the 
inhibition of S. Enteritidis could be due to immune modulation by the two probiotic 
bacteria. In order to determine if immune modulation is dependent upon host 
maturation is the mechanism by which probiotic pathogen inhibition occurs it would be 
useful to test this hypothesis in a SPF chick model.
The first stage of experimentation would focus upon age dependent 
administration of the probiotic preparation. This could be conducted in a direct oral
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contact model similar to the first experiment described in Chapter?. Birds could receive 
single doses at various developmental stages; as immature chicks, chicks with partially 
developed immune systems, birds with fully developed immune systems and birds with 
mature immune systems. This would determine the developmental stage at which 
chickens respond to probiotic administration.
The second stage would investigate the dose dependent effect of probiotic 
Salmonella inhibition. Although this was investigated in Chapter 7 it would be 
beneficial to the product’s development to examine a wider range of dosing regimes. 
Administration of products that affect the immune system, such as vaccines, can lead to 
immune tolerance. A sequentially increasing level of probiotic administration in chicks 
would identify such tolerance thresholds and also elucidate the optimal length of 
dosing.
By combining the results from age dependent and dose dependent 
administration experiments it would be possible to determine the optimal dosing regime 
for a proof of principle direct oral contact SPF model. This would allow for further 
investigations into the mechanistic basis of Salmonella inhibition by the probiotic. As 
was indicated in Chapter 8 the possible mechanism of probiotic inhibition might be due 
to the induction of an inflammatory response. This could be measured in vivo from the 
site of Salmonella infection i.e. the caecal tonsils and from the peripherally infected 
tissues such as the liver and spleen. Various techniques could be employed to measure 
these responses including the recently developed avian immune microarray. This has 
been used to measure host responses to Newcastle disease virus in chicken embryo cells 
and avian macrophage responses to Eimeria infection (Munir et ai, 2005; Dalloul et al, 
2007). These measurements would be made shortly after probiotic administration in 
order to capture a probiotic induced inflammatory burst as was indicated by Salmonella 
reduction patterns in the second in vivo study in Chapter 7. It would also be possible to 
measure acquired immunity using these techniques. It would be interesting to focus on 
the modulation of the host’s cell mediated immune responses as this has been shown to 
play an important role in the clearance of Salmonella species, as discussed in Chapter 1. 
Blood samples could be harvested throughout the study to measure IgG2a and IgGl 
which indicate cell mediated immune driven and humoral driven antibody production 
respectively (Maassen et al, 2000). Work conducted by Koenen and colleagues in 2004 
for example has shown increased IgG and IgM responses to TNP-KLH immunisation 
after the administration of Lactobacillus plantarum and Lactobacillus paracasei to
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layer and broiler chickens (Koenen et al, 2004). This supports the idea that probiotics 
enhance acquired immune responses to immunogens and, interestingly, indicates a role 
for probiotics as vaccine adjuvants. It would also be possible to measure the numbers of 
CD4+ and CD8+ T-helper cells at the Salmonella site of infection and also in 
peripherally infected tissue using flow-cytometry. Previous studies have successfully 
used flow-cytometry to measure peripheral blood cells populations in poultry including, 
heterophils, cytotoxic T-cells, T-helper cells and B-cells (Cheeseman et al, 2004). 
Several cytokines play an important role in the cell mediated immune responses to 
Salmonella infection including INF-y, IL-12 and IL-18 as discussed in Chapter 1. The 
levels of these cytokines could be measured using QRT-PCR to determine if they are 
increased by probiotic administration dose and may indicate the mechanism of action. 
Th-1 type chick immune responses have previously been determined by monitoring 
IFN-y production at the site of the gut mucosa using RT-PCR (Gobel et al, 2003). Th-2 
type immune responses could also be determined by measuring the levels of IL-4 and 
IL-10 production at the site of the gut mucosa (Avery et al, 2004; Maassen et al, 
2000). Other recent work of interest includes the work conducted by Cross et al, (2004) 
who looked at the cytokine response of murine monocyte/macrophage cell line J774A.1 
to Lactobacillus casei and Escherichia coli strain Nissle 1917. Lactobacillus casei was 
shown to induce raised IL-12 and TNF-a without the induction of raised IL-10 levels. 
This type of cytokine profile induces a predominantly Th-1 response (Cross et al, 
2004). Th-1 responses promote the action of cell mediated immunity such as natural 
killer (NK) cell activity with a reduction in the production of antibody to immunogens. 
This type of T-helper (Th) cell response would also indicate a possible mechanism for a 
reduction in hyper-immune reactions. This recent research indicates that different 
probiotics of the same genus can induce significantly different cytokine responses and 
thus have the potential to produce specific probiotic effects through different immune 
responses.
If probiotic inhibition of Salmonella is due to immune-modulation it may also 
be possible to determine the effect of this on the host’s natural flora. In Chapter 7, when 
L. salivarius 59 and E. faecium PXN-33 were administered to chicks in combination, a 
stabilisation of enterococcal PFGE profiles was observed. Host immune-modulation 
may beneficially affect the natural flora of the chick which in turn could result in 
increased Salmonella inhibition. The enriched host micro-flora may lead to the 
production of inhibitory metabolites, improve gut integrity and could also feed back in
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to the chick’s immune system further improving and maturing its immune defence 
against Salmonella colonisation. The intestinal micro-flora changes could be monitored 
using various methods including Terminal Restriction Fragment Length Polymorphisms 
(T-RFLP) which relies on unconserved regions of 16S libosomal ribonucleic acid 
(rRNA) being amplified by the use of conserved regions as primer binding sites 
(Sakamoto et al, 2003). These fragments are tagged using fluorescence markers and 
restricted to produce T-RFLP fragments which are then analysed using sequencer 
machines (Sakamoto et al, 2003). The method has been used to track known and 
unknown bacterial species in human faecal, vaginal and saliva samples, and jejunal and 
cecal samples from broiler chickens (Sakamoto et ah, 2003; Sakamoto et al, 2003; Lan 
et al, 2004; Zhou et al, 2004). In this way Lan and colleagues were able to elucidate 
the enrichment of the resident microbiota by Lactobacillus agilis and Lactobacillus 
salivarius subsp. salicinius under heat stress conditions (Lan et al, 2004). They were 
also able to show that the natural flora of the jejunum was more stable than the bacterial 
communities of the caecum (Lan et al, 2004). Additionally the group was also able to 
show a predominance of Clostridium sub-clusters and how the natural flora of the 
caecal area of avian intestine changes with the age of the broiler chickens (Lan et al, 
2004).
The final and probably most important area of future research and development 
would be the transfer of the proof of principle inhibition seen in Chapter 7 to a 
commercial trial. A partial attempt at natural Salmonella infection of chicks was 
conducted in Chapter 7 but this could be vastly improved. Firstly SPF White Leghorn 
chicks were used as these birds were pathogen free. In order to replicate an industrial 
setting it would be better to use commercial birds such as broilers since broilers and 
SPF White Leghorns have been shown to differ in the development of their immune 
system. Previous reports by Cheeseman et al, (2004) suggested that broilers had 
significantly less CD3+ cells in their peripheral blood compared to Leghorn birds which 
may suggest a difference in immune responses to probiotic stimulation.
It would be impractical to dose commercial birds by oral gavage. In the poultry 
industry probiotic administration is often via feed or water supplementation. Using the 
findings from optimising the dosing regime it would be possible to design the optimal 
age and time of the probiotic within the chicks feed. It would also be interesting to 
compare continuous feeding regimes with those designed from the experiments 
mentioned above. Using a Salmonella seeder bird model in commercial broilers and the
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probiotic as a feed or water supplement on a small scale would allow the demonstration 
of the products efficacy in a commercial environment. By determining the mechanistic 
basis of probiotic inhibition and applying these findings to the commercial development 
of this product it would be possible to expand understanding in the field of probiotic 
competitive exclusion and would also result in the development of a commercially 
viable and robust product.
9.3 Conclusions
The overall aim of this thesis was to determine the efficacy of L. salivarius 59 
and E. faecium PXN-33 to inhibit S. Enteritidis in poultry. From the experiments 
described in the previous Chapters several conclusions can be made:
• The taxonomic identity of L. salivarius 59 and E. faecium PXN-33 were 
confirmed. Both bacteria could be reproducibly strain typed for quality control 
purposes, meeting EU regulations for use as commercial feed additives.
• No toxicity or virulence factors were observed for L. salivarius 59 and E. 
faecium PXN-33 in vitro. No cytotoxicity or significant growth inhibition was 
observed when they were used as feed additives in poultry.
• L. salivarius 59 did not carry any antibiotic resistance genes or display antibiotic 
MIC levels that would indicate the carriage of clinically relevant resistance 
genes. E. faecium PXN-33 did not present any resistance genes that were not 
common among the E. faecium species although resistance to rifampicin was 
above the levels recommended by SCAN.
• In vitro both probiotic bacteria inhibited growth of S. Enteritidis in plate 
diffusion and CFCS assays. Inhibition of S. Enteritidis by L. salivarius 59 was 
entirely pH dependent while by E. faecium PXN-33 occurred by pH dependent 
and pH independent mechanisms.
• Inhibition of S. Enteritidis colonisation of poultry only occurred when the 
probiotic bacteria were used in combination and inhibition was dependent upon 
host maturation. Inhibition of S. Enteritidis in six week old birds was improved 
when birds were dosed later in the study with the two probiotic bacteria.
• In vitro E. faecium PXN-33 primed macrophages to produce pro-inflammatory 
cytokines in response to S. Enteritidis infection. The response produced by 
macrophages was greater than single inoculations of S. Enteritidis and E.
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faecium PXN-33 individually. When both probiotic bacteria were used to prime 
macrophages greater production of IL-6 was observed when macrophages were 
subsequently infected with S. Enteritidis.
It was therefore demonstrated that L. salivarius 59 and E. faecium PXN-33 were 
safe to use as probiotic supplements and that, used in combination, they could inhibit S. 
Enteritidis colonisation of poultry prior to commercial slaughter age. An immune based 
mechanism for S. Enteritidis inhibition by the probiotic bacteria was suggested by in 
vitro studies with avian and murine derived macrophages. Although the aims of this 
project were fulfilled further experimentation would improve confidence in the 
probiotic’s safety and efficacy and determine the mechanism of its action.
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Appendices
Appendix 1 Medium
Agarose gels-1% agarose gels were prepared by the addition of IxTAE (40mM Tris- 
Acetate, ImM EDTA) to Ig of agarose powder (Promega) to a final volume of 1 litre. 
Gels were cast in Perspex trays using the appropriately sized combs (BioRad) to form 
wells. Combs were removed from casting rig before the gels were submerged in IxTAE 
in a DNA Sub-cell™ electrophoresis tank (BioRad).
Brain heart infusion broth- was prepared as follows 1.25% (w/v) calf brain infusion 
solids, 0.5% (w/v) beef heart infusion solids, l%(w/v) protease peptone, 0.5%(w/v) 
sodium chloride, 0.2%(w/v) glucose, 0.20%(w/v) di-sodium phosphate in sterile 
distilled water at pH 7.4
DNA marker-lkb+ ladder (Gibco-BRL) was prepared from stock by addition of 
Orange G loading buffer and 350pl water and to 50pl ladder.
Ethidium bromide-staining of gels- gels were immersed in a IxTAE bath containing 
ethidium bromide (0.5pg/ml)(Sigma) before the DNA was visualised under UV light. 
Heart infusion broth- was prepared as follows 0.5% (w/v) beef heart infusion solids, 
l%(w/v) protease peptone, 0.5%(w/v) NaCl, 0.2%(w/v) glucose, 0.25%(w/v) di-sodium 
phosphate in sterile distilled water at pH 7.4
de Man , Rogosa , Sharpe broth/agar (MRS)- consisted of peptone lO.Og, 'Lab- 
Lemco’ powder 8.0g, yeast extract 8.0g, glucose 20g, sorbitan mono-oleate 1ml, 
dipotassium hydrogen phosphate 2.0g, sodium acetate 3 H2O 5.0g, triammonium citrate 
2.0g, magnesium sulphate 7 H2O 0.2g and manganese sulphate 4 H2O 0.05g. The 
medium was adjusted to pH 6.2 ± 0.2 and then 52g of the powder was added to 1 litre of 
sterile distilled water. MRS was sterilised by autoclaving for 15mins at 15psi pressure 
(121°C) and stored at 4°C until required. For agar, lO.Og of agar was added, brought to 
the boil to dissolve the agar completely and poured into sterile Petri dishes in 20ml 
volumes and then stored at 4°C.
Motility medium- this medium was prepared with LB-G or MRS broth with the 
addition of 0.35% agarose.
Iso-Sensitest agar (2x)-was prepared with 22g hydrolysed casein, 6g peptones, 2g 
glucose, 6g NaCl, 2g soluble starch, 4g di-sodium hydrogen phosphate, 2g sodium 
acetate, 0.4g magnesium glycerophosphate, 0.2g calcium gluconate, 0.002g colbaltous 
phosphate, 0.002g cupric sulphate, 0.002g zinc sulphate, o.oo2g ferrous sulphate.
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0.004g manganous chloride, 0.002g menadione, 0.002g cyanocobalamin, 0.04g L- 
cysteine hydrochloride, 0.04 L-tryptophan, 0.006g pyridoxine, 0.006 pantothenate, 
0.0006 nicotinamide, 0.0006g biotin, 0.00008g thiamine, 0.02g adenine, 0.02g guanine, 
0.02g xanthine, 0.01g uracil and 16g agar made up to a final volume of 1 litre with 
sterile H^O and pH 7.4. 2x Iso-Sensitest agar was sterilised by autoclaving for 15mins 
at 15psi pressure (121°C) and stored at 4°C until required.
Kreb’s Ringers solution- 0.75% (w/v) sodium chloride, 0.0308% (w/v) calcium 
chloride, 0.0318% (w/v) magnesium sulphate, 0.0383% (w/v) potassium chloride and 
5% (v/v) IM Tris-HCL (pH 7.5). The solution was sterilised by autoclaving. 
Luria-Bertani broth/agar (LB)-was prepared as follows; NaCl 10 g, tryptone 10 g, 
yeast extract 5.0 g were added to 1 litre of sterile distilled water at pH 7.5. Sterilisation 
was by autoclaving for 15mins at 15psi pressure (121°C). For agar, lO.Og of agar was 
added, brought to the boil to dissolve the agar completely and poured into sterile Petri 
dishes in 20ml volumes and then stored at 4°C.
Loading buffer-0.25% bromophenol blue and 30% glycerol in water was added to 
DNA in a ratio of 1:5 with the sample before being added to the gel.
Luria agar and broth- LG-G (without addition of glucose), consisted of l%(w/v) 
tryptone, 0.5%(w/v) yeast extract, 0.5%(w/v) NaCl. Agar was prepared by the addition 
of 1.5% agar. The broth and agar was sterilised by autoclaving and then stored at 5°C 
until required.
Peptone water- 1.0% (w/v) peptone and 0.5% (w/v) sodium chloride in water. The 
solution was sterilised by autoclaving.
PFGE agarose gel- 0.8% SeaKem Gold (w/v) and 0.5% THE extended range buffer 
made to 800ml in sterile distilled water.
PFGE lysis buffer- 50mM EDTA at pH 8.2 (v/v), 0.05% N-lauroysarcosine (v/v), 
2mg/ml lysosyme and 3U/ml mutanolysin (w/v) made up to 50ml in sterile distilled 
water.
PFGE lysis solution- lOmM Tris (w/v), 0.5M EDTA at pH 8.5 (v/v), 1% SDS (v/v) 
and 2mg/ml of Proteinase K made up to 50ml in sterile distilled water.
Phosphate buffered saline (PBS)-two solutions were prepared. Solution A was 
prepared with 5.93g Na2HP0, 4.25g NaCl and made up to 1 litre with sterile distilled 
water. Solution B was prepared with 4.53g KH2PO and 4.25g NaCl and made up to 
1 litre with sterile distilled water. Solution A was mixed with solution B until the
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required pH was obtained. Sterilisation was by autoclaving for 15mins at 15psi pressure
(12rC).
Ringers solution- 0.048% (w/v) calcium chloride, 0.042% (w/v) potassium chloride, 
0.02% (w/v) sodium hydrogen carbonate and 0.9% (w/v) sodium chloride in water. The 
solution was then sterilised by autoclaving. Subsequently the pH was adjusted to 7.0 
with sterile IM sodium hydroxide solution.
RNA agarose gel- 1.0% (w/v) Gibco BRL ultra pure agarose electrophoresis grade 
made in IX MESA (MOPS-EDTA-sodium acetate buffer) ran in IX MESA solution. 
RNA loading buffer- 62.5% deionised formamide (v/v), 1.14M MOPS-EDTA-sodium 
acetate buffer (w/v), 200pg/ml bromphenol blue, 200fig/ml xylene cyanole and 
50pg/ml ethidium bromide.
RNA marker- 0.2-10 kb (Sigma) was prepared from stock by addition of lOOpl IX 
TBE electrophoresis buffer (89mM Tris Borate at pH 8.3 and 2mM EDTA) and 300pl 
of DNase free water and to lOOpl ladder.
RNA zap- 10.0% (w/v) lOM NaOH and 0.1% SDS made up to a volume of 500mls 
with sterile distilled water.
SE buffer- 75mM NaCl (w/v) and 25mM EDTA (w/v) made up to a volume of 500mls 
with sterile distilled water and adjusted to pH 7.2 with sterile IM sodium hydroxide 
solution.
Sheep’s Blood agar (5%)-was prepared with 15g agar, 15g pancreatic digest of casein, 
5g papaic digest of soybean meal, 5g NaCl and made up to a volume of 950mls with 
sterile distilled water, mixed thoroughly and gently heated until boiling, then sterilised 
by autoclaving for 15mins at 15psi pressure (121°C). The agar was cooled to 45°C-50°C 
and then 50ml of sterile sheep blood was aseptically added, mixed thoroughly and 
poured into sterile Petri dishes in 20ml volumes and then stored at 4°C.
Slanetz and Bartley agar-consisted of tryptose 20.0g, yeast extract 5.0g, glucose 2.0g, 
di-potassium hydrogen phosphate 4.0g, sodium azide 0.4g, tétrazolium chloride 0.1 g 
and agar lO.Og. 42g of the prepared medium was added to 1 litre of distilled water, 
brought to the boil to dissolve the agar completely and poured into sterile Petri dishes in 
20ml volumes and then stored at 4°C.
TAE buffer- 50x stock was prepared with 242g Tri base, 57.1ml glacial acetic acid, 
100ml 0.5M EDTA (pH 8.0) made up to 1 litre. A working solution was prepared by 
diluting the stock solution 1 in 50 to give a working concentration of 0.04M Tris- 
acetate and 0.00IM EDTA.
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TE buffer-Tris was prepared with 121.1g Tris base dissolved in 800ml sterile distilled 
water and adjusted to the required pH by the addition of HCL. EDTA was prepared 
with 372.2g of d-sodium ethylene diamine tetra-acetate made up to 1 litre with sterile 
distilled water and adjusted to pH 8.0 with NaOH. TE buffer was prepared by adding 
lOmM Tris and ImM EDTA and stored at ambient temperature until required.
Tissue culture medium-was prepared with Modified Eagles Media (Sigma), Dulbeccos 
Media (Sigma) or RPMI (Gibco-BRL) with the addition of 2mM L-glutamine (Sigma), 
10%(v/v) foetal calf serum, l%(v/v) non-essential amino acids (xlOO) and 50pg/ml 
gentamycin for culture of cells and lOOpg/ml for tissue culture assays.
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Appendix 2 Chick feeds
Chick crumbs (Dodson & Horrell): Information provided by the manufacture in accordance with 
Feeding stuffs (Zootechnical Products) Regulations 1998 SI No. 1047 (Chapters 5, 7 and 8)
Component Feed content
Oil 3.5% (w/w)
Protein 19.00% (w/w)
Fibre 4.00% (w/w)
Ash 6.50% (w/w)
Methionine 0.40% (w/w)
Vitamin A 12000 iu/kg
Vitamin D 5000 iu/kg
Vitamin E (as Alpha Tocopheral) 80 iu/kg
Selentine (as Sodium Selenite) 0.4 mg/kg
Copper (as Cupric Sulphate) 25 mg/kg
Raw Materials: Hi-Pro soya (non-GM), Wheatfeed, Confectionary products, Ext sunflower. Beans, 
Fishmeal, Calcium Carbonate, Vegatable fat. Vitamins/minerals premix. Di-calcium phosphate. Salt, 
Methaionine, Acid, Sodium Bicarbonate, Lysine, Phytase and Edo-Xylanase._______________________
Chick pellets (Dodson & Horrell): Information provided by the manufacture in accordance with 
Feedingstuffs (Zootechnical Products) Regulations 1998 SI No. 1047 (Chapters 5, 7 and 8)
Component Feed content
Oil 3.60% (w/w)
Protein 16.00% (w/w)
Fibre 3.30% (w/w)
Ash 12.00% (w/w)
Methionine 0.34% (w/w)
Vitamin A 7500 iu/kg
Vitamin D 3000 iu/kg
Vitamin E 10 iu/kg
Copper (as Cupric Sulphate) 25 mg/kg
Raw Materials: Wheat, Wheatfeed, Full fat soya, Limestone, Hi-pro soya (non-GM), Barley, Maize, 
Beans, Grass, Di-calcium phosphate and Salt.__________________________________________________
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